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Microbial symbionts of insects have been demonstrated to play an important role in the 
nutrition and protection of the host; these include aphids and tsetse.  Studies often use 
antibiotics to eliminate the symbionts but the deleterious impact of using these 
antibiotics is not commonly addressed.  The impact of chlortetracycline treatment on 
Aedes aegypti and Drosophila melanogaster was investigated by assessing life-span, 
fecundity, development time, survival, nutrition and metabolism.  The impact on 
microbial numbers and diversity was also determined. 
With Drosophila, treatment with 50 µg ml-1 and above showed a significant extension in 
development time and life-span, reduction in fecundity and change in nutritional content. 
Microbial numbers were significantly reduced at 50 µg ml-1 and above. Culturable 
techniques and 454 pyrosequencing, demonstrated that the microbial diversity of 
Drosophila was predominantly Acetobacter. Bacterial elimination through egg 
dechorionation yielded some similar results to chlortetracycline treatment.  However, 
fecundity and life-span was not significantly affected.  Microarray analysis established a 
significant reduction in the abundance of transcripts associated with immunity, 
particularly antimicrobial peptides. 
With Aedes aegypti, treatment significantly reduced the survival and also affected the 
life-span and nutrition of the insect.  Microbial numbers of mosquito larvae were reduced 
at 30 and 100 µg ml-1. Colonies grew on plates supplemented with 50 µg ml-1 of 
chlortetracycline, indicating that the larvae bore chlortetracycline-resistant bacteria.  454 
pyrosequencing demonstrated a change in diversity of bacteria found in mosquitoes +/- 
chlortetracycline, switching from Elizabethkingia meningoseptica to Raoultella sp with 
chlortetracycline. 
It is concluded that chlortetracycline significantly impacts the performance of the 2 
insects through bacterial depletion, changes to bacterial diversity and toxicity. 
Nevertheless, different responses were observed with Aedes aegypti and Drosophila 
melanogaster. Moreover, experiments with Drosophila using egg dechorionation, 
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Chapter 1: Introduction 
The role of commensal and mutualistic bacteria have recently become appreciated within 
the scientific community with growing interest in the role of bacteria in humans, with 
models such as mice and Drosophila melanogaster being used (Moran, 2006).  This 
interest has also become widespread within the insect community with research on ants, 
aphids and disease vectors such as Anopheles gambiae (Moran, 2006; Dong et al., 2009).  
Why has there been an increase in interest in bacteria found within these organisms?   In 
this chapter I will outline why the relationship between bacteria and the host are 
important to the host performance in vertebrates but mainly in insect hosts. 
1.1 Commensal bacteria in vertebrate hosts 
The main interest in commensal bacteria in humans is to determine their role in human 
health and disease.  The two groups of bacteria that are dominant in the human gut are 
the Bacteroidetes and Firmicutes (Turnbaugh et al., 2006) and the estimated number of 
bacterial cells within the host outnumbers the cells of the host (Savage,  1977).   
The major question is how do bacteria play a role in protecting the host against immune 
disorders and pathogens?  Several experiments have suggested that the bacteria protect 
the host from allergies and from these results the Hygiene Hypothesis was made.  Where 
it was hypothesised that the presence of bacteria during childhood could educate the 
immune system and prevent the development of an over-active immune system which 
could lead to illnesses such as asthma and hay fever (Lui and Murphy, 2003).  It has also 
been suggested that in children, the exposure to bacterial endotoxins could reduce the 
chance of developing asthma (Lui and Murphy, 2003; Lui, 2002).  Further experiments 
with bacteria have also highlighted the role bacteria can play in the prevention of 







Table: 1.1. Bacteria found to promote health and protection against intestinal diseases. 
Bacteria Name Role in disease 
protection 












integrity and protects 
against enterocolitis 
Reduces inflammation, regulates 
the main components of the 
mucous layer and improves 
intestinal integrity. 





epithelial cell barrier 
function 
Peptide bioactive factors from this 
bacterium retains biological 
function, normalizes gut 
permeability and improves the 
disease colitis.  Changes in MAPK 
and tight junction proteins.  







Increase TGFβ, IL-10 and decrease 
in TNF-α, IL-6 and IL-12. 
S-layer Protein A of L.plantarum 
NCFM regulates immature 
dendritic cells and T Cell function. 
Mice, 
human 
Chen et al., 
2005 
Konstantino





cells) and recovered 
colon length (in mice 
with colitis) 
IL-8 secretion in Caco-2 cells. In 
mice, increased Zolula occludens-1 












Increased NGF levels, inhibits NF-
Κb translocation to the nucleus. 
Human 
cells 







Decrease in TNFα, colonic 
myeloperoxidase activity, 
cyclooxygenase 2 expression and 
an induction of NO (Nitric oxide) 
synthase and increase in SCFA 
(Short-chain fatty acids). 




Increase in survival 
and decrease in 
disease severity of 
colitis in mice 
Decrease in chemokine ligand, 
Intercellular adhesion molecule 
and TNFα.  An increase of IL-10 and 
suppression of apoptosis and 
promoted cell proliferation by PI3K 
and Akt pathway. 




Inhibits E.coli isolated 




Inhibits the interaction of 
adherent-invasive E.coli with 










transit with decrease 
in IBS symptoms 








Activity of polysaccharide A (PSA). Mice Mazmanian 





A decrease in this 
bacterium led to a 
higher risk of post-
operative 
reoccurrence of ileal 
Crohn’s disease.  
Decrease in IL-12, IFN-γ and IL-10.  






Sokol et al., 
2008 
 
Symbiotic bacteria have been suggested to play an important role in preventing 
pathogens establishing within the host by competing with bacteria that can cause disease 
(Guarner and Malagelada, 2003) (Table: 1.1).   The species, Bacteroides fragilis has been 
shown by Mazmanian et al (2008) to protect animals from colitis induced by Helicobacter 
hepaticus (an opportunistic pathogen) through the expression of Polysaccharide A (PSA).  
Furthermore, a recent paper in 2011 demonstrated that Bifidobacteria protect the human 
gut against the shiga toxin (produced by Escherichia coli) by the production of acetic acid, 
which has been suggested to improve intestinal defence (Fukuda et al., 2011).  Gut 
bacteria have been shown to aid digestion by degrading nutrients such as fibre (Hooper, 
2009; Savage, 1986). One example is the bacterium Bacteroides thetaiotaomicron, this 
bacterium has a large number of genes associated with polysaccharide utilisation 
compared with other micro-organisms found within the human gut, suggesting that this 
bacterium aids plant carbohydrate digestion (Hooper et al., 2009; Xu et al., 2003).  Gut 
symbionts are well adapted at utilising the nutrients within the gut, however, pathogenic 
bacteria tend not to be as efficient as symbiotic bacteria and therefore invade host tissue 
to obtain nutrients (Hooper et al., 2009; Stecher et al., 2005; Stecher et al., 2007).  
The balance between the two dominant groups of bacteria in the human gut, play a key 
role in disease (Ley et al., 2005).  In the Western World obesity is fast becoming an 
epidemic in areas including North America and the United Kingdom (Seidell, 2000).  
Research into the cause and differences between obese and lean individuals using mice as 
the model organism have demonstrated the role of gut bacteria in obesity (Turnbaugh et 
al., 2006).  A study using obese mice showed that the population of Bacteroidetes was 
reduced and the Firmicutes was increased (Ley et al., 2005).  Firmicutes have the ability to 
breakdown complex polysaccharides intractable to human digestive enzymes and make 
this available as an energy source for the host (Ley et al., 2005).  If there are excessive 
amounts of this group of bacteria, more energy is made available which could potentially 
be stored as fat.  Furthermore, in one particular study Firmicutes were transferred to lean 
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mice and a weight gain was observed (Ley et al., 2005, Turnbaugh et al., 2006).  This 
research does suggest that the gut bacteria play a role in obesity but this may not be the 
major cause of obesity.  Obese individuals may have a different gut microbiota due to the 
diet consumed such as a high fat diet and/or may have a higher population of Firmicutes 
to deal with the influx of such large amounts of certain nutrients (Ley et al., 2005).  What 
this study shows is the importance of gut bacteria, therefore what effects would happen 
if they were eliminated?  One obvious effect would be the loss in ability to gain calories 
from indigestible food, this may be detrimental to individuals experiencing famine but not 
necessarily those that have food aplenty. Furthermore, the balance of the bacterial 
populations of Firmicutes and Bacteroidetes is not only involved in obesity but has been 
shown to be involved in the autoimmune condition Crohn’s disease (Sokol et al., 2008). A 
decrease in the population of Firmicutes has been shown to be associated with 
individuals who have Crohn’s disease (Sokol et al., 2008). 
1.2 Role of bacterial symbionts in insects 
1.2.1 Role of bacteria in insect nutrition and insect performance 
Many publications have concentrated on the importance of the microbes of insects on 
the impact of immunity and protection, but how do these bacteria promote insect 
performance and nutrition?  In this section I will discuss several examples of experiments 
which have shown the importance of bacteria in the performance of a wide range of 
insects. 
Two of the most famous examples of symbiosis are the aphid-Buchnera aphidicola and 
the tsetse-Wigglesworthia glossinidia interactions.  Aphids contain the obligate symbiont 
Buchnera aphidicola which is found within specialised cells in the aphid known as 
bacteriocytes (Buchner, 1965).  If this particular symbiont is eliminated from the aphid, 
the aphids have a reduction in fecundity and are significantly smaller in size (Houk and 
Griffiths, 1980; Mittler, 1971; Sasaki et al., 1991).  Dietary experiments have shown that 
the Buchnera provide the aphid host with essential amino acids (Douglas, 1998; Sasaki et 
al., 1991).  In tsetse flies, the elimination of the Wigglesworthia glossinidia through the 
treatment with antibiotics affected the performance of the tsetse fly by reducing the 
fecundity (Nogge, 1976.)  This deleterious impact on the fecundity could be reversed by 
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supplementing the diet with Vitamin B, suggesting that this symbiont provides the insect 
host with this vitamin (Nogge and Gerresheim, 1982).   Studies of the genome of the 
insect host and bacteria also demonstrate that the symbiont provides the host with 
essential nutrients (Akman et al., 2002; Snyder et al., 2010).  
 
Several papers have been published regarding the role of the gut microbiota in the locust, 
Schistocerca gregaria.  One publication by Charnley et al (1985) did demonstrate that 
although the elimination of bacteria in the locust does not have a major impact on the 
nutrition of the insect, bacteria-free insects did have a higher lipid and lower 
carbohydrate concentration in the hemolymph compared with control insects.  
 
In Western Flower Thrips, the bacterium Erwinia is obtained through feeding.  The 
production of aposymbiotic insects had a different performance compared with control 
insects (De Vries et al., 2004).  In control insects, the time to maturity was significantly 
shorter and had higher oviposition rates compared with aposymbiotic insects (De Vries et 
al., 2004).  An elimination of the gut microbiota of Tenebrio molitor also led to an impact 
on the performance of the insect where bacteria-free larvae experienced a reduction in 
mass and premature pupation of more than half of the larvae (Genta et al., 2006).  
Furthermore, a diet effect was also observed; a combined effect of the presence of 
antibiotic (ampicillin) and saligenin (the aglycone of the plant glucoside salicin) led to 
even greater reduction in larval mass, premature pupation and even mortality (Genta et 
al., 2006).  This combination effect of the antibiotic and saligenin does suggest that the 
gut microbes aid the digestion of secondary plant productions within this host-symbiosis 
system (Genta et al., 2006).    
 
In termites (Reticulitermes flavipes), synthesis of uric acid occurs via purine-nucleoside 
phosphorylase and xanthine dehydrogenase (Potrikus and Breznak, 1981).   However, 
these insects lack uricase, the uric acid degrading enzyme (Potrikus and Breznak, 1981).  
Symbiotic bacteria have been shown to recycle the uric acid nitrogen which has been 
suggested to be important in nitrogen conservation in oligonitrotrophic insects which 
feed on food with a limited amount of nitrogen (Potrikus and Breznak, 1981).  As 
demonstrated with vertebrates, acetate production by symbiotic bacteria also played a 
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role in termite guts but by providing an oxidizable energy source (Breznak and Switzer, 
1986).  
1.2.2 Bacterial symbionts and insect immunity and protection 
The major benefit of the presence of microbes in humans is the protection against 
pathogens and the education of the immune system (Section: 1.1).  Here I will describe 
how this has also been observed in insects and the changes that occur when the microbes 
are removed. 
In aphids, facultative bacterial symbionts have been demonstrated to protect their host 
from the development of the parasitoid, Aphidius ervi (Oliver et al., 2003).  It was initially 
thought that the facultative symbionts conferred resistance to the parasitoid ovipositing 
in the aphid; however experiments showed that the symbionts caused high mortality of 
the parasitoid larvae (Oliver et al., 2003).  This result also suggests that the facultative 
symbionts protect the host from mortality to ensure the spread and persistence of the 
symbiont within populations (Oliver et al., 2003).   
The European Beewolf hunting wasps have a symbiotic relationship with the bacterium 
Streptomyces (Kaltenpoth et al., 2005).  This bacterium has been shown in experiments 
conducted by Kaltenpoth et al (2005) to enhance larval survival and protect the cocoons 
from fungal infections. 
One of the most famous endosymbiont is the Wolbachia species of bacteria which infects 
20% of insects (Klasson et al., 2009; Welchman et al., 2009).  This bacterium is famous for 
being a parasitic organism that manipulates the reproduction of the insect host to 
promote transmission (Welchman et al., 2009).  Wolbachia infections in Drosophila are 
maternally transmitted (mother to offspring) (Werren, 1997; Hoffman et al., 1990).   
Infected females that mate with uninfected males produce offspring; however, 
uninfected females that mate with infected males produce non-viable eggs (O’Neil and 
Karr, 1990; Yen and Barr, 1971; Werren, 1997; Hoffman et al., 1986).  This process is 
known as cytoplasmic incompatability and drives the infection quickly through the insect 
population (O’Neil and Karr, 1990; Yen and Barr, 1971; Werren, 1997; Hoffman et al., 
1986; Turelli and Hoffman, 1991).   Interestingly, this bacterium has been shown to 
protect Drosophila from RNA viruses (Drosophila C virus, Cricket paralysis virus, Nora virus 
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and Flock house virus), with Wolbachia infected flies having greater survival when 
infected with RNA viruses compared with flies without Wolbachia (Hedges et al., 2008; 
Teixiera., 2008).   
In Aedes aegypti substantial progress has been made to infect the mosquito with 
Wolbachia, a bacterium not found naturally in Aedes aegypti.  Aedes aegypti mosquitoes 
have been infected experimentally with Wolbachia, resulting in infected mosquitoes 
having a shorter life-span when compared with uninfected individuals (McMeniman et al., 
2009).  This introduction of the virulent form of Wolbachia into the mosquito population 
could prove successful as cytoplasmic incompatability will ensure spread within the 
population and the life-span shortening will prevent the maturation of the dengue virus in 
the mosquito vector, preventing spread to humans (McMeniman et al., 2009).  
Furthermore, Wolbachia infection has the potential to inhibit replication of the dengue 
virus through the stimulation of the immune system of the insect (Bian et al., 2010). 
Not only have introduced bacteria proven to provide a strategy for controlling pathogen 
transmission but the endogenous gut microbes within Aedes aegypti has been proven to 
have effects on the dengue virus (Xi et al., 2008).  Experiments using aseptic and control 
mosquitoes demonstrated two-times greater viral titre in aseptic mosquitoes in 
comparison with control mosquitoes (Xi et al., 2008).  The process of reducing the viral 
titre was via the stimulation of the insect immune system rather than a direct effect on 
the virus (Xi et al., 2008). 
In the malaria vector Anopheles, studies have also emphasized the role of gut bacteria 
with pathogen transmission.  Dong et al (2009) revealed that the gut microbes had an 
anti-plasmodium effect by stimulating the insect immune system and that the removal of 
the bacteria resulted in an increase in parasite numbers within the insect.  Specifically, 
gram negative bacteria inhibit the sporogonic-stage of the development of Plasmodium 
falciparum and reduce oocyst densities (Pumpuni et al., 1993; Pumpuni et al., 1996; 





1.3 Impact of tetracycline on microbes in insects  
Antibiotics are commonly used to eliminate endosymbionts and symbionts found in 
insects to determine the impact of these bacteria on the insect host (Table: 1.2).  
However, many have not considered the deleterious effects of using such antibiotics on 
the insect performance, therefore creating a result which is the impact of the antibiotic 
and not the result of the depletion of bacteria. 
One antibiotic which has commonly been used to eliminate the symbionts is tetracycline 
with varying concentrations and in a wide range of insects (Table: 1.2).  Tetracycline 
(Figure: 1.1) kills bacteria by inhibiting protein synthesis (Chopra and Roberts, 2001; Speer 
et al., 1992; Goldman et al., 1983).  Specifically, it prevents the attachment of aminoacyl-
tRNA to the ribosomal acceptor site (Chopra and Roberts, 2001).  This antibiotic targets 
both Gram-positive and Gram-negative bacteria (Chopra and Roberts, 2001).  
Mitochondrial ribosomes are very similar to those found in bacteria (Alberts et al., 2002, 
p769-828). Therefore, at high dosage tetracycline may target the mitochondrial 
ribosomes found in animal cells.  
  
    Chlortetracycline                        Tetracycline 
Figure: 1.1.  Structure of chlortetracycline and tetracycline.  The difference between the 
2 molecules is the extra Cl group found on chlortetracycline.  Image taken from Chopra 
and Roberts (2002). 
This antibiotic is commonly used to eliminate the bacterium, Wolbachia from several 
insects including Aedes albopictus, Drosophila melanogaster and Drosophila simulans and 
is commonly used as a repressor molecule for expression systems used in insects as a 
method of controlling the insect population (Table: 1.2).  Furthermore, only a small 
number of papers have identified the impacts of tetracycline on the insect performance.  
Thompson and Sikorowski (1984) investigated the effects of tetracycline hydrochloride on 
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the performance of Heliothis virescens larvae.  During this study tetracycline 
hydrochloride reduced the larval weight, fatty acid and glycogen content of the insect 
with increasing antibiotic treatment of 0.05-0.4 mg per 100 g of diet (Thompson and 
Sikorowski, 1984).  The protein content of the insects showed a linear decrease with 
increasing antibiotic concentration (Thompson and Sikorowski, 1984).  Larval feeding was 
also found to be lower at 3 hours of feeding with increasing concentration of 
chlortetracycline, but there was no difference after 24 hours (Thompson and Sikorowski, 
1984). 
Table: 1.2. Studies conducted using tetracycline, chlortetracycline and tetracycline 
hydrochloride with different species of insects. 
Insect Name Antibiotic Concentration Reference 
Aedes albopictus Tetracycline 0.33 mg ml
-1 
Kambhampati et al., 1993 
Aedes aegypti Tetracycline/Chlortetracycline 30 µg ml
-1 
Phuc et al.,2007  








O’Neil and Karr, 1990 










Mair et al., 2005 
 
Thomas et al., 2000 
Thermobia domestica Tetracycline 100-1000 µg ml
-1
 Treves and Martin, 1994 
Sitophilus oryzae Tetracycline 1 mg per g of flour Heddi et al., 1999 
Ostrinia scapulalis Tetracycline 0.06-600 mg kg
-1 
and 2.4 mg ml
-1
 
Kageyama et al., 2003 
Anticarsia gemmatalis Tetracycline 32.25-75.27 µg ml
-1
 Visôtto et al., 2009 
Cadra cautella Tetracycline 400 µg ml
-1
 Sasaki et al., 2002 
Ephestia keuhniella Tetracycline 400 µg ml
-1
 Sasaki et al., 2002 
Glossina morsitans 
morsitans  
Tetracycline 25 µg ml
-1
 Dale and Welburn, 2001 
Ostrinia furnacalis Tetracycline hydrochloride 0.6 mg g
-1
 Kageyama et al., 1998 
Myzus persicae Chlortetracycline 10-1000 µg ml
-1
 Douglas, 1988 
Acyrthosiphon pisum Chlortetracycline 50 µg ml
-1
 Prosser and Douglas, 1991 
Sitophilus oryzae Chlortetracycline 100-500 µg ml
-1
 Baker and Lum, 1973 
1.4 Antibiotic resistance 
The widespread use of chlortetracycline has meant that tetracycline resistant bacteria are 
readily found in the environment and within animals (Kümmerer et al., 2004).  This 
resistance in bacteria is mainly due to the over-use of this antibiotic to treat illnesses in 
humans and livestock, where these antibiotics are released non-metabolised in sewage 
and subsequently found in aquatic environments (Kümmerer et al., 2004).  Antibiotics are 
also widely used to treat fruit, bee-keeping and fish farming, therefore it is not surprising 
that the residues of antibiotics are readily found in waste especially sewage waste with 
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E.coli being most resistant to the antibiotic, tetracycline (Kümmerer et al., 2004; 
Reinthaler et al., 2003).     Furthermore, an experiment conducted by Nygaard et al (1992) 
has demonstrated that the addition of oxytetracycline to sediments tripled the number of 
bacteria found to be resistant to the antibiotic.  This provides evidence that the addition 
of these antibiotics into the environment results in the development of antibiotic 
resistance.  
Tetracycline resistance can be developed using three different methods (Figure: 1.2): 1) 
preventing access of tetracycline to the ribosome thus preventing attachment and protein 
synthesis inhibition 2) altering the ribosome structure preventing tetracycline binding and 
3) producing tetracycline-inactivating enzymes (Speer et al., 1992; Salyers et al., 1990).  
 
Figure: 1.2. The impact of tetracycline on tetracycline-sensitive cells and mechanisms of 
resistance.  A) The binding of tetracycline to the ribosome preventing protein synthesis. 
B) A resistance method, a cytoplasmic protein pumping tetracycline out of the cell, 
preventing the accumulation of high concentrations of tetracycline within the cell.  C) 
The presence of a cytoplasmic protein that has the ability to protect the ribosome from 
tetracycline binding. D) An enzyme is produced by the bacterium which has the ability 
to modify and inactivate tetracycline. (Speer et al., 1992; Salyers et al., 1990). Image 
taken from Speer et al (1992) and Salyers et al (1990). 
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1.5 RIDL® sterile insect technique – Controlling insect pests 
One technique used to control insect pests is the RIDL® technique, which uses 
tetracycline to control the genetic expression system.  Here I will describe the technique 
and the insects used with the technique. 
The traditional sterile insect technique (SIT) controls insect pests through the sterilisation 
of males by ionizing radiation resulting in chromosomal fragmentation (Horn and 
Wimmer, 2003).  This ionization can have a negative impact on sperm viability (Horn and 
Wimmer, 2003; Mayer et al., 1998).  SIT is effective with insects that mate synchronously 
and in isolated locations without immigration of untreated insects, e.g. the island of 
Zanzibar where the tsetse fly was eradicated in 1997 (Vreysen et al., 2000).  There can be 
problems with SIT.  The first is that the irradiated males suffer a general malaise and do 
not mate readily with the wild females (Horn and Wimmer, 2003).  The second is that if 
the sexing of the insects is inefficient, females are released potentially increasing the pest 
load in the environment.   
RIDL® sterile insect technique (Release of insects with dominant lethal gene) can improve 
SIT in two ways: to eliminate females from the release population if the tetracycline-
repressible expression system is female-specific and secondly, sterilise male insects if the 
tetracycline-repressible expression system is specific to early development resulting in 
the death of progeny (Alphey, 2002).  Therefore, when tetracycline is removed from the 
diets, female insects die and only males remain (Alphey, 2002). RIDL® males that are 
released into the wild, mate with wild females and produce offspring that die during 
development (Phuc et al., 2007; Alphey, 2002; Thomas et al., 2000). 
The RIDL® technique is used with insects including Mediterranean fruit fly and Aedes 
aegypti (Gong et al., 2005; Phuc et al., 2007).  Aedes aegypti is the vector for Dengue 
fever, a major disease burden with 2.5 billion people at risk worldwide. 
(http://www.who.int/mediacentre/factsheets/fs117/en/). The only control methods 
currently available are; the removal of oviposition sites and the use of insecticides 
(fenitrothion, malathion, deltamethrin, tetramethrin, permethrin (used in thermal 
fogging) (Paeporn et al., 2004) and DDT (dichlorodiphenyltrichloroethane) (Inwang et al., 
1967).  However, the unrestricted use of these insecticides has enabled the mosquito to 
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develop resistance (Gilkes et al., 1956; Porter et al., 1961; Sautet et al., 1958; Inwang et 
al., 1967; Paeporn et al., 2004).  Therefore, with no vaccines and emerging resistance to 
insecticides, Aedes aegypti appears to be good candidate for the use of the RIDL® 
technique. 
An example of the RIDL® system with Aedes aegypti is LA513, a late-acting dominant 
lethal genetic system which causes the death of both male and female mosquitoes at L4-
pupal stage (Phuc et al., 2007, Figure: 1.3).  Released LA513A males into the wild mate 
with wild females and any offspring produced will die at L4-pupae stage.  The release of 
enough males over a long enough period of time will result in population reduction. The 
expression system of tTAV is tetracycline repressible; therefore the RIDL insects are 
reared in water supplemented with tetracycline. Oxitec Ltd currently rear LA513A in 
water supplemented with 30 µg ml-1 of chlortetracycline to suppress the expression of 
tTav (Figure: 1.3).   
a)  
(b)                                                                       (c)     
Figure: 1.3. (a) The structure of the LA513 gene inserted into Aedes aegypti.  LA513 uses a non-
autonomous piggyBac-based transposon system to integrate the RIDL system.  Transgenic mosquitoes 
are identified by red fluorescence (DsRed2) expression driven by Actin5C which gives an all over spotty 
red fluorescence (c).  tTAV is a tetracycline-repressible transcriptional activator that binds to tetO. In 
LA513A in the absence of tetracycline small amounts of tTAV expressed from the minimal hsp70 
promoter bind to the tetO sites and enhance expression of more tTAV, this forms a positive feedback 
loop that produces large amounts of tTAV that builds up and eventually damages the cell.  In the 
presence of tetracycline, the tTAV binds to tetracycline making it unable to bind to tetO, this prevents the 
positive feedback loop and the build-up of tTAV.  Aedes aegypti larvae reared with no tetracycline under 
normal light (b) and the same larvae (c) viewed using the filters for red fluorescence (excitation 510-550, 
emission 590LP), both larvae show the expression of DsRed (Phuc et al., 2007). 
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An example of RIDL® female-specific lethality is OX3604, a repressible female specific 
flightless phenotype (Fu et al., 2010, Figure: 1.4,).  This concept was based on the female-
specific indirect flight muscle Actin4, in which the promoter for this gene was used to sex-
specifically control the expression of tTAV (Fu et al., 2010). The expression of tTAV in the 
absence of tetracycline resulted in a flightless phenotype in female mosquitoes (Fu et al., 
2010). 
 
Figure: 1.4. Structure of the insertion of OX3604 into Aedes aegypti.  Transgenic mosquitoes are 
identified by red fluorescence (DsRed2) expression driven by HR5IE1.  tTAV is a tetracycline-
repressible transcriptional activator which is used as the effector molecule (Fu et al., 2010). In 
the absence of tetracycline tTAV is expressed from the AeAct4 promoter, binds to the tetO sites 
(found within tRE) and enhance expression of more tTAV (Fu et al., 2010). In the presence of 
tetracycline, the tTAV binds to tetracycline making it unable to bind to tetO, this prevents the 
positive feedback loop and the build-up of tTAV (Phuc et al., 2007; Fu et al., 2010).  Image taken 
from Fu et al (2010). 
The potential problem with RIDL® is the possibility that the tetracycline (30-100 µg ml-1) 
used to repress the lethal genes might also eliminate symbiotic bacteria, resulting in 
reduced insect vigour (and hence mating success) and increased susceptibility to 
pathogens in the field.   
1.6 Bacteria in Drosophila melanogaster and Aedes aegypti and the role in 
insect performance  
The RIDL® technique was first developed using Drosophila melanogaster (Thomas et al., 
2000) and is used for controlling one major pest, Aedes aegypti (Phuc et al., 2007).  
Therefore, I will discuss the bacterial diversity in Drosophila melanogaster and Aedes 
aegypti and the implications of removing bacteria on the insect host. 
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1.6.1 Bacterial diversity in Drosophila melanogaster  
One particular investigation into the diversity of bacteria in natural populations of 
Drosophila melanogaster detected members of the phyla Proteobacteria, Bacteroidetes 
and Firmicutes (Corby-Harris et al., 2007).  In laboratory Drosophila (strain Oregon-R), Ren 
et al (2007) discovered both cultured bacteria and non-culturable bacteria (Table: 1.3).  
The bacteria found within lab strains of Drosophila melanogaster were predominantly 
Lactobacillus and Acetobacter (Ren et al., 2007).   
Acetobacter are well adapted in sugar and ethanol rich environments (Crotti et al., 2010).  
This genus of bacteria has been found within Drosophila and on the exterior of the fly 
showing the ability to withstand different conditions (Ren et al., 2007) (Table 1.3).  
Lactobacillus is lactic acid producing bacterium which was also found on the interior and 
exterior of the fly by Ren et al (2007).  Both of these bacterial species were again 
identified by Corby-Harris et al (2007).   
Table 1.3: Bacterial species identified in Drosophila melanogaster (Ren et al., 2007) 
Area of fly Cultured Species Identified by PCR 
Fly Surface Acetobacter aceti Lactobacillus homohiochii 
 Acetobacter tropicalis Acetobacter aceti 
 Acetobacter pasteurianus Lactobacillus fructivorans 
 Lactobacillus plantarum  
Fly Interior Acetobacter pasteurianus Acetobacter tropicalis 
 Lactobacillus sp MR-2 Lactobacillus brevis 
 Acetobacter aceti Lactobacillus plantarum 
 Lactobacillus plantarum Acetobacter pasteurianus 
 Clidosporium sphaerospermum Acetobacter aceti 
1.6.2 Role of commensal bacteria in Drosophila melanogaster 
The two main methods of eliminating bacteria from Drosophila are:  egg 
dechorionation/washing eggs with alcohol and rearing the insects in a sterile 
environment and the second method is to treat the insects with antibiotics. 
As a model organism for humans, there is increasing interest in the interactions between 
Drosophila melanogaster and its resident microbiota, which have been found to enhance 
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life-span (Brummel et al., 2004) (Table: 1.4).   In the experiment conducted by Brummel et 
al (2004), three different antibiotics (ampicillin, tetracycline and rifamycin) were 
administered to the flies to remove the bacteria (Brummel et al., 2004).   The presence of 
bacteria in Drosophila melanogaster enhanced life-span during the first week of adult life 
but could have the potential to reduce life-span later in adulthood (Brummel et al., 2004) 
(Table: 1.4).  An early study conducted by Bakula (1969) identified how Drosophila 
melanogaster become infected with the bacterial symbionts and how the elimination of 
this infection route affects the performance of the fly.   In this study, it was demonstrated 
that Drosophila melanogaster gain the symbionts through the larvae consuming the egg 
chorion which contains the bacteria (Bakula, 1969).  Axenic flies were created by washing 
the eggs with White’s solution (1.8 mM HgCl2, 0.1 M NaCl in 0.05 N HCl solution) to 
surface sterilise the eggs, the resulting flies had an extended development time compared 
with control flies (Bakula, 1969) (Table 1.4).  Recent experiments have further 
demonstrated the role of microbes in Drosophila melanogaster, the removal of the 
symbionts through antibiotic treatment abolished mating preference (Sharon et al., 2010) 
(Table: 1.4).  Reintroduction of these bacterial symbionts through injection preserved 
mating preferences in the flies (Sharon et al., 2010).   
 
Table: 1.4.  The impacts of bacterial depletion in Drosophila melanogaster  
Performance Parameter Result Reference 
Development time Extension  Bakula, 1969 
Life-span Reduction 
No effect 
Brummel et al., 2004 
Ren et al., 2007 
Immune response Decrease in Anti-microbial 
peptides (AMPs) 
Ren et al., 2007 
Mating  Abolishes mating preferences Sharon et al., 2010 
 
One major factor that is involved in the establishment of bacteria is the diet consumed by 
the organism. As nutrition plays an important role in survival, reproduction and fitness of 
Drosophila melanogaster, this would also suggest a link between the diet, bacteria and 
performance of organisms.  Therefore, bacteria could actually promote the performance 
of insects on suboptimal diets and a different response could also be observed with 
axenic flies reared on different diets. 
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Studies have been conducted which have highlighted the effects of nutrition on 
Drosophila melanogaster.  Calorie restriction has been shown to increase life-span, 
reduce reproduction and increase fat content (Piper et al., 2005).  This supports the 
theory that at times of plenty Drosophila investment of energy into reproduction is 
prioritised and during periods of low food availability, energy is invested into preservation 
and survival (Shanley and Kirkwood, 2000; Piper et al., 2005).  However, one paper 
suggested that the protein: carbohydrate ratio within the diet played an important role in 
extending life-span of Drosophila melanogaster rather than the dilution of diets (calorie 
restriction) (Lee et al., 2008).   A high protein diet with low carbohydrate content reduced 
life-span, suggesting that protein at high levels can be toxic and a diet consisting of 1:2 
and 1:1.6 protein-to-carbohydrate ratio was shown to optimize egg laying rate and life-
span, respectively (Lee et al., 2008).   This result was also supported by a paper published 
in 2009 by Ja et al where it was suggested that providing water with the diet abolishes the 
life-span extension with dietary restricted media.  
1.6.3 Bacterial diversity in mosquitoes 
Investigations into the bacterial diversity of mosquitoes have mainly focused on the 
mosquito, Anopheles gambiae to identify the potential use of commensal bacteria in 
controlling the vector of malaria.  Bacteria identified in Anopheles gambiae included; 
Enterobacter asburiae, Microbacterium sp., Sphingomonas sp., Serratia sp. and 
Chryseobacterium meningosepticum (Dong et al., 2009).  Another paper where bacterial 
species were identified in Aedes triseriatus, Culex pipiens and Psorophora columbiae 
discovered there was a huge increase in bacterial numbers in the midgut between larval 
and pupal stage and also in adults after blood-feeding (Demaio et al., 1996). The most 
common bacterial species identified were Serratia marcescens, Klebsiella ozanae, 
Enterobacter agglomerans and Pseudomonas aeruginosa (Demaio et al., 1996). 
Little is known about the importance of the bacterial species present in Aedes aegypti and 
their role in insect performance.  One paper had described how female Aedes aegypti 
preferred to oviposit in water that had bacteria present and that these micro-organisms 
produced oviposition-stimulating kairomones (Ponnusamy et al., 2008). An early paper 
also supported this, with egg hatching being greater in water with bacteria when 
compared with sterile water (Rozeboom, 1934).   
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Within Aedes aegypti, the bacterial diversity has been identified in gut diverticulum 
through 16S rRNA gene analysis, this included Bacillus cereus, Bacillus subtilis and Serratia 
sp (Gusmão et al., 2007).  The Serratia species identified by Gusmão et al (2007) had been 
suggested to play an important role in the metabolism of sugars; therefore it would be 
interesting to discover if bacterial depletion reduces the ability of the mosquito to 
metabolise sugars.   Culture-dependent and culture-independent techniques identified 
the genera Asaia, Bacillus, Enterobacter, Klebsiella and Serratia to be dominant in the 
mid-gut of Aedes aegypti (Gusmão et al., 2010).  The number of CFUs (colony forming 
units) increased from 210 colonies to 2.3 x 107 after 67 hours of being blood-fed (Gusmão 
et al., 2010) indicating the role of these bacteria in metabolism of a blood-meal.   
1.6.4 Role of commensal bacteria in Aedes aegypti 
As with Drosophila melanogaster few experiments have been conducted with Aedes 
aegypti and the cost of removing commensal bacteria from the host.  Lang et al (1972) 
conducted experiments which showed no alteration in growth rates, survival and protein 
content but did observe a change in life-span, lipid and weight.   Research in this area has 
mainly concentrated on the role of bacteria in dengue virus transmission which is 
described in Section: 1.2.2.   
1.7 Thesis Objectives 
To determine the deleterious impact of using chlortetracycline to deplete bacteria and 
during the RIDL® technique, 2 insect systems were assessed; Drosophila melanogaster 
and Aedes aegypti. Drosophila melanogaster was chosen as an ideal system due to the 
low cost, low bacterial diversity and the ability to use egg dechorionation as an 
alternative method to deplete bacteria.  RIDL® is used with Aedes aegypti and was chosen 
to address the impact of chlortetracycline on an insect system which is used for RIDL®.  
Lastly, to gain a greater understanding of the creation of transgenic insects, a female-
specific marker for Aedes aegypti was proposed to provide a method of genetically sexing 
the insects during mass-rearing.   
The three major objectives were:  
1. The impact of chlortetracycline on Drosophila melanogaster and Aedes aegypti 
(Chapter 3 and 5). 
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2. The impact of the depletion of bacteria via egg dechorionation on Drosophila 
melanogaster (Chapter 3 and 4). 
3. The production of a female-specific marker in Aedes aegypti for sex sorting during 





















Chapter 2: Material and Methods 
2.1 Materials 
Unless otherwise stated, chemicals and reagents were supplied by the following 
companies: Sigma Aldrich® U.K and U.S.A (organic compounds, enzymatic assay kits); Bio-
Rad Laboratories (qRT-PCR reagents and protein quantification assay); Fisher (organic 
compounds); Invitrogen™ (PCR reagents). 
2.2 Insect Culture and maintenance 
2.2.1 Drosophila melanogaster rearing and maintenance 
Five strains of Drosophila melanogaster were used:  Oregon-RS (Bloomington Stock 
Centre; Dec 2007), Oregon-RC (Bloomington Stock Centre; Dec 2007), Oregon-RP2 
(Bloomington Stock Centre; Dec 2007), Isogenic (provided by Sean Sweeney, University of 
York, UK; Dec 2007) and Canton-S (provided by Mariana Wolfner Laboratory Department 
of Molecular Biology and Genetics, Cornell University, Ithaca NY; September 2009).   
Drosophila were transferred to fresh diet at least once a week and reared at 25 °C, with a 
12 hour light/dark cycle. 
In preliminary experiments, the performance of the strains was investigated on 5 
different diets: Semi-defined medium; Cormeal, dextrose and yeast medium; General 
media; Ren et al (2007) medium; University of York medium (Table: 2.1).  Of these, the 
University of York diet yielded the most reliable performance, therefore stock flies and 
experiments were conducted using this diet.  The glucose to yeast ratio in the University 
of York diet was 2:1.   
For all experiments the diet was autoclaved and upon cooling to 50 °C, mixed with 
antifungal agents (Nipagin M and CBZ) and chlortetracycline at 0-500 µg ml-1 final 






Table: 2.1: Components of Drosophila diets 
*Stock solutions of Carbendazim (CBZ) and Nipagin M were made up of 200 mg l
-1
 and 100 g l
-1 
respectively, 
27.57 ml of CBZ and 7.35 ml of Nipagin M were added to 1 litre of medium.  
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2.2.2 Aedes aegypti rearing and maintenance 
Asian Aedes aegypti (isolated from Kuala Lumpar, Malaysia in 1975) eggs were hatched 
under a vacuum for 20-60 minutes in distilled water and reared at 28 °C with 60-80% 
humidity.  Larvae were fed with TetraMin tropical fish food (Aquatics Warehouse, UK).  
Emerging pupae were picked daily using a 3ml plastic Pasteur pipette (Scientific Lab 
Supplies) into a small sized weigh boat (7 ml; Fisher Scientific, UK) and placed into a cage 
(15cm x 15 cm x 15 cm) (Talking Plastics Fabs, UK).  Adult mosquitoes were fed on 
defibrinated horse blood (TCS Biosciences, UK) in Hemotek® membrane feeding system 
(Discovery Workshop, UK) for egg laying and fed daily with 10% sugar (Tate and Lyle, UK) 
water plus 14 U ml -1 Penicillin and 14 µg ml -1 streptomycin and filtered through 0.22 µM 
bottle top filters (Corning Inc, U.S.A and VWR, UK). 
2.3 Insect Performance Experiments  
2.3.1 Performance of Drosophila melanogaster Oregon-RS 
Adult females of Drosophila were allowed to oviposit on the University of York medium 
(Table: 2.1) over 24 hours.  The eggs were collected and transferred to the test diets 
under sterile conditions using a fine paintbrush.  The experiment comprised of 10 
replicate vials with 10 eggs on 0, 1, 10, 50, 100, 300, 500 µg ml-1 of chlortetracycline 
supplemented diet.   
The time to the emergence of pupae and flies were recorded.  Once the flies had 
emerged, they were collected, sexed,  placed in liquid nitrogen and stored at -80 °C prior 
to subsequent analysis. 
In a supplementary experiment, the performance was assayed on diets with different 
agar concentrations ranging from 0.9% to 2.5%.  The time to the emergence of pupae and 






2.3.2 Performance of Drosophila melanogaster Canton-S 
2.3.2.1 Development time and survival experiment with chlortetracycline and 
dechorionation on the high and low nutrient diets. 
Adult female Drosophila were allowed to oviposit over 24 hours.  The eggs were collected 
and transferred to the test diets under sterile conditions using a fine paintbrush.  The 
experiment comprised of 12 replicate vials with 10 eggs with 0, 1, 10, 50, 100, 300, 500 µg 
ml-1 of chlortetracycline on the low and high nutrient diet (Table: 2.1).  One extra 
treatment “dechorionation” was conducted alongside the chlortetracycline treatments.  
Egg dechorionation was conducted by washing in sterile water twice, treating with 10% 
bleach for 5 minutes and rinsing with sterile water 3 times.  The time to the emergence of 
pupae and flies were recorded.   
2.3.2.2 Performance experiments with chlortetracycline and dechorionation on the York 
diet 
Experiments were conducted using glass vials with lids or Falcon tubes, both methods of 
rearing created consistent results.  Adult females were allowed to oviposit on the York 
diet over 24 hours.  The eggs were collected and transferred to treatments under sterile 
conditions.  The experiment comprised of 15 glass vials with 10 “untreated” eggs on the 
diet with 0, 50, 300 µg ml-1of chlortetracycline and 15 glass vials with 10 “treated” eggs 
on the diet with 0, 50, 300 µg ml-1 of chlortetracycline.  The treated eggs were 
dechorionated by washing in sterile water twice, treating with 10% bleach for 5 minutes 
and rinsing with sterile water 3 times.   
The development and emergence of pupae and flies were recorded.  Once the flies had 
emerged they were transferred to fresh diet and allowed to mate for 48-72 hours before 
being sexed.  After mating, male flies were used to determine life-span and females were 
used for bacterial counts and quantification of fecundity. 
Ten mated males were placed individually into the same treatment as for rearing (see 
above).  Fresh diet was provided every 3/4 days and every vial was monitored daily until 
the fly died. 
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Ten mated females were randomly selected for fecundity experiments, individual females 
were placed individually in tubes (Corning Inc), with each diet within the lid to allow for 
egg laying and feeding (Figure: 2.1).  Tubes were placed upside down, lids with fresh diet 
were replaced and eggs were counted daily for 7 days. 
a.                                                                                 b. 
        
Figure 2.1: Diagram of the fecundity experiment: a) a female in the Falcon tube and b) 
eggs laid on the food in the lid of the tube. 
In a supplementary experiment, egg hatching rates were assayed on diets with 0, 50, 
300µg ml-1 of chlortetracycline.  A further egg hatching experiment was conducted with 
dechorionated and control eggs where the diet was supplemented for both treatments 
with amaranth dye (300 µg ml-1) to aid the identification of dechorionated eggs which had 
hatched. 
2.3.3 Performance experiments on Aedes aegypti 
Cages of male and female mosquitoes were blood fed and eggs were collected four days 
later.  Approximately 500 eggs were hatched in a vacuum for one hour in 300 ml at 0, 0.1, 
0.5, 1.0, 10, 30, 100 µg ml-1 of chlortetracycline hydrochloride (BioGene, UK) water.  
Hatched eggs were left overnight.  The following day, 7 replicates of 300 larvae were 
transferred into 500 ml plastic pots (Scientific and Medical Products Ltd, UK) with 150 ml 
of each concentration of chlortetracycline, fed according to Table: 2.2 and maintained at 
28 °C with 80% humidity.  The time to pupation and the number of male and female 
pupae were recorded.  Pupae were transferred to small plastic cages (15cm x 15 cm x 15 
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cm) (Talking Plastics Fabs, UK) and each day the number of emerged adults were 
recorded, collected and stored at -80 °C or used for life-span studies as below. 
Five replicates of 30 male and female pupae were placed separately into cages (Scientific 
and Medical Products Ltd, UK).  The mosquitoes were fed with 0.2 µm filtered 10% sugar 
(Tate and Lyle, UK) supplemented with 0, 0.1, 0.5, 1.0, 10, 30, 100 µg ml-1 of 
chlortetracycline.  Life-span was monitored and fed daily for 50 days.   
The effects of chlortetracycline treatment on Mexican Aedes aegypti (Laura Harrington, 
Cornell University, Ithaca, NY) was tested as above, except that 6 replicates of 150 larvae 
were used and life-span was monitored on 6 replicates of 20 male and female mosquitoes 
until all were dead, Tetramin Fish Food was obtained from Walmart and sugar from 
Wegman, Ithaca, NY.  Mexican Aedes aegypti originated from the Tapachula area (14° 
45’N, 92° 15’W) and had been in the colony since 2006, the strain was augmented yearly 
with wild mosquitoes from the collection site.   
The response of transgenic Asian Aedes aegypti to 0-30 µg ml-1 of chlortetracycline was 
also tested as above except that 6 replicates of 150 larvae were conducted and life-span 
was monitored on 6 replicates of 20 male and female mosquitoes until all were dead and 
fed with 10% sugar water only. 
Table: 2.2. Feeding regime for Asian and Mexican Aedes aegypti fed on tropical fish 
food (Tetramin) (Determined by Irka Bargielowski). 













2.4 Microbial Culture  
2.4.1 Culturing microbes in Drosophila melanogaster 
To determine the effect of chlortetracycline on culturable bacteria from Oregon-RS, three 
larvae grown on each concentration of chlortetracycline (0-500 µg ml-1) were sampled, 
surface sterilised with 70% ethanol and homogenised in 0.5 ml of 1X sterile phosphate 
buffer saline solution (pH 7.4).  A sample of the homogenate (0.1 ml) was plated onto 
nutrient agar (Oxoid – 28 g l-1) and plates were incubated for 7 days at 37 °C when the 
number of colonies was recorded. 
To check for culturable bacteria in Canton-S culture medium derived from dechorionated 
eggs (Section 2.3.2.2), food was sampled on Day 14 (after most of adults had emerged) 
and plated onto nutrient agar plates.  These plates were grown at 25 °C for 7 days and 
growth was monitored on Day 1, 3 and 7.  Bacterial counts on females were conducted on 
7-10 day old flies.  Five female flies were randomly selected from each treatment and 
individually homogenised in 250 µl of sterile 1X phosphate buffer saline solution (pH 7.4) 
using a small pestle until pieces of tissue were no longer visible (Ren et al., 2007).  
Samples (100 µl) of the homogenate at X 1, X 1/10, X 1/100 and X1/1000 dilutions were 
plated onto nutrient agar plates (Oxoid – 28gl-1) with +/- 50 µg ml-1 chlortetracycline 
(shown to eliminate chlortetracycline sensitive E.coli cells) using sterile techniques.  The 
homogenate from flies derived from dechorionated eggs were not diluted. 
2.4.2 Culturing microbes in Aedes aegypti 
To determine whether the treatment of mosquitoes with 0 to 100 µg ml-1  of 
chlortetracycline had an effect on the culturable bacteria found in mosquitoes,  mosquito 
larvae were grown on each concentration of chlortetracycline (0-100 µg ml-1) and 
sampled on Day 7.  Three larvae were then surface sterilised with 70% ethanol, 
homogenised in 0.5 ml of sterile 1X phosphate buffer saline solution (pH 7.4) and 0.1 ml 
of the homogenate was plated nutrient agar (Oxoid – 28 g l-1) plates with and without 50 
µg ml-1 chlortetracycline for the identification of chlortetracycline resistant bacteria.  The 
agar plates were incubated for 7 days at 28 ± 1 °C (temperature used for Aedes aegypti 
culture) and the number of colonies was recorded. 
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Five (Asian) and six (Mexican) colonies from each plate were picked at random to 
inoculate 5 ml nutrient broth and placed in a shaking incubator at 28 ± 1 °C overnight.  
DNA was extracted from 1 ml samples in Section 2.8.1. 
2.5 Nutrition Assays 
2.5.1 Wing length and area measurements 
Due to experimental constraints the weight of the insect could not be measured in some 
experiments therefore, the size of the insects was estimated from wing length 
(mosquitoes) or area (Drosophila).  Drosophila wing area was chosen as a suitable 
measure of size according to Shingleton et al., 2005 and wing length (from wing notch to 
tip, Nasci 1990) was measured as a measure of size for mosquitoes (Figure: 2.3). Wings of 
mosquitoes and Drosophila were removed using scissors and forceps and placed onto a 
glass slide.  The wings were either digitally scanned (Canon LiDE 200 colour image 
scanner) or photographed using the Olympus SZX9 stereomicroscope.  Wing length and 
wing area was measured using ImageJ (http://rsbweb.nih.gov/ij/) or using a leaf-area 
measurement machine (LI-COR Portable area meter model: LI-3000A) (Figure: 2.2).   
 
 
Figure: 2.2. a) Mosquito wing length from wing notch to wing tip excluding hairs and b) 






1a)       1b) 
 
2a)       2b) 
 
 
Figure 2.3: 1) Wing length and weight measurements were made with 20 males (a) and 
females (b) Aedes aegypti.  The linear regression of the weight and wing length was 
calculated.  Regression significantly departed from zero in males (F1, 18 = 4.965, p<0.05) 
and females (F1, 17 = 31.912, p<0.001). These results suggest that wing length is a 
suitable measure of size. 2) Wing area measurements were made with 20 male (a) and 
female (b) Drosophila. The linear regression of the weight and wing area was measured.  
Regression significantly departed from zero in males (F1, 18 = 17.408, p<0.01) and 
females (F1,16 = 8.448, p<0.05). 
2.5.2 Tissue Preparation 
Individual Drosophila and mosquitoes were homogenised in 80 µl and 60 µl of extraction 
buffer, respectively in Tris-EDTA buffer (10mM Tris, 1 mM EDTA, pH 8.0, with 0.1% (v/v) 
Triton-X-100 (Dionne et al., 2006).  Samples were centrifuged for one minute at 17,949 g 
and 4°C and the supernatant was removed and placed in new tube.  Samples were kept 
on ice while assays were conducted to prevent degradation of nutrients. 
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For Drosophila Oregon-RS sample flies were homogenised in 200 µl of Lysis Buffer (150 
mM NaCl, 20 mM Tris (pH 8.0), 2 mM EDTA, 0.5% nonylphenoxypolyethoxylethanol (NP-
40) and protease inhibitors – Roche tablets (Cat no: 1 836 153 1 tablet/10 ml) and 
incubated on ice for 15 minutes.  Samples were then centrifuged at 4 °C at 17,949 rpm for 
10 minutes and the supernatant was placed in a new tube and analysed immediately. 
2.5.3 Protein Assays  
Two assays were used, Pierce for Oregon-RS and Bio-Rad for Canton-S.   
For the Bio-Rad assay, samples were diluted 1 in 5 in TE buffer.  Five micro-litres of the 
sample and Bovine Albumin Serum standards were placed into a 96 well plate.  A Bio-Rad 
(Bio-Rad Laboratories, USA) protein assay was conducted by adding 25 µl of reagent A 
and 200 µl of reagent B (samples were mixed by pipetting) and allowed to incubate for 15 
minutes at room temperature.  The absorbance was measured at 750 nm on a Bio-Rad 
xMarkTM microplate spectrophotometer with 0-2.4 µg BSA (Bovine Serum Albumin). 
For the Pierce Assay, samples were diluted in Lysis buffer. Twenty-five micro-litres of the 
sample and Bovine Albumin Serum standards were placed into a 96 well plate. A Pierce 
BCA (Thermo Scientific) protein assay was conducted by adding 200 µl of BCA reagent 
(made from Reagent A and B at a 50:1 ratio) to each sample/standard and mixed by 
pipetting.  The plate was incubated for 30 minutes at 37 °C and the absorbance measured 
at 544 nm on a BMG Labtech POLARstar OPTIMA spectrophotometer.  
2.5.4 Assay for Glucose, Glycogen and Trehalose  
Five micro-litres of the samples and standards were placed into the wells of a 96 well 
plate.  The glucose assay was conducted by adding 150 µl of enzyme cocktail containing 
500 units of glucose oxidase and 100 units of peroxidase (39.2 ml of Milli-Q water to the 
enzyme tablet and 800 µl of o-Dianisidine reconstituted in 1 ml of Milli-Q water) to each 
well and mixed by pipetting.  The plate was then incubated for 30 minutes at 37 °C.  The 
reaction was terminated by adding 150 µl sulphuric acid (6 M).  The absorbance was 




To assay glycogen and trehalose, samples were pre-treated with amyloglucosidase and 
trehalase respectively.  For glycogen assays, 5 µl of 2 U ml-1 of amyloglucosidase in 10 mM 
acetate buffer was added to each sample and to one of 2 glycogen standard curves. The 
plate was incubated for 1 hour (Aedes aegypti) and overnight (advised for Drosophila 
samples) at 37 °C.   Glucose quantity was then measured using the method described 
above.   
For the trehalose assay, 2 µl of 0.2M sodium citrate and 1 mM of EDTA was added to the 
samples and 1 of 2 trehalose standards.  The plate was incubated at 37 °C for 10 minutes, 
this was followed by the addition of 2.5 µl of trehalase (3.7 U/ml) (converts trehalose to 
glucose) to the samples and 1 of 2 standards. The plate was then incubated for 60 
minutes at 37 °C and the glucose quantity then measured using the method described 
above.  
For both the glycogen and trehalose assays, the quantity of trehalose and glycogen was 
calculated by subtracting the value gained from the glucose assay from the value gained 
from the trehalose/glycogen assay. 
2.5.5 Assay for glycerol and triglyceride Assay  
The glycerol and triglyceride assay were conducted using Sigma Triglyceride Assay Kit.  
This kit quantifies glycerol by the addition of 1.25 U ml-1 of glycerol kinase (converts 
glycerol to glycerol-1-phosphate), 2.5 U ml-1 of glycerol phosphate oxidase (converts 
glycerol-1-phosphate to hydrogen peroxide and dihydroxyacetone phosphate) and 2.5 U 
ml-1 of peroxidase (converts hydrogen peroxide, 4-aminoantipyrine and sodium N-ethyl-
N-[3-sulfopropyl]m-anisidine to Quinoneimine dye).  The triglyceride reagent converts 
triglycerides to glycerol and fatty acids by using 250 U ml-1 of lipoprotein lipase.  
Fifteen micro-litres of the samples and 15 µl of the glycerol standards (0-6.25 ug) were 
placed into a 96 well plate.  The assay was conducted by adding 200 µl of pre-warmed 
glycerol reagent (resuspended in 40 ml Milli-Q water) to each well and mixed by 
pipetting.  The plate was then incubated for 10 minutes at 37 °C.  The absorbance was 
measured at 540 nm using a xMarkTM microplate spectrophotometer.  
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Following the glycerol assay, the triglyceride was quantified.  Fifty micro-litres of pre-
warmed triglyceride reagent (reconstituted in 10 ml of Milli-Q water) was added to the 
plate after the glycerol was quantified and incubated for 10 minutes at 37 °C.  The 
absorbance was measured at 540 nm using an xMarkTM microplate spectrophotometer.    
The triglyceride content was calculated by subtracting the value for free glycerol (first 
reading) from the final absorbance.   
2.5.6 Total Lipid Content 
Total lipid content was measured by drying individual insects (Drosophila and Mexican 
Aedes aegypti) or groups of 20 (Asian Aedes aegypti at Oxitec Ltd to weigh accurately) in 
eppendorf tubes to a constant weight at 50 °C for 48 hours.  After determination of dry 
weight of insect on a microbalance (Drosophila and Mexican Aedes aegypti; Mettler MT5 
microbalance and Asian Aedes aegypti; Mettler Toledo AG104 balance), 1 ml (5 ml for 
Asian Aedes aegypti) of 2:1 methanol/chloroform mix was added to each tube and 
incubated at room temperature for 24 hours.  The methanol/chloroform mix was then 
removed and left in the fume hood for 24 hours to allow the evaporation of the 
methanol/chloroform mix.  The insects were then re-weighed and the change in weight of 
the dried insects after methanol/chloroform treatment was calculated to produce the 
total lipid content per insect (Cockbain, 1962). 
2.6 Respirometry 
The O2 consumption and CO2 production of male and female flies of 7-10 day old 
Drosophila Canton-S was determined by stopped-flow respirometry, with 5 flies per 
replicate.  Flies were transferred to a 5 ml syringe and allowed to acclimate for 30 
minutes prior to analysis.  All experiments were conducted in dim light (0.02 µE m-2 s-1) to 
minimise movement, and the time of experiment was scored.  The input to the 
respirometer was room air with water vapour and CO2 removed by two silica columns and 
one ascarite column respectively. To initiate each experiment, the air in the syringe was 
replaced by 3.2 ml of dried CO2 free air, with airflow at 57 ml min
-1.  The CO2 and O2 
content of the syringe was determined at 30 minutes by injecting 3 ml of the syringe 
volume into Sable Systems SS3 Gas Analyzer Sub-sampler with an FCA-10A CO2 analyzer 
49 
 
and FC-10 O2 Analyzer (Sable systems, Nevada, USA) respectively.  CO2 and O2 content 
was calibrated with 50 ppm CO2 gas and 20.9% O2 gas. 
CO2 and O2 content were analysed using the Sable System data acquisition software 
(Expedata, Sable Systems, Nevada, USA). 
2.7 Drosophila Gut Dissections 
Adult flies were surface sterilised with three washes in 1 ml 10% sodium hypochlorite, 
followed by three rinses with sterile water.  Drosophila guts were dissected in sterile 
Ringer’s solution (3 mM CaCl2, 182 mM KCl, 46 mM NaCl and Tris 10 mM, pH 7.2) using 
sterilised forceps and scissors. 
2.8 16S rRNA Gene Analysis 
2.8.1 DNA extraction 
Bacteria colonies were cultured from the insects (Section 2.4). 
Three different methods were used to extract DNA.  For bacterial colonies obtained from 
Oregon-RS and for Oregon-RS larvae, DNA was extracted by using a modified method 
from Short Protocols in Molecular Biology 4th Edition.  This involved precipitating the DNA 
in one volume of isopropanol, washing the DNA pellet in 500 µl of 70% ethanol and re-
suspending the dried pellet in 100 µl of sterile water (Ausebel, 1999 page 2-12).   
 
For bacterial colonies obtained from Canton-S and for Canton-S adults (Section: 2.3.2.2), 
DNA was extracted using a modified method from Cenis et al (1993).  This involved a pre-
incubation step in 180 µl enzymatic lysis buffer (20 mM Tris-Cl, 2 mM sodium EDTA, 1.2% 
Trition-X-100 and 20 mg lysozyme per ml) at 37 °C for 45 minutes.  Followed by, bead-
beating with 0.1 mm cell disruption beads (50% volume) using a DisrupterGenie (Scientific 
Industries, Inc).  The samples were incubated for a further 45 minutes at 37 °C.  One 
hundred microlitres of Extraction Buffer (200 mM Tris-HCl, pH 8.5, 250 mM NaCl, 25 mM 
EDTA, 0.5% [W/V] SDS) and 25 µl of proteinase K (20 mg ml-1) was added to each sample.  
The samples were mixed and incubated at 55 °C for 1 hour, followed by the addition of 
150 µl of 3M NaOAc, pH 5.2.  The samples were transferred to -20 °C for 10 minutes and 
centrifuged for 5 minutes at 17,949 g.  The supernatant was transferred to a new tube 
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and 1 volume of 100% freezing isopropanol was added.  The samples were incubated at 
room temperature for 30 minutes, followed by centrifugation at 17,949 g for 30 minutes.  
The supernatant was removed and the pellet was washed in 500 µl of ice cold 70% 
ethanol. The DNA samples were then vortexed, centrifuged at 17,949 g at room 
temperature and the supernatant was discarded.  The dried DNA pellet was re-suspended 
in 100 µl of sterile water.  
 
For liquid microbial cultures obtained from Asian Aedes aegypti, DNA was extracted by 
using Nucleospin® Tissue kit (Clontech) and cultures from Mexican Aedes aegypti DNA 
were extracted by the same method for Canton-S (Cenis et al., 1993).   
2.8.2 PCR Amplification 
The bacteria were identified by 16S rRNA gene PCR using general primers 16SA1 (5’ – 
AGA-GTT-TGA-TCM-TGG-CTC-AG-3’) and 16SB1 (5’ – TAC-GGY-TAC-CTT-GTT-ACG-ACT-T-
3’) from Fukatsu and Nikoh (1998).  PCR amplification was performed in 25 µl of a sterile 
mix containing 1X Taq polymerase buffer, 0.24 mM of each deoxynucleoside 
triphosphate, 2 mM MgCl2, 0.32 µM of each primer, 1 µL of template DNA/colony sample 
and 0.025 U of Platinum Taq.  The PCR mixtures were incubated for 5 minutes at 94 °C, 
followed by one cycle of 1 minute at 55 °C, 72 °C for 2 minutes and 25-30 cycles of 1 
minute at 94 °C, 1 minute at 55 °C and 2 minutes at 72 °C with a final incubation of 8 
minutes at 72 °C.  Negative controls with no DNA addition and a positive control 
(Ochrobactrum anthropi DNA/control fly DNA) were also prepared. 
To certify amplicon size (1.5 kb), a 3 µl aliquot of the PCR product was run on either a 
1.5% agarose gel stained with Sybr Safe (Invitrogen) (Drosophila and Mexican Aedes 
aegypti) or 0.8% gel stained with ethidium bromide (Asian Aedes aegypti) and visualized 
using UV. PCR samples were purified using QIAquick PCR purification kit (Qiagen, 
Valencia, California, USA and Qiagen, Crawley, West Sussex, UK) following the manual 
instructions.  PCR products were then sequenced with 16SA1 and 16SB1 primers using 
Macrogen (Oregon-RS), GATC Biotech, Germany (Asian Aedes aegypti) and with 16SA1 
only at Cornell Life Sciences Core Laboratory Centre, Biotechnology, Cornell University, 
Ithaca, NY (Canton-S and Mexican Aedes aegypti). 
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Sequences were then trimmed using Sequencher 4.10.1 and blasted using NCBI 
nucleotide BLAST tool to identify the closest match for each sequence.  This analysis was 
conducted between November 2010 and February 2011.  
2.8.3 Wolbachia identification in Drosophila melanogaster using PCR 
Wolbachia was identified by 16S rRNA gene PCR using universal primers wsp 81F: 5’ TGG 
TCC AAT AAG TGA TGA AGA AAC and wsp 691R: 5’ AAA AAT TAA ACG CTA CTC CA from 
Zhou et al (1998).  PCR amplification was performed in 20 µl mix containing 1X Taq 
polymerase buffer, 0.40 mM of each deoxynucleoside triphosphate, 2.5 mM MgCl2, 0.32 
µM of each primer, 1 µL template DNA and 0.02 U Platinum Taq.  Negative controls with 
no DNA addition and a positive control (Isogenic strain) were also prepared.  The PCR 
mixtures were incubated for 1 minute at 95 °C, followed by 30 cycles of 1 minute at 95 °C, 
1 minute at 54 °C and 1 minute at 72 °C with a final incubation of 5 minutes at 72 °C. To 
certify amplicon size (590-632 bp), a 8 µl aliquot of the PCR product was run on a 1.5% 
agarose gel stained with Sybr Safe (Invitrogen)   
2.9 454 pyrosequencing 
2.9.1 Sample Preparation and DNA Extraction 
Fifty guts were dissected from the Drosophila (Canton-S, male and female).  For DNA 
extraction the guts were placed in 180 µl enzymatic lysis buffer (20 mM Tris-Cl, 2 mM 
sodium EDTA, 1.2% Trition-X-100 and 20 mg lysozyme per ml). Twenty male adult Aedes 
aegypti treated with 30 µg ml -1 of chlortetracycline, non-chlortetracycline treated male 
adults, non-chlortetracycline treated female adults and non-chlortetracycline treated 
larvae were also placed in 180 µl enzymatic lysis buffer.  The samples were homogenised 
with a pestle and mortar, and incubated at 37 °C for 45 minutes.  Then, 0.1 mm cell 
disruption beads (50% volume) were added to the samples and bead-beating was 
conducted using a DisrupterGenie (Scientific Industries, Inc).  DNA extraction was 
continued using the DNeasy® Blood and Tissue Kit (Qiagen, Valencia, California, USA) 
following the protocol for Gram-Positive DNA and eluted in 30 µL of buffer EB. 
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2.9.2 Amplification of Variable Region 2 (V2) of bacterial 16S rRNA gene (assisted by 
Adam Wong) 
PCR amplification of the Variable Region 2 (V2) of bacterial 16S rRNA gene was conducted 
using the primers 27F (5’ – AGA-GTT-TGA-TCM-TGG-CTC-AG-3’) and 338R (5’ – TGC-TGC-
CTC-CCG-TAG-GAG-T-3’) with a sample-specific 27F primer with a specific multiplex 
identifier (MID) sequence.  All 27F and 338R primers were modified with 5’-Adaptor A and 
5’-Adaptor B sequences, respectively for the pyrosequencing (Roche).  PCR amplification 
was conducted in triplicate on six DNA samples containing 1X Taq polymerase buffer, 0.24 
mM of each deoxynucleoside triphosphate, 2 mM MgCl2, 8 pM each primer, 1 µL 
template DNA and 0.6 U Platinum® Taq DNA polymerase.  The 25 µl PCR mixtures were 
incubated for 10 minutes at 94 °C, followed by 25 cycles of 1 minute at 94 °C, 1 minute at 
58 °C and 1 minute at 72 °C with a final incubation of 8 minutes at 72 °C.   PCR reactions 
(22.5 µl) were purified using Agencourt Ampure® SPRI kit and quantified using the Quant-
iT™ PicoGreen® kit.  Each reaction was diluted to 1 x 109 molecules µl -1.  Equal volumes of 
the three reaction products per sample were mixed together and diluted to 1 x 107 
molecules for emulsion PCR at one copy per bead using only “A” beads for unidirectional 
sequencing.  Beads were subjected to one full plate of the 454 GS-FLX pyrosequencing 
instrument using standard Titanium chemistry (Cornell Life Sciences Core Laboratory 
Centre, Biotechnology, Cornell University, Ithaca, NY).  
2.9.3 Analysis of 454 sequences 
Sequences were checked for quality using Genome Sequencer FLX System Software 
Manual, version 2.3 and clustered at 97% or more identity using Pyrotagger 
(http://pyrotagger.jgi-psf.org/release/; Kunin and Hugenholtz, 2010) (assisted by Adam 
Wong).  Sequences were identified using the NCBI nucleotide Basic Local Alignment 
Search tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify the closest match for each 






2.10 Microarray analysis 
A microarray analysis of Drosophila melanogaster was conducted to gain a global 
overview of the effect of diet and bacteria depleted conditions (flies derived from 
dechorionated eggs) on gene expression.  
2.10.1 Insect rearing 
Drosophila Canton S was reared on the Cornell diet (Table: 2.1).  Flies were transferred 
into egg-laying cages with 1% grape juice agar overnight.  On Day 1, 200 control 
(untreated) and 200 dechorionated eggs (Section: 2.3.2.1) were transferred onto 
autoclaved diets: low nutrient (20 gl-1 of glucose and yeast) and Cornell (High nutrient) 
(80 gl-1 of glucose and yeast).  Both diets were autoclaved at 121°C for 20 minutes.  
Emerged adults were collected and placed onto fresh diet for 3/4 days before being flash 
frozen with liquid nitrogen and stored at -80 °C.   
2.10.2 RNA Extraction and Sample Preparation (Method from John Ramsey) 
RNA extraction was conducted on 10 male flies per replicate, 3 replicates per treatment.  
Flies were placed into chilled tubes on dry ice with 2 metal beads per tube and ground at 
1600 strokes/min, for 95 seconds (2000 Geno/Grinder).  Five hundred micro-litres of 
Trizol® (Invitrogen) was added to each tube and homogenised with a needle and 1 ml 
syringe.  The mix was then centifuged at 10,000 g for 10 minutes.  The supernatant was 
transferred to a new tube and 50 µl of bromochloropropane was added to the sample, 
the sample was mixed by invertion and left for 5 minutes at room temperature.  The 
samples were centrifuged for 10 minutes at 10,000 g at 4 °C, the upper aqueous layer was 
transferred to a new tube and 100 μl of ethanol was added to the sample.  The sample 
was then added to a cartridge (Ambion, Ribopure™ Kit), centrifuged for 30 seconds at 
10,000 g and the eluent discarded.  The cartridge was washed with 500 μl wash buffer 
(Ambion, Ribopure™ Kit), centrifuged for 30 seconds at 10,000 g and the eluent 
discarded. The centrifugation step was repeated and the remaining eluent was discarded. 
The RNA was eluted in 50 μl RNase-free water was added to the cartridge, left for 2 
minutes at room temperature and centrifuged for 1 minute at 10,000 g. The quantity of 




The microarray used was a Drosophila Single Channel Gene Expression Microarray 
(Agilent, California, USA) with a format of 4 x 44k and 44,000 60-mer drosophila probes.  
RNA sample quality and integrity was evaluated using an Agilent Bioanalyzer. The RNA 
sample was amplified and labelled with Cy3 Amino Allyl MessageAmp™ II aRNA 
Amplification Kit (Ambion/Applied Biosystems) according to instructions, hybridised to 
the 4 x 44k microarray and washed according to manufacturers protocols. The microarray 
was scanned by an Axon 4000B scanner; fluorescent signals were obtained using Agilent 
Feature Extraction software (Cornell Life Sciences Core Laboratory Centre, Biotechnology, 
Cornell University, Ithaca, NY).   
2.10.4 Microarray Analysis 
The data were analysed by Limma (analysis with John Ramsey) and GeneSpring®.   
For the analysis using Limma, the raw data files were imported into R 2.10.1 (cran-r-
project.org/) and analysed with BioConductor (www.bioconductor.com) package Limma. 
The median foreground probe intensities were calculated without background 
subtraction, as recommended by Zahurak et al (2007).  The values were then log2 
transformed and normalised using the vsn (Variance Stabilization and Normalization) 
package in R (R2.10.1, cran-r-project.org/).  Variance Stabilization and Normalization 
method is based on the fact that variance of the microarray depends on the signal 
intensity  
Normalisation using the vsn method of analysis is based on three assumptions: 1) The 
variance of the measurements on a probe depends on the mean intensity 2) The 
relationship of measurements between samples is by an affine-linear transformation and 
3) The variance-stabilised intensities per spot are normally distributed (Huber et al., 
2002).  This method is used to preprocess microarray intensity data by an affine 
transformation of each column, followed by a variance-stabilising transformation of the 
whole data (Huber, 2006; Huber, 2010).  The method is summarised by the equation; > e2 
<-vsn(e1) where e1 is the raw intensity measurements and e2 is the calibrated and 
generalised log-transformed data (Huber, 2006). The generalised log-transformed data is 
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a function similar to natural logarithm for large values (large compared to the background 
noise) but is less steep (has a smaller slope) for smaller values (Huber et al., 2003; Huber, 
2006; Huber, 2010).  The difference between the transformed values is the generalised 1 
log-ratio (Huber, 2006; Huber, 2010).  These generalised 1 log-ratios are shrinkage 
estimators of the natural logarithm of the fold change where shrinkage estimators at low 
intensities are smaller than or equal to to the naive log-ratios and become equal at large 
intensities (Huber, 2006; Huber, 2010).  Therefore, they are not affected by the variance 
divergence of the naive log-ratios at the lower intensity which allows the value to 
maintain a significant result when the data are negative or close to zero (Huber, 2006; 
Huber, 2010). This method removes the intensity dependence of the variance (Huber et 
al., 2003). 
For the analysis using GeneSpring® GX Software Version 11 (Agilent), the raw data files 
were imported into GeneSpring® and the data was normalised using Quantile 
Normalisation (reduces variance between arrays).  Quantile normalisation is performed 
by sorting the expression values of each sample into ascending order and placed next to 
each other.  The mean of the sorted order across all samples is taken; therefore each row 
in the matrix has equal variance to the previous mean.  The modified matrix which has 
been obtained is then re-arranged to have the same ordering as the input matrix (Details 
obtained via email contact with Agilent Technologies). 
Differential Expression analysis was performed with both methods at the 0.05 level.   
A comparison of the two methods of analyses (GeneSpring® and Limma) were conducted 
by comparing the number of genes where the expression was significantly changed 
(p<0.05) to determine which analysis was the most conservative.  With the exception of 
the comparison of low nutrient diet dechorionation v high nutrient diet dechorionation 
(Figure: 2.4d), GeneSpring® was shown to be the most conservative with similar number 
of genes as with Limma for the High nutrient diet comparison (Figure: 2.4b) and lower 
genes with the low nutrient (Figure: 2.4a) and control comparison (Figure: 2.4c).  
The gene ontology of each sequences was gained through the use of Blast2GO 
(blast2go.org) and searches using NCBI (http://www.ncbi.nlm.nih.gov/), panther 
56 
 
(www.pantherdb.org/), DGI TC Annotator (http://compbio.dfci.harvard.edu) and FlyBase 
(www.flybase.org). 
 a)  Low nutrient diet: Dechorionation V Control                b)   High nutrient diet: Dechorionation V Control 
  
c)  Low nutrient diet control V High nutrient      d) Low nutrient diet dechorionation V High nutrient        
     diet control               diet dechorionation 
  
Figure 2.4:  Comparison of the two different methods of analysis, GeneSpring® and 
Limma with the number of genes where expression is significantly altered; a) low 
nutrient diet: dechorionation V control b) high nutrient diet: dechorionation V control c) 
low nutrient diet control V high nutrient diet control d) low nutrient diet 
dechorionation V high nutrient diet dechorionation. Overlapping numbers represented 
the number of genes shared by both methods; numbers within each circle represents 
the number of genes found to have a significantly altered expression.  The Venn 
diagram was created using an online source produced by Oliveros (2007). 
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2.10.5 Quantitative RT-PCR 
Quantitative RT-PCR (qRT-PCR) was conducted to confirm the results gained from the 
microarray data. 
The samples used for the microarray were treated with DNase (Ambion) to remove 
contaminating DNA from the samples by the addition of 1X DNase I buffer and 1 µl 
rDNase I. The samples were incubated for 30 minutes at 37 °C and the reaction was 
terminated by the addition of 5 µl of inactivation reagent. The samples were then 
centrifuged for 1.5 minutes at 10,000g. 
The cDNA was created by adding 200 ng of random primers (Fisher), 200 ng RNA, 10 
pmole dNTPs and made up in sterile distilled water.  The mixture was heated to 65 °C for 
5 minutes and chilled on ice.  1 X First-Strand Buffer and 0.01M Dithiothreitol were added 
and gently mixed and incubated at 25 °C for 2 minutes. Two hundred units of 
SuperScript™ II RT (Invitrogen) was added and mixed by pipetting.  The sample was then 
incubated at 25 °C for 10 minutes, followed by incubation at 42 °C for 50 minutes and 
heat inactivated for 15 minutes at 70 °C.  The cDNA was stored at -20 °C.   
 Table: 2.3. Primers (designed using Primer-BLAST, NCBI) used for quantifying Diptericin, 
Diptericin B, Fat Body Protein 1, CG31148. Defensin and Phosophoenolpyruvate 
carboxykinase by qRT-PCR with the housekeeping gene RPL32 and Zwischenferment 
gene with no fold change expression across treatments in the microarray analysis. 
 
 The qRT-PCR reactions were performed in 96 well plates using 2 μl cDNA and 19 μl 
master mix, consisting of 1X Power Sybr Green PCR Master mix (Applied Biosystems) and 
Gene name Forward sequence (5’-3’) Reverse sequence (5’-3’) 
DiptericinB TTGGACTGGCTTGTGCCTTCTCG TTGGGAGCATATGCCAGTGGTTCA 
Fat Body Protein 1 GCTGCAGGCCATTAATCCATCCGT TGCCAGTCAGATTCATGCCCATCG 
CG31148 AGCTTGGGATGGACGCCACA TGGTCGAGTGCGGTTCATCATTTT 




Diptericin GCAGTTCACCATTGCCGTCGC GCAGTTCACCATTGCCGTCGC 
Zwischenferment (control) GCAGTTCACCATTGCCGTCGC ACCGCCGCCTCCCTGAAGAT 





2.5 pM of the forward and reverse primers (Table 2.3).  Two negative controls were also 
prepared, the reagent only negative controls which contained sterile distilled water with 
no DNA sample and No RT (Reverse transcriptase) control. The qRT-PCR reactions were 
carried out in a CFX96 Real time system on a C1000 thermal cycler (BioRad) with the 
following thermal profile: 2 minutes at 50 °C, 10 minutes at 95 °C followed by 40 cycles of 
15 seconds at 95 °C and 1 minute at 60 °C. To ensure primer specificity to each gene, a 
melt curve was run for each plate from 65-95 °C with an increment of 0.5°C (Figure: 2.5). 
 
Figure: 2.5. An example of a melt-curve analysis with the primer pairs of 
Zwischenferment (control) with cDNA from replicate 1 of the control flies reared on a 
low nutrient diet. 
The expression level of each gene (Table: 2.2)  was determined by the comparative CT 
value method where the CT value obtained for each gene was normalized to the CT 
values obtained for the housekeeping gene RPL32.  
2.11 Statistical Analysis 
Statistical analyses were conducted using SPSS Inc 16.0 and 17.0 (Dytham, 2003 p66-
199.).  Significance was tested at 95% and above confidence level.  The statistical test was 
selected depending on the data type and distribution. 
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For normally distributed and continuous data with 2 or more sample groups; an analysis 
of variance (ANOVA) was conducted.  For data with a non-normal distribution and 
discontinuous data; a Mann-Whitney U test, a Kruskal-Wallis test and a Scheirer-Ray-Hare 
test was selected according to the number of groups and factors.  Catagorical data was 
analysed using a Chi2 analysis.  
Table: Summary table of statistical tests used in this thesis (Dytham, 2003). 
Samples/Groups Factors Data type Statistical test 
2 1 Catagorical Chi2 test 
Discontinuous Mann-Whitney U test 
Continuous t-test, one-way 
ANOVA 
>2 1 Catagorical Chi2 test 
Discontinuous Kruskal-Wallis test 
Continuous One-way ANOVA  
2+ >1 Discontinuous Scheirer-Ray-Hare test 
Continuous Two-way ANOVA, 
Multi-way ANOVA and 
















Chapter 3:  Bacteria and performance of Drosophila melanogaster 
3.1 Introduction 
There is growing interest in the importance of gut microbes in animals and how the 
depletion of these microbes affects the health and performance of the animal.  Several 
scientists have investigated the implications of antibiotics on the gut microbiota; in mice 
antibiotics have been shown to alter the diversity of bacteria found within the gut 
(Antonopoulos et al., 2009).   In control mice the microbes were Firmicutes and 
Bacteroidetes but with antibiotic treatment the gut microbiota was predominantly 
Proteobacteria (Antonopoulos et al., 2009).   
Drosophila melanogaster has been used for decades as one of the most useful model 
organisms when researching human diseases, and now there has been an increase in the 
use of Drosophila melanogaster to enable scientists to gain more insight into the role of 
gut bacteria.  Sharon et al (2010) has shown that commensal bacteria play an important 
role in the mating preferences in Drosophila melanogaster and that diet also determines 
the species diversity in the insects.   In this study it was shown that on a cornmeal-
molasses-yeast diet, the insects have a more diverse population of bacteria in the gut 
compared with the insects on starch diet where only Lactobacillus plantarum was 
identified. 
The importance of symbiotic bacteria to the host has also been demonstrated by several 
other authors (Ren, et al., 2007; Brummel, et al., 2004; Bakula, 1969) with Drosophila 
melanogaster (Chapter 1).  Nevertheless, these studies have been inconsistent and in 
some cases not repeatable due to differences in conditions such as; the  diet, the 
methods used to produce bacteria-free flies (use of antibiotic treatment and egg 
dechorionation) and how bacteria-free flies were characterised (culturable (Bakula, 1969)  
and 16S rRNA gene analysis (Ren, et al., 2007).  Certain authors have used high 
concentrations of antibiotics to deplete the bacteria however they have not considered 
the implication of using such a high dose on the insect performance an example is a study 




Most papers investigating the importance of Drosophila melanogaster symbionts in the 
host performance concentrate on life-span with only Bakula (1969) measuring 
development time.  One particular aspect which has not been investigated is the role of 
Drosophila symbionts in host nutrition.  Therefore, in this chapter I determine the impact 
of chlortetracycline on two wild-type lab strains: Oregon-RS and Canton-S by treating the 
Drosophila melanogaster with a range of chlortetracycline concentrations (0-500 μg ml-1).  
Survival and development to pupae/adulthood, lifespan, the nutrition and respiration of 
the flies were measured.  The effect of the treatment with chlortetracycline on the 
bacterial content within larvae and adults was also investigated by culturable bacterial 
counts and 454 pyrosequencing to compare the bacterial diversity with chlortetracycline 
and non-chlortetracycline treated adult flies.  Further experiments using Canton-S with 
bacteria depleted flies (derived from egg dechorionation) were also used as a comparison 
with chlortetracycline treated flies, and to determine whether the depletion of bacteria 
or toxicity of the chlortetracycline was responsible for the changes in performance.  
Finally, survival studies with Drosophila melanogaster (Canton-S) using a high nutrient 
(Cornell diet) and low nutrient diet will establish whether different responses are 
observed with different diets when the bacteria are depleted in flies via treatment with 











3.2 Oregon-RS survival and development 
3.2.1 Oregon-RS survival and sex-ratio 
Initial experiments using the lab strain, Oregon-RS were used to test whether 
chlortetracycline treatment had a significant impact on Drosophila melanogaster. 
Oregon-RS eggs were transferred to the York diet containing different concentrations of 
chlortetracycline up to 500 µg ml-1.  The mean number of individuals that survived to 
pupation varied from 5.1-7.2 out of 10 and did not vary significantly with treatment 
(Kruskal-Wallis: H6 = 5.973, p>0.05) (Figure: 3.1).  Pupal mortality was also low such that 
4.9-6.8 survived to adulthood, again with no significant difference between treatments 
(Kruskal-Wallis: H6 = 6.039, p>0.05) (Figure: 3.1).   At the lower concentrations of 
chlortetracycline (0-10 µg ml-1) the flies had a tendency to stick to the diet upon 
emergence, these were still alive when the numbers were recorded.  The diet appeared 
to be more liquid than diets with a higher concentration of chlortetracycline (100 µg ml-1 
and above).  The “sticking” to the diets could possibly be due to the growth of bacteria on 
the diets as this was not observed with the diets containing 100 µg ml-1 and higher of 
chlortetracycline.  Therefore, the addition of antibiotics could actually prevent this 
process from occurring and the survival data could have been different if the flies that 
were “stuck” on the food had not been removed on the day of their emergence. 
 
Figure: 3.1. Mean percent survival to pupae and adulthood of the 10 vials (10 eggs per 
vial) of each treatment of 0-500 µg ml-1 chlortetracycline (Methods Chapter, Section: 
2.3.1, page 39). 
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The ratio of males and females was also analysed to determine whether chlortetracycline 
had an impact on the number of males and females in the population. The sex ratio did 
not vary significantly with increasing concentration of chlortetracycline.  At 0 µg ml-1, the 
ratio was 26:31 and for 500 µg ml-1 the ratio was 26:37 (males to females) (Table: 3.1).  
The concentration of chlortetracycline where there was quite a variation was at 1, 10 and 
50 µg ml-1 where at 50 µg ml-1 there was double the number of females compared to 
male flies.  Using a goodness of fit chi-square statistical test, the sex ratio was analysed to 
determine whether there is a significant effect on the sex ratio of Drosophila by antibiotic 
treatment.  This analysis revealed no significant difference between the ratios of males 
and females (Χ26
 = 8.321, p>0.05) between the different treatments.   
Table: 3.1. Sex ratio of Drosophila treated with 0-500 µg ml-1 chlortetracycline, number 
of replicates = 10 (Methods Chapter, Section: 2.3.1, page 39).  




Sex ratio Males:Females (% males) 
 
0 26:31 (45.6%) 
1 27:41(39.7%) 
10 16:30 (34.8%) 
50 18:38 (32.1%) 
100 28:28 (50%) 
300 29:29 (50%) 














3.2.2 Development time to pupae and adulthood 
Development time measurements were also included in this experiment to determine 
whether the removal of the bacteria altered the development time. The development 
time of Oregon-RS to pupation (p<0.001, Table 3.2) and adulthood (p<0.001, Table: 3.2) 
varied significantly with chlortetracycline concentration.  At 0 µg ml-1 of chlortetracycline, 
larvae started to develop into pupae by day 7.  As the concentration of antibiotic 
increased, pupae formation was delayed in 2 steps; firstly, the median development to 
pupae was extended by one day at 1-10 µg ml-1 of chlortetracycline and by 2 days at 50-
500 µg ml-1 of chlortetracycline. This delay in development was also observed in the 
emergence of adults, median development to adulthood was extended from 11 days to 
12 days at 1-10 µg ml-1 and 13 days at 50-500 µg ml-1. 
Table: 3.2. The effect of chlortetracycline on the development time of Drosophila 
melanogaster (Oregon-RS) of 10 vials (10 eggs per vial) of each treatment of 0-500 µg 
ml-1 chlortetracycline (Methods Chapter, Section: 2.3.1, page 39).   
  
Median development time (Days) 
 
Concentration of chlortetracycline µg ml
-1
 to pupae to adulthood 
0 7 11 
1 8 12 
10 8 12 
50 9 13 
100 9 13 
300 9 13 
500 9 13 










3.2.3 Behaviour of larvae on chlortetracycline 
Oregon-RS larvae behaved differently on diet with high a concentration of 
chlortetracycline (100-500 µg ml-1) compared with the larvae reared on the diet with 0-50 
µg ml-1 of chlortetracycline.  Larvae on low concentrations of chlortetracycline were able 
to burrow into the food, but at higher concentrations the larvae had a tendency to 
remain on the surface.  One possible explanation to this observation is that the bacteria 
that grow on the diets with low concentrations of chlortetracycline are softening the diet 
and therefore the larvae have the ability to tunnel through the diet.  At higher 
concentrations of chlortetracycline there is little or no bacterial growth and therefore the 
diet remains solid and harder for the larvae to tunnel into the food.  Another possible 
explanation for this observation could be that the larvae treated with high concentrations 
of chlortetracycline are less vigorous and are not able to penetrate the food as much as 
the larvae treated with 0-50 µg ml-1 of chlortetracycline. 
To test whether the extension of development time was due to a direct effect of 
chlortetracycline rather than a deleterious consequence of feeding on the surface, control 
Oregon-RS was reared on a diet with 0.9-2.5% agar.  This experiment showed that there 
was a significant difference in the median development time (p<0.001. Table: 3.3).  The 
concentration where a difference was observed was at 2% agar where the median 
development time was shortened from 11 days to 9 days, suggesting that this result could 
be an artefact rather than a real result as the reduction in development time was not 
observed at concentrations of agar higher than 2% and no difference was observed 
between the other concentrations (Table: 3.3).   Larvae were also observed to persist on 
the top of the diet at 1.5% and at percentages greater than 1.5%, larvae were found 
within the cracks in the food.  At 0.9-1%, larvae were able to penetrate the food and were 






Table:  3.3. The effect of agar percentage in the diet on the development time of control  
Drosophila melanogaster (Oregon-RS) of 10 vials (10 eggs per vial) of each treatment of 
0.9-2.5% agar (Methods Chapter; Section: 2.3.1, page 39).  All data are median. 







KW: H5 = 46.08, p<0.001  
 
3.3 Effects of Chlortetracycline on Oregon-RS size and nutrition  
As described in the introduction, experiments have been conducted with flies which 
included measurements for life-span and survival.  The change in the nutrition of the flies 
has not been considered, therefore in this section I will describe the changes which occur 
with flies treated with chlortetracycline.  
3.3.1 Effects of chlortetracycline on Oregon-RS wing area 
Size of the flies was assessed using wing area which had previously been shown by 
Shingleton et al (2005) and in Chapter 2 to be positively correlated with weight.  The wing 
area was used as a measure of size; wing area was compared between flies treated with 
0-500 µg ml-1.   A 2-way ANOVA was conducted to test whether chlortetracycline affected 
the wing area. There was no significant difference observed between the different 
concentrations of chlortetracycline (F6, 43 = 1.889, p>0.05) (Figure: 3.2). The graph (Figure 
3.2) shows that the wing area did not vary dramatically between the different treatments 
(in males; mean value of 1.368 mm2 at 0 µg ml-1 and 1.357 mm2 at 500 µg ml-1 and in 
females; 1.8 mm2 at 0 µg ml-1 and 1.55 mm2 at 500 µg ml-1).  Female flies have a greater 
wing area than males as they were much larger than the male flies (F1, 43 = 85.988, 
p<0.001). However, there was no significant difference in the effect of chlortetracycline in 




Figure: 3.2. Average wing area of male and female flies treated with 0-500 µg ml-1 of 
chlortetracycline, number of replicates per treatment = 5 (Methods Chapter; Section: 
2.5.1, page 44).   
3.3.2 Effects of chlortetracycline on Oregon-RS protein content 
The average protein content of the flies varied from 157 to 248 µg.  The average protein 
content of female flies was 243.3 µg of protein at 0 µg ml-1, this reduced to 202.2 µg at 
500 µg ml-1 (Figure: 3.3). In male flies the protein content varied from 157 to 190 µg.  
An analysis of covariance (ANCOVA) was conducted to take into account the size of the fly 
using the wing area as a covariate (F1, 54 = 0.110, p>0.05).  This analysis showed that 
protein content varied significantly with chlortetracycline treatment (F6, 54 = 6.598, 
p<0.001) and between sexes (F1, 54 = 46.601, p<0.001).  Yet, the test showed that there 
was a significant difference in response of male and female flies (F6, 54 = 3.534, p<0.01).  
As the statistical test suggested; the response of male and female flies differed, a one-
way ANOVA was conducted separately for the 2 sexes.  This analysis showed wing area 
did not differ in male (F1, 26 = 2.304, p>0.05) and female flies (F1, 27 = 0.238, p>0.05).     
Furthermore, the protein content varied significantly with chlortetracycline treatment in 




Figure 3.3: The protein content of flies treated with 0-500 µg ml-1 chlortetracycline, 
number of replicates per treatment = 5 (Methods Chapter; Section: 2.5.3, page 46).   
3.3.3 Effects of chlortetracycline on Oregon-RS lipid content 
Lipid content was the second nutrient to be quantified in chlortetracycline treated flies.  
As the dry weight of the flies was measured to calculate the lipid content of the flies, the 
lipid content was normalised to the dry weight of the fly.   
An ANOVA was conducted to determine whether there was a significant impact of 
chlortetracycline treatment on the lipid content of flies.   Chlortetracycline had a 
significant impact on the lipid content of the flies (F6, 54 = 15.086, p<0.001).  This response 
to chlortetracycline treatment was observed in both males and females (F6, 54 = 1.979, 
p>0.05).  However, there was a significant difference in lipid content between sexes, 
generally greater in males than in females (F1, 54 = 27.222, p<0.001).  In females the lipid 
content (per mg of dry weight) increases from 0.302 mg at 0 μg ml-1 to 0.371 mg at 100 
μg ml-1 (Figure 3.4). In males the lipid content increases from 0.294 mg at 0 μg ml-1 to 
0.436 mg at 100 μg ml-1 (Figure: 3.4). 
LSD (Least significant difference) post-hoc statistical test showed that the lipid content of 
the female flies treated with no chlortetracycline was significantly different from the flies 
treated with 100 μg ml-1. The lipid content of females peak at 100 μg ml-1 of 
chlortetracycline.  This result suggests that it could be an artefact, as the same trend was 
not observed at the concentrations of 300-500 μg ml-1.  In males, post-hoc tests suggest 




Figure: 3.4: The lipid content of female and male flies treated with 0-500 µg ml-1 of 
chlortetracycline, number of replicates per treatment = 5 (Methods Chapter; Section: 
2.5.6, page 48).   
Analysis of dry weight of the flies showed that the weight of the chlortetracycline treated 
flies was significantly affected by chlortetracycline treatment (F6, 54 = 9.5, p<0.001). There 
was a significant difference between male and female flies (F1, 54 = 224.738, p<0.001).  
The response to chlortetracycline differed in male and female flies (F6, 54 = 2.661, p<0.05).  
LSD post-hoc statistical test showed that the weight was significantly different at 100 μg 
ml-1 of chlortetracycline in both male and female flies (Figure: 3.5). 
  
Figure: 3.5: The average dry weight of male and female flies treated with 0- 500 µg ml-1 
of chlortetracycline, number of replicates per treatment = 5 (Methods Chapter; Section: 
2.5.6, page 48).   
70 
 
 3.4 Canton-S survival, development, lifespan and fecundity 
Experiments with chlortetracycline were repeated with Canton-S, to demonstrate that 
the observations made in Oregon-RS can also be observed in another wild-type laboratory 
strain.  Furthermore, another method was used to deplete bacteria in the flies via egg 
dechorionation.  A 2X2 factorial experiment was conducted with control flies and flies 
derived from dechorionated eggs treated with 0, 50 and 300 µg ml-1 of chlortetracycline. 
3.4.1 Survival to pupae and adulthood 
The average survival of the strain Canton-S to pupae and adulthood varied from 39-76%.  
The survival to pupae and adulthood was not significantly affected by chlortetracycline or 
by egg dechorionation (Table: 3.4) (p>0.05), yet it does appear that chlortetracycline and 
dechorionation does improve the survival of Canton-S but not when flies derived from 
dechorionated eggs are treated with chlortetracycline.  In control flies the survival was 
39-47%, this increased to 57-76% with flies derived from dechorionated eggs without 
chlortetracycline and control flies treated with chlortetracycline. In flies derived from 
dechorionation and treated with chlortetracycline the survival was similar to the control 
flies, which could suggest that the dechorionation and chlortetracycline treatment had a 
deleterious effect on survival, however chlortetracycline treatment and dechorionation 
alone improved survival. 
Table: 3.4: Survival to pupae and adulthood of control flies and flies derived from 
dechorionation treated with 0-300 µg ml-1 of chlortetracycline and Scheirer-Ray-Hare 
statistical analysis, number of replicates = 15 (Methods Chapter; Section: 2.3.2.2, page 
40).   










Control Dechorionation Control Dechorionation 
0 47 ± 7 62 ± 4 39 ± 7 57 ± 5 
50 71 ± 4 38 ± 6 66 ± 4 35 ± 6 







F6, 84 = 0.728, p>0.05 
F1, 84 = 0.738, p>0.05 
F1, 84 = 2.025, p>0.05 
 
 
F6, 84 = 0.366, p>0.05 
F1, 84 = 1.541, p>0.05 
F1, 84 = 2.530, p>0.05 
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3.4.2 Development time to pupae and adulthood 
The development time to pupation of the strain Canton-S varied significantly with 
chlortetracycline concentration (p<0.05) (Table: 3.5).  At 0 µg ml-1 chlortetracycline, larvae 
started to develop into pupae by day 7.  Pupae formation was delayed by one day at 50 
and 300 µg ml-1 of chlortetracycline. Egg dechorionation also caused a significant effect 
on development time with an extension of one day (p<0.01, Table: 3.5). This experiment 
was repeated and an extension of development was again observed with treated 
Drosophila.  Furthermore, the result supports the data obtained with Oregon-RS.  It does 
suggest that the extension in development is due to the removal of bacteria and not a 
toxicity issue.   
Table: 3.5: Median development time (Days) of control flies and flies derived from 
dechorionation treated with 0-300 µg ml-1 of chlortetracycline and Scheirer-Ray-Hare 



















Control Dechorionation Control Dechorionation 
0 7 8 11 12 
50 8 8 12 12 






F6, 501 = 9.54, p<0.05 
F1, 501 = 64.65, p<0.001 
F2, 501 = 4.64, p>0.05 
 
F6, 469 = 9.54, p<0.05 
F1, 469 = 64.65, p<0.05 




3.4.3 Life-span of male Canton-S  
To gain an overall understanding about how chlortetracycline treatment and egg 
dechorionation affect Canton-S, lifespan and fecundity experiments were conducted. 
The life-span of male flies varied significantly with chlortetracycline concentration 
(p<0.001), but no significant difference was observed between control and with egg 
dechorionation (p>0.05) and there was no significant difference in response of 
dechorionated and control flies to chlortetracycline treatment (p>0.05) (Table: 3.6).  LSD 
post-hoc tests showed that control male flies on no chlortetracycline had a significantly 
lower life-span (41 days) compared with 60-64 days of control flies treated with 
chlortetracycline (Table: 3.6).  Flies derived from dechorionated eggs and no treatment 
with chlortetracycline had an average life-span of 52 days; however, chlortetracycline 
treatment appears to extend life-span further to 59 and 64 days at 50 and 300 µg ml-1, 
respectively. 
Table: 3.6: Average (mean) male life-span of control flies and flies derived from 
dechorionated eggs treated with 0-300 µg ml-1 of chlortetracycline, number of 














 Average adult life-span (Days) n=10 
Concentration of chlortetracycline (µg 
ml
-1
) Control Dechorionation 
0 41 ± 5.273 (8) 52 ± 3.271 (10) 
50 64 ± 2.805 (10) 59 ± 3.437 (10) 







F1,51 = 1.055, p>0.05 
F2,51 = 9.419, p<0.001 
F2,51 = 1.894, p>0.05 
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3.4.4 Fecundity of Canton-S 
Female flies were used to assess the fecundity of chlortetracycline treated flies and flies 
derived from dechorionated eggs.  A Scheirer-Ray-Hare test was conducted to determine 
whether there was a significant effect on the fecundity of control flies and flies derived 
from dechorionated eggs treated with chlortetracycline.  Chlortetracycline treatment was 
shown to have a significant effect (p≤0.05, Table: 3.7) on egg laying, with the median egg 
laying capacity being 113 eggs for the control flies and 49.5 and 72 eggs for 50 and 300 µg 
ml-1, respectively.  Dechorionation had no significant effect on fecundity (p>0.05, Table: 
3.7).  Flies derived from dechorionated eggs without chlortetracycline treatment were 
shown to have no significant difference compared with controls (112 and 117, 
respectively) (Table: 3.7).  The response to chlortetracycline of control flies and flies 
derived from dechorionated eggs was not significantly different (p>0.05, Table: 3.7).  Flies 
derived from dechorionated eggs treated with 50 and 300 µg ml-1 chlortetracycline 
showed an egg laying capacity of 68 and 104 eggs, respectively.   
This result suggests that bacteria depletion does not have an effect on the fecundity of 
Drosophila, but the presence of chlortetracycline reduces fecundity.  This may be due to 2 
reasons; 1) the toxicity of chlortetracycline causes a reduction in the reproduction 
capacity 2) the females are deterred from ovipositing on the diet containing the 
antibiotic.  
Table: 3.7. Median number of eggs laid over 7 days of control flies and flies derived 
from dechorionated eggs treated with 0-300 µg ml-1 of chlortetracycline and Scheirer-
Ray-Hare statistical analysis, number of replicates = 10 (Methods Chapter; Section: 
2.3.2.2, page 41). 
  
Median number of eggs laid 
over 7 days (n=10) 
  
Concentration of chlortetracycline (µg ml
-1
) Control Dechorionated 
0 113 117 
50 49.5 68 






F2,53 = 3.69, p<0.05 
F1,53 = 0.36, p>0.05 




3.4.5 Egg Hatching Experiment 
Bacteria depleted flies where the eggs were dechorionated have been observed to have 
an extended development time to pupae and adulthood when compared with control 
flies.  Johnston and Crickmore (2010) reported that axenic (bacteria-free) Manduca sexta 
showed a delayed development; they suggested that the treatment rather than the 
removal of bacteria had caused the extension.  From this suggestion, egg hatching was 
monitored to determine whether the dechorionation caused the eggs to hatch later than 
controls.  Bacteria depletion did not appear to cause a delay in egg hatching (MWU: Z1 =    
-1.463, p>0.05), with the median egg hatching time 19 hours after treatment (Table: 3.8). 
Table: 3.8. Median egg hatching time (Hours) of control and dechorionated eggs, 
number of replicates = 10 (Methods Chapter; Section: 2.3.2.2, page 41). 
Treatment  Median egg hatching time (Hours) 
Control 19  
Dechorionated 19 
 
Egg hatching was also measured to determine whether a delayed egg hatching is 
responsible for a delay in development time to pupae and adulthood when treated with 
chlortetracycline.  Eggs were transferred to the control diets and diets with 50 and 300 µg 
ml-1 of chlortetracycline.   Number of eggs hatched was counted at the beginning and end 
of each day.  Chlortetracycline treatment appears not to have an effect on the egg 
hatching (H2 = 0.820, p>0.05), with the median time to hatch of 19 hours after transfer to 
chlortetracycline or non-chlortetracycline diet (Table: 3.9).  A Kruskal-Wallis test was 
conducted on the data which was shown to have a distribution which was significantly 
different from normal (p<0.001).   
Table: 3.9. Median egg hatching time (Hours) of eggs transferred to diet supplemented 
with chlortetracycline, number of replicates = 10 (Methods Chapter; Section: 2.3.2.2, 
page 41). 








3.5 Effects of Chlortetracycline on Canton-S size and nutrition  
3.5.1 Effect of chlortetracycline on Canton-S wing area 
The size of the flies was inferred from the wing area of the flies and used for nutritional 
analysis. The wing area of male flies was not significantly affected by either 
chlortetracycline treatment or by egg dechorionation (p>0.05, Table: 3.10). The average 
wing area of female flies was significantly reduced with chlortetracycline treatment and 
the treatment with chlortetracycline and egg dechorionation with the exception of 
dechorionation with treatment of 50 µg ml-1 of chlortetracycline diet (Table: 3.10). 
Table: 3.10. The wing area  of male and female control flies and flies derived from 
dechorionated eggs (Dechorionation) treated with chlortetracycline (0-300 µg ml-1) and 






















Control Dechorionation Control  Dechorionation 
0 1.36 ± 0.04 1.36 ± 0.01   1.84 ± 0.02 1.80 ± 0.01
 
50 1.38 ± 0.01 1.41 ±  0.02   1.75 ± 0.01 1.84 ± 0.02 






F1,22= 0.218, p>0.05 
F2,22 = 0.988, p>0.05 
F2,22 = 0.244, p>0.05 
 
F2,22 =  3.750, p>0.05 
F2,22 = 4.107, p<0.05 
F2,22 = 10.637, 0.001<p<0.01 
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3.5.2 Effect of chlortetracycline on Canton-S triglyceride content 
The triglyceride content of the Drosophila melanogaster was quantified in order to 
determine whether bacterial depletion through chlortetracycline treatment and 
dechorionation affected the lipid nutrition of the insect.   Wing area was used as a 
covariate in this analysis to take into account the size differences between samples.  The 
triglyceride content of male flies was not significantly affected by egg dechorionation, 
however treatment with chlortetracycline did.   In males the triglyceride content 
decreases from 13.9 µg at 0 μg ml-1 to 12.2 and 11.5 µg at 50 and 300 μg ml-1 of 
chlortetracycline, respectively (Table: 3.11).  Flies derived from dechorionated eggs and 
reared on 50 μg ml-1 of chlortetracycline actually had a greater triglyceride content (17.2 
µg) compared with control flies (13.9 µg), this result was supported by the significant 
interaction between chlortetracycline and egg dechorionation (p<0.001). In females the 
same pattern was observed, there was no significant effect of egg dechorionation but 
there was a significant reduction in triglyceride content in the presence of 
chlortetracycline (p<0.05). In females, the triglyceride decreases from 23.5 µg at 0 μg ml-1 
to 17.3 and 21.2  µg at 50 and 300 μg ml-1 respectively (Table: 3.11).  The same pattern 
was observed in flies derived from dechorionated eggs treated with chlortetracycline 
(p>0.05).  
Table: 3.11 Triglyceride content of control flies and flies derived from dechorionated 
eggs treated with 0-300 µg ml-1 of chlortetracycline and ANCOVA statistical analysis, 





Triglyceride content (µg) per fly 




Control Dechorionation Control  Dechorionation 
0 13.9 ± 0.5 12.0 ± 0.5   23.5 ± 0.6 21.1 ± 1.0
 
50 12.2 ± 1.1 17.2 ± 0.5   17.3 ± 1.2 17.7 ± 2.5 
300 11.5 ± 0.5 10.4 ± 1.3*   21.2 ± 1.2 15.8 ± 0.7* 
ANCOVA 





F1,21= 2.498, p>0.05 
F1,21 = 0.349, p>0.05 
F2,21 = 20.799, p<0.001 
F2,21 = 12.830, p<0.001 
 
F1,22 =  0.206, p>0.05 
F1,22 = 0.521, p>0.05 
F2,22 = 6.294, 0.05>p>0.01 
F2,22 = 1.603, p>0.05 
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3.5.3 Effect of chlortetracycline on Canton-S protein content 
In male flies there was a significant effect of egg dechorionation on the protein content of 
the flies but chlortetracycline treatment alone had no significant effect on the protein 
content (p>0.05) (Table: 3.12). The protein content was significantly reduced in flies with 
egg dechorionation and treatment with chlortetracycline (decreases from 102.8 µg in 0 μg 
ml-1 control to 78.2 µg) (p≤0.05).  In female flies dechorionation has no significant effect 
on the protein content, nevertheless chlortetracycline treatment did;  protein content 
decreases from 165.6 µg at 0 μg ml-1 to 126.6 and 141.5  µg at 50 and 300 μg ml-1, 
respectively (Table: 3.12).  The same pattern was also observed with flies derived from 
dechorionated eggs and exposed to chlortetracycline (138.7 and 121.2 µg at 50 and 300 
μg ml-1, respectively) which is supported by the non significant result for the interaction 
between egg dechorionation and chlortetracycline.  This result observed in the female 
flies suggests that the chlortetracycline could be altering protein metabolism/synthesis 
and not as a result of depleting the bacteria as there was no significant difference with 
egg dechorionation alone.  However, this was not observed in male flies.  The only 
significant reduction was observed in flies with egg dechorionation and treated with 
chlortetracycline, suggesting that there is an interaction between chlortetracycline and 
egg dechorionation. 
Table: 3.12: The protein content of control flies and flies derived from dechorionated 
eggs treated with 0-300 µg ml-1 of chlortetracycline and ANCOVA statistical analysis, 






Protein content (µg) per fly 




Control Dechorionation Control  Dechorionation 
0 102.8 ± 7.3 106.9 ± 4.0   165.6 ± 8.3 152.8 ± 4.6
 
50 108.7 ± 8.6 87.7 ± 5.2   126.6 ± 10.3 138.7 ± 2.5 
300 104.3 ± 6.8 78.2 ± 6.5*   141.5 ± 8.1 121.2 ± 4.8* 
ANCOVA 





F1,21 = 2.230, p>0.05 
F1,21 = 7.763, p<0.05 
F2,21 = 2.644, p>0.05 
F2,21 = 3.394, p≤0.05 
 
F1,22 =  0.147, p>0.05 
F1,22 = 0.582, p>0.05 
F2,22 = 5.939, 0.01>p>0.001 
F2,22 = 1.583, p>0.05 
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3.5.4 Effect of chlortetracycline on Canton-S glucose content 
The carbohydrate content of the flies were quantified, the carbohydrate sources that 
were analysed were glucose, trehalose and glycogen.  On average, the glucose content of 
the flies ranged from 4-12 µg (Table: 3.13).  The glucose content of male and female flies 
was approximately 60% greater in flies reared with egg dechorionation excluding the flies 
also reared with 300 µg ml-1.  Chlortetracycline also promoted the quantity of free 
glucose; still there was only approximately a 40% increase. This result suggests that in the 
presence of bacteria, free glucose levels are depressed, chlortetracycline does not 
eliminate all of the bacteria and therefore the effect is less pronounced.  The flies with 
dechorionation and reared on 300 µg ml-1 of chlortetracycline did have a lower quantity 
of glucose, but this could be the result of a build-up effect of a high concentration of 
chlortetracycline on a fly with an already depleted gut microbiota.  
Table: 3.13. The glucose content of control flies and flies derived from dechorionated 
eggs treated with 0-300 µg ml-1 of chlortetracycline and ANCOVA statistical analysis, 











Glucose content (µg) per fly 
Mean ± s.e. (n=5, except 
 
*n=3 # n=4) 
Males Females 
Control Dechorionation Control  Dechorionation 
0 4.9 ± 0.4 8.3 ± 0.6   7.9 ± 0.5 12.3 ± 0.8#
 
50 5.1 ± 0.3 8.6 ± 0.6   8.1 ± 0.4 13.5 ± 1.3 
300 6.7 ± 0.3 5.0 ± 0.5 *   10.7 ± 1.1 4.9 ± 0.3* 
ANCOVA 





F1,21 = 0.249, p>0.05 
F1,21 = 18.441, p<0.001 
F2,21 = 1.943, p>0.05 
F2,21 = 15.727, p<0.001 
 
F1,20 =  5.830, p<0.05 
F1,20 = 1.279, p>0.05 
F2,20 = 5.363, p<0.05 
F2,20 = 36.873, p<0.001 
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3.5.5 Effect of chlortetracycline on Canton-S trehalose content 
On average the trehalose content of the flies ranged from 4-14 µg (Table: 3.14).  In male 
flies chlortetracycline treatment appeared to increase the trehalose content of the flies 
by approximately 30 percent.  Again, this supports the theory suggested for the glucose 
data that the bacteria utilise the sugar and therefore deplete levels within the fly.  
However, the same pattern was not observed with egg dechorionation, a reduction was 
actually observed at 0 and 50 µg ml-1 of chlortetracycline.  In female flies the same 
pattern was observed as with male flies.  An increase in free trehalose for the 
chlortetracycline treated flies was demonstrated, this increase was substantial with up to 
a 3 fold change. In female flies with egg dechorionation, an increase was also observed 
and at a similar quantity as the treatment with 300 µg ml-1 (a concentration of antibiotic 
which depletes most of the bacteria). 
Table: 3.14. The trehalose content of control flies and flies derived from dechorionated 
eggs treated with 0-300 µg ml-1 of chlortetracycline and ANCOVA statistical analysis, 











Trehalose content (µg) per fly 
Mean ± s.e. (n=5, except 
 
*n=3 # n=4) 
Males Females 
Control Dechorionation Control  Dechorionation 
0 5.5 ± 0.4 4.1 ± 0.7   4.3 ± 0.4 12.1 ± 2.0#
 
50 6.3 ± 0.6 2.0 ± 1.4   7.8 ± 1.3 11.3 ± 1.2 
300 7.2 ± 1.0 6.1 ± 0.7*   11.8 ± 0.8 14.1 ± 1.3* 
ANCOVA 





F1,21= 0.401, p>0.05 
F1,21 = 9.035, p<0.01 
F2,21 = 3.766, p<0.05 
F2,21 = 2.096, p>0.05 
 
F1,20 =  1.324, p>0.05 
F1,20 = 22.962, p<0.001 
F2,20 = 4.332, p<0.05 
F2,20 = 1.692, p>0.05 
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3.5.6 Effect of chlortetracycline on Canton-S glycogen content 
The final carbohydrate that was quantified was glycogen.  On average the glycogen 
content of the flies was 4-22 µg (Table: 3.15).  In male flies there was no distinct trend, 
there was no significant difference between flies with and without egg dechorionation.  
However, there was a significant difference in glycogen levels of chlortetracycline treated 
flies at 300 µg ml-1 where a 30% increase was observed. The flies without egg 
dechorionation had a greater quantity of glycogen levels compared to the control flies, 
but this was not significant (p>0.05). At 50 µg ml-1 of chlortetracycline with 
dechorionation, the glycogen levels were approximately 50% greater.  This result was 
supported by the statistical significance of the interaction between egg dechorionation 
and chlortetracycline.  In female flies, a more distinct trend was observed where female 
flies on high concentrations of chlortetracycline (300 µg ml-1) and with egg 
dechorionation had a significantly greater quantity of glycogen. A 20-300% increase was 
observed in females treated with chlortetracycline and reared without egg 
dechorionation.  Female flies reared without egg dechorionation and in the presence of 
chlortetracycline had a much greater quantity of glycogen compared with control with 
chlortetracycline; therefore a significant interaction between egg dechorionation and 
chlortetracycline was observed.   
Table: 3.15. The glycogen content of control flies and flies derived from dechorionated 
eggs treated with 0-300 µg ml-1 of chlortetracycline and ANCOVA statistical analysis, 





Glycogen content (µg) per fly 
Mean ± s.e. (n=5, except 
 
*n=3 # n=4) 
Males Females 
Control Dechorionation Control  Dechorionation 
0 5.5 ± 0.7 7.0 ± 0.3   7.0 ± 0.3 8.6 ± 1.1*
 
50 4.1 ± 0.3 8.6 ± 1.0 #   6.7 ± 1.1 10.1 ± 0.5# 
300 7.3 ± 1.0 6.9 ± 0.4*   10.2 ± 1.1 22.2 ± 3.9* 
ANOVA 





F1,20 = 0.205, p>0.05 
F1,20 = 2.603, p>0.05 
F2,20 = 8.274, p<0.01 
F2,20 = 4.113, p<0.05 
 
F1,18 =  0.230, p>0.05 
F1,18 = 14.501, p<0.01 
F2,18 = 10.074, p<0.01 
F2,18 = 5.256, p<0.05 
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3.6 Respirometry analysis with chlortetracycline treatment and egg 
dechorionation reared on the York diet 
Respirometry analysis was conducted with male and female Canton-S reared on the York 
diet, the 2-factor experiment involved; chlorteracycline and dechorionation.  The 
respirometry analysis involved the quantification of oxygen consumption, carbon dioxide 
production and from these values the repiratory quotient (RQ) value (CO2/O2) was 
calculated. 
In male flies the mean oxygen consumption varied from 0.054-0.089 µl per minute with 
the control flies consuming the greatest oxygen volume per minute (Figure: 3.6a). Carbon 
dioxide production varied from 0.08-0.10 µl per minute, again with control flies producing 
the greatest volume (Figure: 3.6a).  The respiratory quotient varied from 1.16-1.77, with 
the greatest RQ value with flies derived from dechorionated eggs treated with 300 µg ml-1 
chlortetracycline (Figure: 3.7a).    
In female flies the oxygen consumption was greater than with male flies which would be 
expcted as female flies were greater in size. As with male flies the greatest oxygen 
consumption was observed with control flies, the oxygen consumption across all 
treatments varied from 0.11-0.18 µl per minute (Figure: 3.6b). Carbon dioxide production 
varied from 0.10-0.16 µl per minute, again with control flies producing the greatest 
volume (Figure: 3.6b).  The respiratory quotient for females, varied from 0.90-1.21 with 
the greatest RQ value with flies derived from dechorionated eggs treated with 50 µg ml-1 
chlortetracycline (Figure: 3.7b). 
Analysis of covariance was conducted with oxygen consumption, carbon dioxide 
production and RQ values with the wing area as the covariate.   
Statistical analysis of the oxygen consumption for male and female flies showed that wing 
area did not differ significantly between the treatments  (F1, 65 = 0.118, p>0.05).  
Chlortetracycline (F6, 65 = 2.219, p>0.05) did not have a significant effect on the oxygen 
consumption but dechorionation did (F1, 65 = 3.894, p=0.05).  Sex did have a significant 
effect on the oxygen consumption values (F1, 65 = 4.240, p<0.05) with females consuming 
more oxygen than male flies.  The interactions of dechorionation*chlortetracycline 
treatment also had a significant effect on the oxygen consumption (F2, 65 = 3.724, p<0.05) 
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with dechorionation and treatment with 50 µg ml-1 chlortetracycline of male flies having a 
greater consumption compared with control flies treated with 50 µg ml-1 
chlortetracycline.   The interactions of sex*chlortetracycline, sex*dechorionation, 
sex*dechorionation*chlortetracycline did not have a significant value (Figure: 3.6). 
The graphs in Figure: 3.6 suggests that oxygen consumption was significantly decreased 
with chlortetracycline treatment in comparison to control flies, therefore a separate 
analysis was conducted with the values gained for chlortetracycline treated and control 
flies only.  An analysis of covariance demonstrate that wing area was not significantly 
different (F1, 40 = 0.442, p>0.05).  Chlortetracycline treatment significantly impacted 
oxygen consumption (F2, 40 = 9.157, p<0.01).  The same observation was made in male and 
female flies (F2, 40 = 1.054, p>0.05), yet there was a significant difference in oxygen 
consumption between the 2 sexes (F1, 40 = 6.370, p<0.05). 
Analysis of carbon dioxide production of male and female flies, showed that wing area did 
not differ significantly between the treatments  (F1, 66 = 2.219, p>0.05).  Chlortetracycline 
(F6, 66 = 1.040, p>0.05) and dechorionation (F1, 66 = 0.816, p>0.05) did not have a significant 
effect on the carbon dioxide production.  Sex also did not have a significant effect on the 
carbon dioxide production values (F1, 66 = 0.097, p>0.05).  As with oxygen consumption the 
interactions of dechorionation*chlortetracycline treatment did also have a significant 
effect on the carbon dioxide production (F2, 66 = 4.244, p<0.05) with dechorionation and 
treatment with 50 µg ml-1 chlortetracycline of female flies having a greater consumption 
than control flies treated with 50 µg ml-1 chlortetracycline.   The interactions of 
sex*chlortetracycline, sex*dechorionation, sex*dechorionation*chlortetracycline did not 
have a significant value (Figure: 3.6). 
Again the graphs in Figure: 3.6 suggests that carbon dioxide production was significantly 
decreased with chlortetracycline treatment in comparison to control flies.  Once again a 
separate analysis was conducted with the values gained for chlortetracycline treated and 
control flies only.  ANCOVA statistical analysis demonstrated that wing area was not 
significantly different (F1, 41 = 1.404, p>0.05).  Chlortetracycline treatment significantly 
impacted carbon dioxide production (F2, 41 = 5.125, p<0.05).  The same observation was 
observed in male and female flies (F2, 41 = 1.269, p>0.05) and there was no significant 
difference between the 2 sexes (F1, 41 = 0.021, p>0.05). 
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For the RQ data for male and female flies, wing area was not significantly different 
between the different treatments (F1, 64 = 1.483, p>0.05).  Chlortetracycline (F6, 64 = 1.208, 
p>0.05) and dechorionation (F1, 64 = 2.239, p>0.05) both did not have a significant effect 
on the RQ values.  However, sex did have a significant effect on the RQ values (F1, 64 = 
4.587, p<0.05) with females having a lower RQ value than male flies.  The interactions of 
dechorionation*sex, dechorionation*chlortetracycline, sex*chlortetracycline and 
sex*dechorionation*chlortetracycline all had significant values exceeding the critical 

















Variable O2 Consumption CO2 Production 
Wing Area F1, 65 = 0.118, p>0.05 F1, 66 = 2.219, p>0.05 
Chlortetracycline F2, 65 = 2.219, p>0.05 F2, 66 = 1.040, p>0.05 
Dechorionation F1, 65 = 3.894, p=0.05 F1, 66 = 0.816, p>0.05 
Sex F1, 65 = 4.240, p<0.05 F1, 66 = 0.097, p>0.05 
Dechorionation*Chlortetracycline F2, 65 = 3.724, p<0.05 F2, 66 = 4.244, p<0.05 
Sex*Chlortetracycline F2, 65 = 0.347, p>0.05 F2, 66 = 0.139, p>0.05 
Sex*Dechorionation F1, 65 = 0.490, p>0.05 F1, 66 = 0.032, p>0.05 
Sex*Dechorionation*Chlortetracycline F2, 65 = 0.286, p>0.05 F2, 66 = 1.364, p>0.05 
Figure: 3.6. O2 consumption and CO2 production of male (a) and female (b) flies treated 
with chlortetracycline and dechorionation with ANCOVA analysis.  Number of replicates 
= Control male flies: 10 0tet, 8 50tet, 11 300tet; Male flies derived from dechorionated 
eggs: 6 0tet, 7 50tet, 3 300tet; Control female flies: 5 0tet, 3 50tet, 9 300tet; Female flies 
derived from dechorionated eggs: 5 0tet, 4 50tet, 3 300tet. Methods Chapter; Section: 













Figure: 3.7. RQ values of male (a) and female (b) flies treated with chlortetracycline and 
dechorionation with ANOVA analysis and ANOVA statistical analysis.  Number of 
replicates = Control male flies: 10 0tet, 8 50tet, 11 300tet; Male flies derived from 
dechorionated eggs: 6 0tet, 7 50tet, 3 300tet; Control female flies: 5 0tet, 3 50tet, 9 
300tet; Female flies derived from dechorionated eggs: 5 0tet, 4 50tet, 3 300tet. 
Methods Chapter; Section: 2.6, page 48. 
a 
b 
  Wing Area          F 1 , 64 
  
= 1.483, p> 0.05   
Dechorionation         F 1, 64 
  
= 2.239 , p>0.05   
Chlortetracycline         F 2 , 64 
  
=  1.208 , p>0.05   
Sex            F 1 , 64 
  
= 4.587, p< 0.05   
Dechorionation *Sex       F 1 , 64 
  
= 0.012 , p>0.05   
Dechorionation*Chlortetracycline     F 2 , 64 
  
= 1.281 , p>0.05   
Sex* Chlortetracycline       F 2 , 64 
  
= 0.529 , p>0.05   
Dechorionation*Sex*Chlortetracycline   F 2 , 64 
  




3.7 The impacts of chlortetracycline and egg dechorionation on Canton-S 
reared on a high and low nutrient diet 
The survival to pupae with flies reared on the high nutrient diet supplemented with 0-500 
µg ml-1 of chlortetracycline ranged from 84-72%, with the survival to pupae not 
significantly affected by the treatment with chlortetracycline (Kruskal-Wallis: H6 = 5.854, 
p>0.05) (Figure: 3.8).   However, the survival to adulthood with flies reared on the high 
nutrient diet supplemented with 0-500 µg ml-1 ranged from 7-57%.  The lowest survival 
was at the high concentrations of chlortetracycline of 300-500 µg ml-1 with a survival of 7-
8%.  This result suggests that the mortality occurred at the pupal stage as the survival to 
pupae was 85-86% at 300-500 µg ml-1 compared to 7-8% survival to adulthood.  
Therefore, 78-79% mortality had occurred at the pupal stage. This difference with 
chlortetracycline treatment on the survival to adulthood was shown to be significantly 
different (Kruskal-Wallis: H6 = 38.204, p<0.001). 
 
Figure: 3.8. Percent survival from egg of Canton-S reared on the high nutrient diet 
supplemented with 0-500 µg ml-1 of chlortetracycline, number of replicates = 12 with 10 
eggs per replicate (Methods Chapter; Section: 2.3.2.1, page 40). 
A different response was observed with flies reared on the low nutrient diet compared 
with those on the high nutrient diet.  The survival of the flies to pupae on a diet 
supplemented with 0-500 µg ml-1 of chlortetracycline varied from 83% to 55%, with a 
significantly lower survival at 100 and 300 µg ml-1 of chlortetracycline of 55% and 56%, 
respectively compared with 75% with control flies (Kruskal-Wallis: H6 = 16.138, p<0.05) 
(Figure: 3.9).  The survival to adulthood ranged from 51-81%, a greater survival compared 
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with the high nutrient diet but still with a significantly lower survival at 100-500 µg ml-1 
chlortetracycline of 48-52% compared with control flies with a 71% survival (Kruskal-
Wallis: H6 = 23.043, p<0.01). 
 
Figure: 3.9. Percent survival from egg of Canton-S reared on the low nutrient diet 
supplemented with 0-500 µg ml-1 of chlortetracycline, number of replicates = 12 with 10 
eggs per replicate (Methods Chapter; Section: 2.3.2.1, page 40). 
 
Alongside the experiment with chlortetracycline treatment, bacteria depletion was also 
conducted via egg dechorionation.  The survival to pupae and adulthood of these flies 
was compared with control flies on the high and low nutrient diets.  The survival to pupae 
of control flies reared on the high nutrient diet was higher than flies derived from 
dechorionated eggs of 84% and 69% respectively, yet this difference was not significant 
(Mann Whitney U: Z1 = -1.267, p>0.05).  The survival to adulthood was lower for both 
treatments, with a 57% and 39% survival for control and dechorionation respectively.  
Again, there was no significant difference between the two treatments (Mann Whitney U: 




Figure: 3.10. The percent survival of control and flies derived from egg dechorionation 
on the high nutrient diet, number of replicates = 12 with 10 eggs per replicate (Methods 
Chapter; Section: 2.3.2.1, page 40). 
Flies reared on the low nutrient diet had a lower survival to pupae compared with the 
high nutrient diet but did have a higher survival to adulthood.  The survival to pupae of 
control flies and with dechorionation was 75% and 64% respectively, this difference was 
found not to be significantly different (Mann Whitney U: Z1 = -1.445, p>0.05) (Figure: 
3.11).  The survival of the flies to adulthood was 71% for control flies and 66% with 
dechorionation.  Again, statistical analysis showed that there was no significant difference 
between the survival of control flies and with egg dechorionation (Mann Whitney U: Z1 = -
0.874, p>0.05) (Figure: 3.11). 
 
Figure: 3.11. The percent survival of control and flies derived from egg dechorionation 
on the low nutrient diet, number of replicates = 12 with 10 eggs per replicate (Methods 
Chapter; Section: 2.3.2.1, page 40). 
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3.8 Impact of chlortetracycline on Drosophila microbiota  
3.8.1 Impact of chlortetracycline on Drosophila microbiota (Oregon-RS) 
Antibiotic treatment was shown to have an effect on the development of Drosophila. To 
determine whether this was in fact due to the removal of bacteria in the flies, larvae were 
sampled from each treatment and plated onto nutrient agar plates. 
This experiment showed a clear difference in bacterial content in the larvae treated with 
50-500 µg ml-1 chlortetracycline. Even though there were still bacteria present on these 
plates they were present at a lower number (Table: 3.16). Larvae treated at lower 
concentration of chlortetracycline had a greater number of bacteria present across the 
entire agar plate with the number of colony forming units ml-1 of homogenate ranging 
from 26 to 1632 (Χ26 =6393.36, p<0.05)( Table: 3.16). 
Table: 3.16. The Colony Forming Units (CFUs) of the culturable bacteria found in 3rd 
instar larvae reared on 0-500 µg ml-1 chlortetracycline with Chi2 analysis (Methods 
Chapter; Section: 2.4.1, page 43). 
Concentration of chlortetracycline (µg ml
-1
)  Number of colony forming units per 3
rd
 instar 
larva (1-2 replicates per treatment).  
   
0  490 
1  26; 424 
10  1632 
50  0; 8 
100  1; 4 
300  3; 4 
500  0; 11 
Χ26 =6393.36, p<0.05 
To determine the culturable species of bacteria present in Oregon-RS, 16S rRNA gene 
sequence analysis was conducted on 10 sampled colonies.  BLAST analysis showed that 
there were several sequences matching the sequence of the 16S rRNA gene of four main 
bacterial species.  These species were Lactobacillus plantarum, Lactobacillus pentosus, 
Acetobacter pasteurianus and Acetobacter pomorum (Table: 3.17).   
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Table: 3.17. The bacterial identification of colonies sampled from Oregon-RS (with 
number of sequences and the % sequence identity) (Methods Chapter; Section: 2.8.2, 
page 49). 
Species Name NCBI Accession Number 
Lactobacillus plantarum strain HDRS1 16S ribosomal RNA gene, partial 
sequence (99%) 
(5 forward sequences) 
Lactobacillus plantarum 16S rRNA gene, clone 6C4 (98-99%) 





Lactobacillus plantarum strain ZDY128 16S ribosomal RNA gene, partial 
sequence (99%)/ Lactobacillus pentosus gene for 16S rRNA, partial sequence, 
strain: NRIC 1837 (99%) (1 sequence) 
EU559599.1/AB362758.1 
Acetobacter pasteurianus gene for 16S ribosomal RNA, complete sequence, 
strain: SKU1108 (96-99%)  
(4 forward/reverse sequences)  
Acetobacter pomorum strain EW816 16S ribosomal RNA gene, partial 






3.8.2 Identification of Wolbachia in Oregon-R and Canton-S 
Tetracycline is often used to remove Wolbachia in laboratory-reared Drosophila (Fry and 
Rand, 2002).  To identify whether this bacterium was present in the 2 strains of 
Drosophila (Oregon-RS and Canton S), a diagnostic PCR was conducted. 
The results suggest Oregon-RS and Canton-S stains do not have Wolbachia, this is shown 
by the absence of a band at ~600 base pairs (Figure: 3.12).  The Isogenic (ISO) strain was 
known to be infected with Wolbachia and was used as a positive control. 
 
Figure: 3.12. Wolbachia detection using PCR, water was used as a negative control and 
ISO (Isogenic) line as the positive control (band at ~600 bp).    Size detection using 1kb 




3.8.3 Impact of chlortetracycline on Drosophila (Canton S) microbiota 
Female adult (7 day old) Drosophila were sampled, these flies were homogenised and 
plated onto nutrient agar.  This experiment showed a clear difference in bacterial content 
in the female Drosophila treated with 50 and 300 µg ml-1 of chlortetracycline (Table: 
3.18). A one-way ANOVA showed that the depletion of bacteria was significant in the 
presence of chlortetracycline (F2, 29 = 53.005, p<0.001).  Bacteria were also present on 
plates with 50 µg ml-1 of chlortetracycline suggesting that a number of bacteria may be 
chlortetracycline resistant.  No culturable bacteria were found in the flies derived from 
dechorionated eggs however, 16S rRNA gene analysis suggests that unculturable bacteria 
were still present in the bacteria depleted flies (presence of a band at 1.5 kb) (Figure: 
3.13).  Furthermore, secondary bands were present which have not been seen before in 
previous PCR reactions, this suggests that the higher prevelance of secondary bands with 
samples of dechorionation/chlortetracycline treatment may have a low number of DNA 
copies in comparison with control flies.  An alteration in the annealing temperature 
should improve the PCR reaction. 
Table: 3.18. The culturable content of control females and females derived from egg 
dechorionation treated with and without chlortetracycline (0-300 µg ml-1) on nutrient 
agar plates supplemented with and without of 50 µg ml-1 of chlortetracycline, number 
of replicates = 10 (Methods Chapter; Section: 2.4.1, page 43). 
 Log10 (CFUs) per fly on non- 
chlortetracycline plates ± s.e (n=10) 
Log10 (CFUs) per fly on plates 
supplemented with 50 µg ml
-1 
of 






Control Dechorionated Control Dechorionated 
0 4.326 ± 0.308 0 
 
2.395 ± 0.426 0 
50 2.195 ± 0.304 0 0.749 ± 0.339 0 








Figure: 3.13: Bacterial 16s rRNA gene analysis using PCR.  Separation conditions 1.5% 
agarose gel, 1 X TAE using a separation voltage of 100 and a PCR product of 1.5 kb.  Size 
detection using 1kb plus DNA ladder (Invitrogen). M = ladder; 1-5, 19-23, 36-37 = egg 
dechorionation; 6-10, 24-28 = egg dechorionation with 50 µg ml-1 of chlortetracycline; 
11-15, 29-33, 38-39 = egg dechorionation with 300 µg ml-1 of chlortetracycline; 16, 33, 
40, 43 = positive controls (untreated); 17, 34, 41, 44 = 50 µg ml-1 of chlortetracycline; 18, 
35, 42, 45 = 300 µg ml-1 of chlortetracycline; RC = reagent control; -ve = negative control 
(Methods Chapter; Section: 2.8, page 49). 
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3.8.4 Impact of chlortetracycline on Drosophila (Canton S) microbiota diversity  
The culturable bacterial colonies reared from flies treated with 0 and 50 µg ml-1 of 
chlortetracycline were identified using 16S rRNA gene analysis (Appendix: Table: 7.1, 7.2). 
The culturable bacteria in flies reared with no chlortetracycline showed to have a 
population predominantly Acetobacter pasteurianus, with Acetobacter cerevisiae and 
Acetobacter pomorum also being identified.  Interestingly, the bacterial colonies 
identified in flies reared on food supplemented with 50 µg ml-1 of chlortetracycline had a 
more diverse population with Acetobacter pasteurianus, Acetobacter malorum, 
Acetobacter pomorum, Lactobacillus plantarum, Lactobacillus brevis and Micrococcus 
luteus.  To determine whether the bacterial colonies were chlortetracycline resistant, 
colonies were reared on nutrient agar plates supplemented with 50 µg ml-1 of 
chlortetracycline (Appendix: Table: 7.3).  The bacterial colonies identified in flies reared 
with no chlortetracycline included Acetobacter pasteurianus, Acetobacter malorum, 
Acetobacter pomorum, Lactobacillus plantarum and Lactobacillus pentosis. Similar 
bacterial species were also identified in flies reared with 50 µg ml-1 chlortetracycline with 
the only bacteria which wasn’t identified being Lactobacillus pentosis.   
The food used to rear the flies was also sampled to determine whether the bacterial 
diversity within the food was similar to the bacterial community within the fly (Appendix: 
Table: 7.1, 7.2).  The bacterial colonies identified in food with no chlortetracycline 
included Acetobacter pasteurianus, Acetobacter cerevisiae, Acetobacter pomorum and 
Lactobacillus plantarum. Again, similar species were identified on the diet supplemented 
with 50 µg ml-1 of chlortetracycline but Acetobacter cerevisiae was not identified. 
The 454 analysis showed that Acetobacter cerevisiae and Acetobacter 
pasteurianus/Acetobacter pomorum were the dominant symbionts in both control and 
chlortetracycline treated flies (Appendix: Table 7.4, 7.5; Table: 3.19, Table: 3.20).   Further 
species were identified in control flies; yet these have not been previously identified in 
Drosophila and appear to be contaminants.  An example being Buchnera aphidicola which 





Table: 3.19. 454 pyrosequencing analysis of the bacterial species in control flies. The 
species identified with sequences with greater than 100 hits (Methods Chapter; Section: 
2.9, page 51). 
Accession number Bacterial name Percent Identity Number of hits 
CP001161 Buchnera aphidicola str. 5A (Acyrthosiphon 
pisum), complete genome 
100 10909 
HM080051.1 Uncultured Actinomycetales bacterium 







Acetobacter cerevisiae strain LMG 1625 16S 
ribosomal RNA, partial sequence 
>gi|23892796|emb|AJ419843.1| 
Acetobacter cerevisiae 16S rRNA gene, 
strain LMG 1625 
100 2020 
GQ477828.1 Uncultured bacterium clone MS-123 16S 
ribosomal RNA gene, partial sequence 
99.6 2020 
HM027569.1 Bacillus subtilis strain zj2008 16S ribosomal 
RNA gene, partial sequence 
100 1715 
AM087199.1 Asticcacaulis benevestitus partial 16S rRNA 
gene, type strain Z-0023T 
99.6 312 
AB461807.1 Acinetobacter sp. M522 gene for 16S rRNA, 
partial sequence, strain: M522 
100 212 
EU096229.1 Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence 
100 186 
AB308058.1 Acetobacter pasteurianus gene for 16S 
ribosomal RNA, complete sequence 
100   
AJ318114.1 Uncultured gamma proteobacterium 16S 
rRNA gene, clone BIci4 
99.6 171 
 
Table: 3.20. 454 pyrosequencing analysis of bacterial species in chlortetracycline 
treated flies. The species identified with sequences with greater than 100 hits, number 
of replicates = 12 with 10 eggs per replicate (Methods Chapter; Section: 2.9, page 51). 




Acetobacter cerevisiae strain LMG 1625 
16S ribosomal RNA, partial sequence 
>gi|23892796|emb|AJ419843.1| 
Acetobacter cerevisiae 16S rRNA gene, 
strain LMG 1625 
100 29544 
EU096229.1 
Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence 
100 314 
AB308058.1 
Acetobacter pasteurianus gene for 16S 







The results in this chapter do show the importance in commensal bacteria in Drosophila 
melanogaster but further highlights the implications of using antibiotics as a method of 
removing bacteria.  The different methods of bacterial depletion through 
chlortetracycline (an antibiotic) treatment and dechorionation (surface sterilisation of the 
egg) have enabled a comparison of the results gained through the 2 different treatments 
and to distinguish between the effect of toxicity and bacterial depletion. 
The major impact of chlortetracycline treatment and dechorionation was the extension of 
larval development time in both strains of Drosophila which was determined by 
examining the hatch rates of the treated eggs.   As the same result was observed by egg 
dechorionation and antibiotic treatment and bacterial numbers were significantly 
reduced with chlortetracycline, the extension does appear to be the result of bacterial 
depletion rather than deleterious effects through the toxicity of chlortetracycline.  One 
explanation is that bacterial depletion results in flies taking longer to reach the critical 
weight to allow for pupation which may involve changes in the insulin/insulin-like growth 
factor signalling which has previously been suggested to control the time to pupation and 
to reach the critical weight for pupation (Edgar, 2006; Beadle et al., 1938; Bakker, 1959; 
Robertson, 1963; Moed et al., 1999).  Therefore, microbial symbionts may play a critical 
role in the regulation of this pathway.  Changes in ecdysone levels have also been 
demonstrated to play a significant role in the regulation of the insulin/insulin like growth 
factor signalling; therefore the microbial symbionts could also regulate the levels of these 
hormones (Colombani et al., 2005).  The third reason for the extension could be due to 
the changes in behaviour of the larvae on the treated diets.  As described in Section 3.2.3, 
larvae on treated diet did not appear to penetrate the diet and the diet had a more solid 
consistency compared with control diets.  Therefore, the larvae may have found it more 
difficult to feed and as a consequence taken longer to grow, however, the experiment 
using different concentrations of agar does appear to contradict this theory.  
Chlortetracycline did reduce the fecundity of female flies which could be due to two 
possibilities; 1) the female flies were not as fit when reared on diet with chlortetracycline 
and had a reduced reproductive capacity and 2) the flies were deterred from laying eggs 
on a diet containing chlortetracycline.  Both reasons are plausible, in Canton-S the 
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triglyceride content was reduced with chlortetracycline treatment; lipid content of 
females has been shown to play an important role in reproductive maturation of female 
animals (Chehab et al., 1997; Kennedy and Mitra, 1963) therefore there could be a 
relationship between these results.  Secondly, female flies may detect chemical in the 
food and did not lay on the food as the fitness of the offspring may be compromised.   
The male life-span results were unexpected and contradicted the results gained by 
Brummel et al (2004) and Mair et al (2005) but supported the results gained by Ren et al 
(2007).  Control flies had a shorter life-span compared with flies with egg dechorionation 
and chlortetracycline treatment; yet egg dechorionation alone did not significantly affect 
the life-span.   
This extension of lifespan through chlortetracycline treatment could be due to the 
removal of “pathogenic” bacteria but not all the bacteria allowing the fly to live longer.  
Further extension in longevity with chlortetracycline treatment and dechorionation could 
be the result of a combination factors including the removal of bacteria and the chemical 
itself.   This result was interesting as Mair et al (2005) did not find a significant effect of 
tetracycline treatment on life-span. However, this difference could be accounted for as a 
different strain of Drosophila and diet was used.  As Cooper et al (2004) suggested,  the 
shortening of life-span of control flies on a rich diet could be due to the proliferation of 
bacteria within the gut, in antibiotic treated flies the tetracycline would control this 
proliferation resulting in an enhancement in life-span.   
Nutrition analysis demonstrated that female flies had a greater response to 
chlortetracycline treatment and dechorionation due to reasons such as differences in 
metabolism of male and female animals and the requirement for females to lay eggs and 
produce offspring.  In both sexes an alteration in carbohydrate levels with 
chlortetracycline treatment and dechorionation suggest that the bacteria consume some 
of the glucose within the gut of the host.  Bacterial depletion will therefore increase the 
levels of available carbohydrate being absorbed through the gut and resulting in a greater 
pool of carbohydrate as an energy source. 
Oregon-RS and Canton-S female flies had a reduced protein content with 
chlortetracycline treatment but not with dechorionation (Canton-S only), suggesting that 
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chlortetracycline (a protein synthesis inhibitor in prokaryotes) could be targeting 
eukaryotic ribosomes, inhibiting protein synthesis and leading to a reduction in levels of 
protein.   The reduction in triglyceride levels of both sexes with chlortetracycline 
treatment suggests that the toxicity of the antibiotic was responsible for the change and 
not bacteria depletion.  Two reasons for this could be; 1) chlortetracycline may be 
targeting lipid metabolism and 2) the flies consumed less food on the diet supplemented 
with chlortetracycline meaning lower calories were consumed leading to a reduced pool 
of triglycerides.  
Respirometry data showed a significant reduction in respiration rates of flies with 
bacteria depletion.  This result has also been observed in mice and rats (Wostman et al., 
1982 and Levenson et al., 1969).  This change could be due to multiple reasons: the 
removal of bacteria could result in differences in the utilisation of nutrients resulting in a 
decrease in oxygen consumption (Wostman et al., 1982), changes in the morphology of 
the gut due to the absence of bacteria which have been shown to play a role in gut 
development (Wostmann et al., 1982, Shirkey et al.,2006) and in mice and rats it has been 
suggested that bacteria influence hormones such as nor-epinphrine (octopamine in 
insects) which may be linked to an increase in oxygen consumption (Levenson et al., 
1969).    
 
The experiments conducted with the high and low nutrient diets with chlortetracycline 
and dechorionation treatment have further demonstrated that experimental results do 
depend on the diet used.  What is particularly interesting is that survival is significantly 
reduced when the flies were treated with high concentrations of chlortetracycline (100-
500 µg ml-1) on both diets, with the high nutrient diet showing the greatest decrease in 
survival.  The results with the high nutrient diet does suggest that the chlortetracycline 
treatment was toxic affecting the survival to adulthood and causing pupal mortality which 
was greater than observed with the low nutrient diet.  This difference between the 2 diets 
suggests that there may be differences in feeding rates.  If this is the case, the flies reared 
on a high nutrient diet may have consumed more food leading to a greater exposure to 
and consumption of chlortetracycline. 
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The experiments with flies derived from dechorionation did not show a significant 
decrease in survival, therefore, the changes in survival with the chlortetracycline treated 
flies does again suggest a link with toxicity and not with the removal of bacteria.   
 
The microbial diversity gained through the sequences from culturable bacteria suggested 
that chlortetracycline treatment may deplete the population of Acetobacter allowing the 
population of Lactobacillus to increase.  454 pyrosequencing showed that Acetobacter 
was the dominant species in control flies; this bacterium has previously been found in 
Drosophila melanogaster by Corby-Harris et al (2007) and Ren et al (2007).   
3.10 Conclusion 
Experiments with Drosophila melanogaster have highlighted the impact of 
chlortetracycline and egg dechorionation on the insect and have demonstrated that 
bacterial depletion had a significant impact on the carbohydrate levels in flies, respiration 
rates and the development time to pupae/adulthood. This does suggest that the microbes 
play an important role in nutrient acquisition and metabolism of nutrients to allow for 
growth and development. Lastly, this study has highlighted the deleterious impact of 
using antibiotics to deplete bacteria which should be considered when studying the role 









Chapter 4: The impact of bacterial depletion on Drosophila melanogaster 
gene expression  
4.1 Introduction 
The bacterial symbionts in Drosophila melanogaster have previously been suggested to 
be found on the surface of the egg shell (Bakula, 1969).  Larvae gain the symbionts 
through the ingestion of the food where the eggs are laid and the consumption of the 
chorion of the egg (Bakula, 1969 and observation by myself).  
Experiments have demonstrated that these symbionts are important for the performance 
of Drosophila melanogaster, such as life-span enhancement (Brummel et al., 2004) and 
shortening of development time (as demonstrated in Chapter3, Bakula, 1969).   
Drosophila melanogaster has become a model for investigating the innate immune 
response (Hoffman, 2003).  Drosophila lacks an adaptive immune response and depends 
on the innate response which includes the use of physical barriers, antimicrobial peptides, 
hemocytes and reactive oxidative species for protection against pathogens (Hoffman, 
2003; Lemaitre and Hoffman, 2007).  Two main pathways are involved in the humoral 
response to microorganisms, the Toll pathway which responds to fungi and Gram-positive 
bacteria (Hoffman, 2003; Rutschmann et al., 2002) and IMD pathway which mainly 
responds to Gram-negative bacteria (Hoffman, 2003; Ferrandon et al., 2007) (Figure: 4.1).   
This activation of the TOLL pathway involves the proteolytic cleavage of Spaetzle 
(Morisato and Anderson, 1994; Schneider et al., 1994; Valanne et al., 2011) which binds 
as a dimer to the Toll ectodomain (Hoffman, 2003; Arnot et al., 2010).  The 
intracytoplasmic TIR domain of Toll interacts with three partners, MyD88, Tube and Pelle 
(Horng and Medzhitov, 2001; Tauszig-Delamasure et al., 2002; Sun et al., 2002; Xiao et al., 
1999; Moncrieffe et al., 2008; Valanne et al., 2011). The Toll pathway then activates the 
Dorsal-related immunity factor (DIF)/Dorsal which dissociates from the ankyrin-repeat 
inhibitory protein Cactus through signal-dependent phosphorylation and degradation of 
Cactus (Wu and Anderson, 1998; Hoffman, 2003; Valanne et al., 2011).  The activated 
Dorsal/DIF then directs the expression of antimicrobial peptides in the nucleus (Valanne 
et al., 2011; Hoffman, 2003).  
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The IMD pathway is activated by Gram-negative bacteria which is detected by PGRP-LC 
and involves a signalling cascade of IMD, FADD, DREDD and TAK1 (TGFβ-activated kinase) 
(Gottar et al., 2002; Hoffman, 2003). TAK1 activates the IKK-γ and IKK-β complex which 
phosphorylates and cleaves Relish (Lu et al., 2001; Silverman et al., 2003; Vidal et al., 
2003; Ferrandon et al., 2007).  DREDD (Death-related ced-3/Nedd-2 like protein) and 
FADD (Fas-associated death domain) can also associate with Relish and cleave Relish 
(Leulier et al., 2002; Naitza et al., 2002; Hoffman, 2003; Leulier et al., 2000; Ferrandon et 
al., 2007). The activated Relish can then promote the expression of the antimicrobial 
peptides (Hoffman, 2003; Ferrandon et al., 2007).   Furthermore, TAK1 can activate the 
expression of cytoskeletal proteins in the nucleus (Boutros et al., 2002; Hoffman, 2003; 
Ferrandon et al., 2007). 
  
Figure: 4.1. The Toll and IMD pathways, which are activated by Gram-positive, Gram-
negative bacteria and fungi.  These pathways are induced by peptidoglycan recognition 
proteins (Hoffman, 2003), the activation of these pathways results in the expression of 
antimicrobial peptides including Drosomycin (Toll pathway); Diptericin, Cecropins, 




A limited number of studies investigating the changes of gene expression of bacteria 
depleted flies have been performed; studies have mainly concentrated on the response of 
Drosophila immune system to pathogens.  Ren et al (2007) determined the changes in 
AMP (antimicrobial peptide) expression in axenic flies.  In this paper, qRT-PCR and 
northern blots were used to assay the gene expression.  The expression of AMP genes 
were found to be reduced in axenic flies, these AMPs included Diptericin, Defensin, 
Cecropin and Attacin (Ren et al., 2007).  The possible reason for this response was the 
reduced bacterial load in axenic flies which reduced the stimulation of immune response.   
A genome-wide study has not been conducted to explore the alteration in the transcript 
levels in bacteria-depleted flies when derived from dechorionated eggs and how this 
response differs between different diets. Therefore, in this chapter I describe the 
genome-wide response of flies derived from egg dechorionation and how the response 














4.2 Microarray study on bacteria-depleted Drosophila 
4.2.1 The impact of egg dechorionation and diet on the gene expression of Drosophila 
A genome wide analysis using Agilent microarray chip was performed with control flies 
and flies derived from dechorionated eggs on a high and low nutrient diet.  The analysis 
involved the comparisons between; dechorionation and control flies on a high nutrient 
diet; dechorionation and control flies on a low nutrient diet; control flies on the 2 diets 
and dechorionation on the 2 diets. The analysis has shown that 88-89% of the genes 
assessed using the microarray had an expression value 2 times greater than the negative 
controls, indicating that these genes were expressed (Table: 4.1).  When the comparisons 
between the treatments were made, less than one percent of the genes assessed in the 
microarray were significantly changed in abundance (Table: 4.2).  The results have 
indicated that fewer transcripts (42) were significantly changed in abundance with 
dechorionation on a low nutrient diet in comparison with dechorionation on the high 
nutrient diet (136 transcripts).  These results demonstrate a difference in response to the 
2 diets, which is supported by the significant differences in the abundance of transcripts 
during the comparison of control flies (89 transcripts) and with dechorionation (212 
transcripts) on the 2 diets. 
Table: 4.1. The number of sequences expressed in the different treatments. 
Treatment Average number of sequences expressed (n=3) 
(Expression = 2X negative controls) ± s.e (% 
sequences expressed) 
Egg dechorionation on the rich diet 39017 ± 51 (89%) 
Egg dechorionation on the poor diet 38794 ± 327 (89%) 
Control on the rich diet 38716 ± 216 (89%) 
Control on the poor diet 38512 ± 195 (88%) 
 
Table: 4.2. The number of transcripts with a significant change in abundance of 2 fold or 
more (p<0.05). 
Comparison Sequences significantly expressed of 2 fold 
or more with p<0.05 (change of >3 fold) 
High nutrient dechorionation versus high nutrient control  136 (36)  (up=47 and down=89) 
Low nutrient dechorionation versus low nutrient control 42( 15) (up=13 and down=29) 
Low nutrient control versus high nutrient control 89( 19) (up=45 and down=44) 
Low nutrient dechorionation versus high nutrient 
dechorionation 
212 (37)  (up=140 and down=72) 
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An analysis was conducted on the number of transcripts which had been identified to be 
significantly altered in abundance and which were shared by the treatments, 
dechorionation on the high nutrient diet (High), dechorionation on the low nutrient diet 
(Low), control flies on the 2 diets (Controls) and dechorionation samples on the 2 diets 
(Dechorion). The Venn diagram (Figure: 4.2) has highlighted that with dechorionation on 
the high diet, a high proportion of transcripts significantly altered in abundance were only 
found within this treatment; 71 down-regulated and 44 up-regulated.  Eleven of the total 
transcripts (1 up-regulated and 10 down-regulated) were shared with dechorionation on 
the low nutrient diet, 7 (5 down-regulated and 2 up-regulated) with the control flies on 
the 2 diets and 1 down-regulated with dechorionation on the 2 diets.   
Low nutrient diet with dechorionation had a lower number of transcripts (22; 13 down-
regulated and 9 up-regulated) which were significantly altered and only found with this 
treatment.  In comparison, dechorionation on a high nutrient diet (104), control flies on 
the 2 diets (62) and dechorionation on the 2 diets (182) all had a greater number of 
transcripts that were only found within each treatment.  No transcripts were shared 
between the dechorionation on the low nutrient diet and the comparison of control 
(control) flies on the 2 diets and only 8 (5 down-regulated and 3 up-regulated) with 
dechorionation on the 2 diets.  The comparisons between the 2 diets with control flies 
and flies derived from egg dechorionation only had 19 (7 down-regulated and 12 up-
regulated) which were shared between the 2 treatments.  No transcripts were shared 






Figure: 4.2. a) Venn diagram showing the comparison of transcripts with a significant decrease 
in abundance in the treatments: dechorionation versus control on the high nutrient diet (High), 
dechorionation versus control on the low nutrient diet (Low), control flies on the 2 diets 
(Controls) and dechorionation samples on the 2 diets (Dechorion) b) Transcripts with a 
significant increase in abundance.  Overlapping numbers show transcripts shared by the 
treatments and the numbers which are not overlapping are found only in that particular 
treatment. The Venn diagram was created using an online source produced by Oliveros (2007).  
4.2.2 Analysis of the function of the transcripts with a significant change in abundance 
Across all comparisons, 40-54% of the sequences with a significant change in abundance 
had no assigned Gene Ontology term/number.  This was due to little experimental 
evidence to identify the function of the gene or that the gene was a short sequence such 
as an expression sequence tag or a tentative consensus sequence associated with a gene 
with no Gene Ontology number.  However, 46-60% of the sequences were identified to 
have a Gene Ontology term with a function which had been experimentally demonstrated 
or that Blast2Go had suggested that the sequence has similar sequence identity to genes 
with known functions.  Dechorionation on the high nutrient diet (Figure: 4.3a) did show 
that the majority of the transcripts assigned a function were metabolic (23%) with 
transcripts associated with the immune system being the second most prominent (12%).  
A lower number of metabolic transcripts were altered in abundance on the low nutrient 
diet; with a total of 12%, the same percent as the immune transcripts.  The greatest 
number of transcripts was associated with binding and transport (22%) (Figure: 4.3b).  
Both the low and high nutrient diets with dechorionation, had the identical proportion of 
transcripts associated with immunity.  For the comparison of control flies reared on the 
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high and low nutrient diets, no immune transcripts were identified to have a significant 
change in abundance.  More than a quarter of the sequences were associated with 
metabolism (28%), and 17% with transport and binding (Figure: 4.3c).  This was also 
observed with the dechorionation with the 2 different diets, where the majority of the 
sequences were metabolic (25%) and binding/transport transcripts (15%).  Immune 
transcripts were also identified to have a significant change in abundance (6%), which was 
not observed when the control flies were compared (Figure: 4.3d).  
In comparison with the major functions of metabolism, immunity and binding/transport, 
a smaller percentage of the transcripts had miscellaneous and DNA/RNA 
replication/transcription functions which were identified across all comparisons (0-8%) 
(Figure: 4.3). 
 
Figure: 4.3.  The proportion of the transcripts with a significant change in abundance of 2 fold or 
more with a Gene Ontology of metabolism (GO:0008152), transport (GO:0006810) and binding 
(GO:0005488), immunity (GO:0006955), DNA/RNA replication (GO:0006260)/transcription 
(GO:0009299), miscellaneous and unknown (a = dechorionation versus comventional on the 
high nutrient diet, b = dechorionation versus control on the low nutrient diet, c = control flies 
on the high and low nutrient diet, d = dechorionation on the high and low nutrient diet. 
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4.2.3 Microarray analysis of transcripts associated with Drosophila melanogaster 
immunity 
This analysis has demonstrated that dechorionation significantly changes transcripts 
associated with the immune response (Table: 4.3; Appendix, Table: 7.6, 7.13, and 7.25).   
The sequences that were significantly changed in abundance on the low nutrient diet 
were also significantly changed on the high nutrient diet.  However, the level of change 
and the number of transcripts altered in abundance associated with the immune system 
differed between the 2 diets.  On the low nutrient diet, only 5 immune related sequences 
were identified to have a significant alteration in expression, on the high nutrient diet 16 
sequences were identified (Table: 4.3; Appendix, Table: 7.13, 7.6).  Furthermore, the 
transcript with the greatest change in abundance differed with diet.  On the low nutrient 
diet, the greatest change was observed with Diptericin (33.96 fold change) and on the 
high nutrient, Cecropin C (51.84 fold change).  The changes in both of these diets shown 
in Table: 4.3 suggest that the major response to bacterial depletion is the decrease in the 
expression of antimicrobial peptides (Diptericin, Attacin C, Cecropin C, Attacin A, 
Defensin), antifungal genes (Toll pathway) and peptidoglycan recognition proteins.   
These antimicrobial peptides are associated with the IMD pathway and target gram-
negative bacteria (Hoffman, 2003).  The remaining sequences were associated with 
phagocytosis and defence against bacteria. 
The comparison between the control flies on the different diets did not show a significant 
difference in the abundance of immune associated sequences. However, dechorionation 
on the low and high nutrient diets did (Table: 4.3; Appendix, Table: 7.25).  The absolute 
fold change in abundance (5.4 to 2.0) of the immune transcripts was not as high as the 
comparison of dechorionation versus control flies (51.8-2.1). Thirteen sequences were 
identified to have a significant change in abundance of 2 fold or more, with the greatest 
change observed with the down regulation of a lysozyme precursor (5.38 fold change), 
and the antimicrobial peptides Diptericin and Defensin (4.96 and 3.86 fold change, 
respectively).  A further 8 transcripts were significantly increased, these included 





Table: 4.3 Transcripts associated with immunity and significantly changed in abundance 
of 3 fold or more (NSC=no significant change, SC=significant change, - =down regulated). 



























Sequence Name Gene Ontology 
(GO) Numbers 















Defense response to fungus 
Defense response to bacterium 
Extracellular region 
Extracellular space 
Antibacterial humoral response 
Defense response to Gram-
negative bacterium 
Defense response to Gram-
positive bacterium 
-51.84 NSC NSC NSC 







Antibacterial humoral response 
Antifungal humoral response 
Defense response 
Defense response to fungus 
Defense response to Gram-
negative bacterium 
Defense response to Gram-
positive bacterium 
Extracellular region 
-36.11 -15.02 NSC NSC 




Antibacterial humoral response 
Defense response to Gram-
negative bacterium 
-15.85 NSC NSC NSC 
CG10794 Diptericin b GO:0019731 
GO:0005576 
Antibacterial humoral response 
Extracellular region 
-14.94 -13.24 NSC NSC 






Antibacterial humoral response 
Defense response to Gram-
positive bacterium 
Defense response to bacterium 
Positive regulation of 
biosynthetic process of 
antibacterial peptides active 
against Gram-positive bacteria 
-10.64 NSC NSC -3.86-
2.428 





Antibacterial humoral response 
Defense response to Gram-
negative bacterium 
Defense response to bacterium 
Innate immune response 
Extracellular region 
-10.24 -33.96 NSC -4.96 





Antibacterial humoral response 
Defense response 
Extracellular space 
Defense response to bacterium 
Extracellular region 
-8.29 -5.67 NSC NSC 














Negative regulation of immune 
response 
Negative regulation of innate 
immune response 
Negative regulation of 
peptidoglycan recognition 
protein signaling pathway 
-4.43 NSC NSC NSC 
CG16876 Nimrod c4 GO:0043277 
GO:0006911 

































Integral to plasma membrane 
Peptidoglycan catabolic process 
Peptidoglycan binding 
Microtubule associated complex 
Immune response 


















Phototransduction, visible light 
Phototransduction, UV 
Rhodopsin biosynthetic process 
Cell adhesion 
Integral to plasma membrane 
carotenoid transport 
Scavenger receptor activity 
Membrane 














Cell wall macromolecule 
catabolic process 
Antimicrobial humoral response 
Lysozyme activity 














Hemolymph coagulation  
Hemostasis 
Melanization defense response 
Wound healing 




Chitin metabolic process 





4.2.4 Microarray analysis of transcripts associated with Drosophila melanogaster 
metabolism 
In total, 5 sequences associated with metabolism were significantly altered in abundance 
with dechorionation on the low nutrient diet and only one sequence (Obstructor-G) 
having a 3 or greater fold change (Table: 4.4), this sequence was up-regulated. The 
sequences with a significant change were associated with a range of functions including 
proteolysis, cholesterol transport, oxidation reduction and glutathione metabolism 
(Table: 4.4; Appendix, Table: 7.15) which were all down-regulated except for cholesterol 
transport. 
With dechorionation on the high nutrient diet, 31 metabolic transcripts were significantly 
changed in abundance at 2 fold or more, 8 of which had a fold change greater than 3 
(Table: 4.4; Appendix, Table: 7.8).  The metabolic transcripts were predominantly down-
regulated, 26 out of 31 sequences.   The sequences with a significant change in 
abundance were associated with proteolysis, carbohydrate metabolism, glutathione 
biosynthesis/metabolism, glutathione peroxidase activity, lipid/fatty acid metabolism, 
chitin metabolism and oxidation/reduction. All of which were down-regulated with 
dechorionation.  The gene with the greatest change in abundance was glutamate-cysteine 
ligase catalytic subunit, where a 4.5 fold decrease was observed.  Glutamate-cysteine 
ligase catalytic subunit was also down-regulated with dechorionation on the low nutrient 
diet. 
For the comparison of the control flies reared on the 2 diets, 25 sequences with functions 
associated with metabolism were observed to have a significant change in abundance of 
2 fold or more (Appendix, Table: 7.20; Table: 4.4).  Out of the 25 sequences, 7 had a fold 
change in abundance of 3 or more.  The majority of the transcripts that were significantly 
changed in abundance had functions associated with having nutrient reservoir activity, 
chitin metabolism and serine proteolysis.  The transcripts associated with nutrient 
reservoir and storage activity had the greatest change in abundance (29.11-5.44 fold 
change), and were down-regulated in flies reared on the low nutrient diet.  Chitin 
metabolism was also down-regulated by 7.6-2 fold and serine endopeptidases were 
down-regulated by 2 fold.  Further transcripts were identified to be up-regulated in flies 
on a low nutrient diet.  The gene, phosphoenolpyruvate carboxykinase was increased by 
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3.3 fold in flies on a low nutrient diet, suggesting the use of gluconeogenesis during 
energy metabolism. 
Flies derived from egg dechorionation on the high and low nutrient diet had 54 metabolic 
transcripts with significant changes in abundance (Appendix, Table: 7.27; Table: 4.4).  
Nine transcripts were shown to have a 3-fold or more change in abundance.  Similar to 
the comparison of the control flies on the 2 diets, the major changes occurred with 
transcripts associated with chitin metabolism (CG7017) which was down-regulated in 
both of the comparisons.  Furthermore, the nutrient reservoir transcripts (Fat body 
protein 2, Fat body protein 1, Larval serum protein 1 alpha and Larval serum protein 1 
beta) were identified to be down-regulated by 7-3.2 fold. Several more transcripts have 
been identified to have a significant change in abundance; these transcripts included 
functions of serine proteolysis, glutathione transferase activity and carboxylesterase 
activity which were all down-regulated in flies reared on a low nutrient diet.  The majority 
of metabolic transcripts were up-regulated which included; glucuronosyltransferase 
activity, hexokinase, associations with the tricarboxylic acid cycle, glycerol-3-phosphate 
dehydrogenase activity, glutamine biosynthesis, glycolysis, citrate and transmembrane 
transporter actvity and pyruvate dehydrogenase activity.  The up-regulation of these 













Table: 4.4. Metabolic transcripts down or up-regulated by greater than threefold (NSC = 
no significant change, SC = significant change, - = down regulated). 






















































Glutamate-cysteine ligase activity 
Protein binding 
Glutathione biosynthetic process 
Glutathione metabolic process 
Response to DNA damage stimulus 
Glutamate-cysteine ligase complex 
Nucleus 
Perinuclear region of cytoplasm, 









Protein prenyltransferase activity 
Protein amino acid prenylation 
Protein farnesyltransferase complex 
4.072 NSC NSC NSC 
CG4500 - GO:0001676, 
GO:0007498, 
GO:0004467 





-3.99 NSC NSC NSC 
CG14205 - GO:0016747 Transferase activity, transferring 
acyl groups other than amino-acyl 
groups 
-3.61 NSC NSC NSC 






Chitin metabolic process 
structural constituent of peritrophic 
membrane 







Nucleotide and nucleic acid 
metabolic process  
DNA binding 







Voltage-gated potassium channel 
complex 













Central nervous system 
development 
Dorsal closure 
Intestinal cholesterol absorption 
Hedgehog receptor activity 
Integral to membrane 
Plasma membrane 
peripheral nervous system 
development 
-3.15 NSC NSC NSC 





Chitin binding  
Chitin metabolic process 
Structural constituent of peritrophic 
membrane 
NSC 3.32 NSC NSC 







Oxygen transporter activity 
Protein transporter activity 
Lipid particle 
Storage protein import into fat body 
NSC NSC -29.1 NSC 





Alcohol dehydrogenase (NAD) 




















Oxygen transporter activity 
Larval serum protein complex 
Nutrient reservoir activity 
Lipid particle 
Transport 
NSC NSC -5.44 -3.62 





Chitin metabolic process 














carboxykinase (GTP) activity 
Mitochondrion 
NSC NSC 3.31 NSC 
CG33467 CG33467  GO:0004672 
GO:0006468 
GO:0005524 
Protein kinase activity 
Protein amino acid phosphorylation 
ATP binding 































Tricarboxylic acid cycle 
4 iron, 4 sulfur cluster binding 
Aconitate hydratase activity 
Mitochondrion 
Tricarboxylic acid cycle 










Oxygen transporter activity 
Protein transporter activity 
Lipid particle 
Storage protein import into fat body 













Oxygen transporter activity 
Larval serum protein complex 








































N-acylmannosamine kinase activity  
Adenylate cyclase inhibiting 
metabotropic glutamate receptor 
activity 
Protein binding 
Hexokinase activity  
Group III metabotropic glutamate 
receptor activity  
Metallopeptidase activity 
Zinc ion binding 
Carbonate dehydratase activity  
Calmodulin binding 




epimerase activity  
Protein homodimerization activity 
Phosphoglycerate dehydrogenase 
activity  







Presynaptic active zone 




4.2.5 Microarray analysis of transcripts associated with transport and binding in 
Drosophila melanogaster  
With dechorionation on the low nutrient diet, 9 had a significant change in abundance 
with 2 having a change of 3 fold or greater (Appendix, Table: 7.14; Table: 4.5).  The 
significant changes were observed with transcripts associated with odorant binding, 
RNA/Nucleic acid binding and ion binding.  With dechorionation on the high nutrient diet, 
8 transcripts also had a significant change in expression of 2 fold and above, these 
included: protein and metal ion binding (Appendix, Table: 7.7; Table: 4.5).  Only 1 of the 8 
transcripts had a change in abundance which was 3 fold or greater, Metallothionein A was 
down-regulated by 3.1 fold.   
As with dechorionation on the low nutrient diet, the comparison between the control 
flies on the high and low nutrient diet demonstrated a difference in abundance of 
transcripts associated with odorant binding and ion transport and binding (Appendix, 
Table: 7.19; Table: 4.5).   Fifteen transcripts were established to have a significant change 
in abundance, with only one transcript having a fold change 3 fold or greater.  The 
transcript with the greatest fold change that was significantly up-regulated by 4.2 fold 
was associated with zinc ion binding.  The analysis of the flies derived from egg 
dechorionation on the 2 diets demonstrated a greater response, with 32 transcripts with 
a significant change in abundance (Appendix, Table: 7.26; Table: 4.5).  The majority of 






























Metabotropic glutamate receptor, 
adenylate cyclase inhibiting 
pathway 
Learning and/or memory 






Table: 4.5. Transport and binding transcripts down or up-regulated by greater than 































e  Name 












CG9470 Metallothionein A GO:0046872 Metal ion binding -3.10 NSC NSC NSC 
NM_001
015210 






Nucleic acid binding 
Zinc ion binding 
protein binding 
 
NSC -3.26 4.20 NSC 
CG11123 mgc69156 protein GO:0003723 RNA binding NSC 3.09 NSC NSC 







Sensory perception of 
chemical stimulus  
Odorant binding 
NSC NSC NSC -3.27 
CG4950 Carboxypeptidase n 
subunit 2 
GO:0005515 Protein binding SC down 
<3 fold 
NSC NSC 3.24 
CG4139 Karl  GO:0005488 Binding SC down 
<3 fold 
NSC NSC 3.11 





Sensory perception of 
chemical stimulus 
































NSC NSC NSC 3.13 
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4.2.6 Microarray analysis of transcripts with miscellaneous and DNA/RNA replication or 
transcription functions in Drosophila melanogaster  
Eight sequences with miscellaneous functions had a significant change in abundance on 
the high nutrient diet with none being identified on the low nutrient diet (Appendix; 
Table: 7.10, Table: 4.6).  Out of the 8 sequences, only 1 had a fold change greater than 3.  
Two of the transcripts were associated with puparial adhesion and were down regulated 
by 2-7 fold, the remaining transcripts had associations with structural properties, 
signalling and hemopoiesis.   
Six transcripts had a significant change in abundance with control flies reared on the 
different diets (Appendix, Table: 7.22; Table: 4.6).  Four transcripts had a change in 
abundance of 3-fold or more.  Two transcripts associated with the structural constituent 
of chitin/cuticle had a 9.1-4.6 fold change in abundance, and were down-regulated in flies 
on a low nutrient diet.  Regulators of growth were up-regulated by 3 fold in flies reared 
on the low nutrient, suggesting differences in the growth rates of the flies reared on the 
different diets. 
Seventeen transcripts were identified to have a significant change in abundance when 
comparing the flies derived from egg dechorionation on the high and low nutrient diet 
(Appendix, Table: 7.29;  Table: 4.6).  The up-regulated transcripts were associated with 
growth regulation, signalling, cell proliferation and hormone activity.  The change in 
expression was less than 3 fold for all the transcripts except TC215525, which was down-
regulated and has a function associated with the structure of chitin and, CG14669 and 
CG33519 with signalling activities which were up-regulated by 3.4-5 fold.  
On the low nutrient diet with dechorionation, only 1 transcript (CG5303) was identified to 
have a major function involved in DNA/RNA replication or transcription this was 
upregulated by 2 fold (Appendix, Table: 7.16).  Four transcripts were identified to have a 
significant change in abundance with dechorionation on the high nutrient diet and only 
one transcript (Cubitus interruptus) with a fold change greater than 3 (Appendix, Table: 
7.9; Table: 4.7). With comparison of control flies on the high and low nutrient diet, 5 
transcripts had a significant change in abundance; none of these transcripts had a fold 
change greater than 3 (Appendix, Table: 7.21; Table: 4.7).  The comparison of the flies 
derived from dechorionation on the low and high nutrient diets had a greater number of 
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transcripts with a significant change in abundance, with 12 transcripts and only 2 with a 
fold change greater than 3 (CG10110-RA and TC219369) (Appendix, Table: 7.28; Table: 
4.7). 
Table: 4.6. Miscellaneous transcripts down or up-regulated by greater than threefold 
(NSC = no significant change, SC = significant change, - = down regulated). 
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nutrient 
diet 
































Structural molecule activity 




GO:0042302 Structural constituent of 
cuticle 
Structural constituent of 
chitin-based larval cuticle 




GO:0008011 Structural constituent of 
pupal chitin-based cuticle 
 











exchange factor activity 
Regulation of ARF protein 
signal transduction 
Intracellular     
NSC NSC 3.16 SC up <3 
fold 
CO181664 - GO:0040018 Positive regulation of 
multicellular organism 
growth 







Structural constituent of 
chitin-based cuticle  
Structural constituent of 
chitin-based larval cuticle 
NSC NSC NSC -4.66 






Small GTPase mediated 
signal transduction 
Membrane 
NSC NSC NSC 3.40 








ATP binding  
Protein serine/threonine 
kinase activity  
Rho guanyl-nucleotide 
exchange factor activity 
Protein amino acid 
phosphorylation 
Regulation of Rho protein 
signal transduction 
Intracellular   
Adult somatic muscle 
development 
Sarcomere organization 
NSC NSC NSC 5.022 
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Table: 4.7. Transcripts associated with DNA/RNA replication/transcription down or up-
regulated by greater than threefold (NSC = no significant change, SC = significant 
change, - = down regulated). 













































RNA binding  
RNA-directed DNA polymerase 
activity 
RNA-dependent DNA replication 













mRNA polyadenylation mRNA 
cleavage and polyadenylation 
Specificity factor complex 
mRNA 3'-UTR binding,  
Protein binding 
mRNA cleavage 













































Transcription activator activity 
Cuticle pattern formation 
Dendrite morphogenesis 
 Epidermis development 
 Eye morphogenesis 
Genital disc anterior/posterior 
pattern formation 
 Heart formation 
 Neuron development, 
Labial disc development 
Oogenesis 
Positive regulation of epithelial 
cell differentiation 
Positive regulation of S phase of 
mitotic cell cycle  
Positive regulation of 
transcription from RNA 
polymerase II promoter 
Regulation of mitotic cell cycle 
Segment polarity determination 
Smoothened signaling pathway 
Spiracle morphogenesis, open 
tracheal system 
Wing disc anterior/posterior 
pattern formation 
Cytoplasm 




Transcription factor activity 
Transcription repressor activity 
Zinc ion binding 
Blastoderm segmentation 
Negative regulation of 
transcription from RNA 
polymerase II promoter 
Ovarian follicle cell development 
Regulation of transcription 
Smoothened signaling pathway 
Nucleus 
-3.81 NSC NSC NSC 
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4.2.7 Microarray analysis of transcripts with no assigned Gene Ontology number 
Overall, 69 sequences were identified to have a significant change in abundance with 
dechorionation on the high nutrient diet (Appendix, Table: 7.11, 7.12; Table: 4.8). 
Fourteen of these transcripts, expression sequence tags and tentative annotative 
sequences with no assigned Gene Ontology number had a change in expression of 3 fold 
or greater (Appendix, Table: 7.11, 7.12; Table: 4.8).  The transcript with the greatest 
change in expression was CG32185 with a very greatest fold change of 118.8. On the low 
nutrient diet with dechorionation, 22 sequences with no assigned gene ontology number 
had a significant change in expression of 2 fold and greater, with 8 having a change in 
abundance of 3 fold or more (Appendix, Table: 7.17, 7.18; Table: 4.8).    As with the high 
nutrient diet, the greatest change was also observed with CG32185 which was down-
regulated by 35 fold.  TC218200 and EC265593 were also down-regulated on both diets 
with dechorionation.  
With the comparison of control flies reared on the high and low nutrient diet, 38 
sequences with no assigned gene ontology number had a change in expression of 2 fold 
and greater (Appendix, Table: 7.23, 7.24; Table: 4.8).  Seven out of the 38 transcripts had 
a change in abundance of 3 fold or higher, the greatest change was observed with 
TC198490.  TC198490 was down-regulated by 17-fold in flies reared on the low nutrient 
diet, and was also down-regulated when the comparison was made between flies derived 
from egg dechorionation on the 2 diets.  A much greater number of sequences were 
identified with dechorionation on the 2 diets; 84 sequences had a significant change in 








Table: 4.8. Sequences with no assigned Gene Ontology number and a fold change of 




  High nutrient diet Low nutrient 
diet 
Low V high 
nutrient diet 
Low V high 
nutrient diet 




Control flies Dechorionation 
Sequence  Number Sequence Description Fold change Fold change Fold change Fold change 
CG32185 - -118.89 -35.34 NSC NSC 
 
EC265593  Expression sequence 
tag 
-40.33 -16.36 NSC 
 
NSC 
TC218200 Tentative consensus 
sequence 
-9.01 -11.09 NSC NSC 
 
CG34143  Ionotropic receptor 
10a 
7.00 NSC NSC NSC 






CG33553-RF - -4.61 NSC NSC NSC 
TC212147   Tentative consensus 
sequence 
-4.04 NSC -3.76 NSC 
 






CG16775 - -3.81 NSC 
 
NSC NSC 
CG31711-RA - -3.59 NSC NSC 
 
NSC 
TC213322   Tentative consensus 
sequence 
-3.50 NSC NSC NSC 
 
CG41233 - -3.41 NSC 
 
NSC NSC 
TC217958  Tentative consensus 
sequence 
3.13 NSC NSC 
 
NSC 
CG12998 - -3.01 NSC NSC NSC 
 




-5.67 NSC NSC 
TC210124 Tentative consensus 
sequence 
NSC -5.22 NSC 
 
NSC 
TC218367 Tentative consensus 
sequence 
NSC -4.65 NSC 4.57 




-4.21 NSC NSC 
CG13445 - NSC 3.32 SC up <3 Fold NSC 
TC198490   Tentative consensus 
sequence 
NSC NSC -17.05 -4.50 





TC216174  Tentative consensus 
sequence 
NSC NSC 3.86 NSC 
 
CG13962 - NSC NSC -4.31 NSC 







CG40203 - NSC NSC 3.59 NSC 
TC217285 Tentative consensus 
sequence 
NSC NSC NSC 10.07 
TC201533 Tentative consensus 
sequence 































TC214613 Tentative consensus 
sequence 
NSC NSC NSC -4.31 









CG4996 - NSC NSC NSC 3.81 
CG34206 - NSC NSC NSC -3.79 









CG17761-RA - NSC NSC NSC 3.42 
AW944513  Expression sequence 
tag 
NSC NSC NSC -3.35 









TC201327 Tentative consensus 
sequence 
NSC NSC NSC -3.13 
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4.3 Quantitative RT-PCR of bacteria-depleted flies on a high and low nutrient 
diet 
Quantitative RT-PCR (qRT-PCR) was conducted to verify the results gained from whole-
genome expression profile using microarray analysis.  A small group of transcripts were 
chosen to determine whether the significant difference in abundance of these transcripts 
was also observed with qRT-PCR. 
The qRT-PCR data did support some of the microarray results of flies reared on a high 
nutrient diet with dechorionation (Figure: 4.4). As with the microarray, qRT-PCR showed 
that the gene expression of the antimicrobial protein (AMP) Diptericin and Defensin were 
reduced by 23 and 4 fold, respectively with dechorionation.  Furthermore, Diptericin B 
with an immune-related function was shown to decrease by 18 fold in expression.  The 
gene CG31148, with a role in carbohydrate and lipid metabolism was demonstrated to 
have a decrease by 2 fold in expression with dechorionation.  These were identified to 
change in expression with dechorionation by both the microarray and qRT-PCR, other 
transcripts were shown to have a change in abundance with qRT-PCR and not with the 
microarray.  These were Phosphoenol-pyruvate carboxykinase (PEPCK) and Fat body 
protein 2 with a 2 and 5-fold change, respectively. 
Flies reared on the low nutrient diet showed a change in the immune transcripts, 
Diptericin and Diptericin B with a 23 and 9-fold change in abundance which supports the 
results gained from the microarray (Figure: 4.4).  As with the high nutrient diet, 
Phosphoenol-pyruvate carboxykinase (PEPCK) was shown to have a 3-fold change in 
transcript levels unlike the microarray.  Low levels of change in expression of Defensin, 
Fat body protein 2 and CG31148 were observed, but not with a change of greater than 3-
fold.   An additional control gene, Zwischenferment (involved in glucose-6-phosohate 
dehydrogenase activity) was quantified with all treatments as the expression of this gene 
was not significantly altered by 2 fold or more in any of the comparisons during the 
microarray analysis.  The expression of this gene was not significantly altered by 2 fold or 













Absolute change in expression 
(n=3) 





Diptericin B  (DptB) CG10794 Down 14.94 7.39-13.24 
 
Fat body protein 2 (FBP2) CG3763 / NSC NSC 
CG31148 CG31148 Down 2.62 NSC 
Defensin (Def) BT023384 Down 10.64 NSC 
Phosphoenol- pyruvate carboxykinase (PEPCK) CG17725 Down NSC NSC 
Diptericin (Dpt) CG12763 Down 10.24 33.96 
Zwischenferment (ZW) Negative Control CG12529 / NSC NSC 
Figure: 4.4. a) qRT-PCR results of DptB = Diptericin B; Fbp2 = Fat body protein 2; 
CG31148; Def = Defensin; PEPCK = Phosphoenol-pyruvate carboxykinase; Dpt = 
Diptericin; ZW = Zwischenferment. These were selected for the comparison with the 
microarray for the treatments of dechorionation on a high and low nutrient diet  b) 









Not only was the impact of dechorionation on the transcript abundance in Drosophila 
analysed but also the impact of diet.  Two comparisons were made with the first 
comparing control flies on the high and low nutrient diets and the second, with the flies 
derived from dechorionated eggs on the 2 diets.  
The qRT-PCR data with control flies reared on the high and low nutrient diet did show 
some support with the microarray results, however some differences were also observed 
(Figure: 4.5). As with the microarray, qRT-PCR showed that the gene expression of Fat 
body protein 2 did decrease in the low nutrient diet, with a 22 fold change.  However, 
Phosphoenol-pyruvate carboxykinase (PEPCK) which had a 3 fold change, was not shown 
to have a significant change with qRT-PCR.  Furthermore, qRT-PCR did show that there 
was a change in expression of Defensin, Diptericin B and Diptericin with a 5, 3 and 3-fold 
change, which was not shown by the microarray.  Both CG31148 and the control gene, Zw 
did not show a fold change of 2 or more. 
The results for dechorionation with the high and low nutrient diet, again showed a 
change in transcript abundance of the immune gene, Diptericin by 4 fold and the 
metabolic gene Fat body protein 2 with a 4 fold change (Figure: 4.5).  However, the gene 
Defensin which was identified by the microarray with a significant change in abundance 
did not show a change of greater than 2 fold.  Diptericin B, CG31148, PEPCK and the 
control gene Zw were all shown not to have a change in expression of 2 fold or greater by 






















Absolute change in expression 
(n=3) 
Control flies Dechorionation 
Diptericin B  
(DptB) 
CG10794 Down NSC NSC 




CG31148 CG31148 / NSC NSC 
Defensin (Def) BT023384 Down NSC 2.43 
 
Phosphoenol- pyruvate carboxykinase (PEPCK) CG17725 Up 3.31 
 
NSC 
Diptericin (Dpt) CG12763 Down NSC 4.96 
 
Zwischenferment (ZW) Negative Control CG12529 / NSC NSC 
Figure: 4.5. a) qRT-PCR results of DptB = Diptericin B; Fbp2 = Fat Body Protein 2; 
CG31148; Def = Defensin; PEPCK = Phosphoenol- pyruvate carboxykinase; Dpt = 
Diptericin; ZW = Zwischenferment.  These were selected for the comparison with the 
microarray for the treatment, controls on a high and low nutrient diet and 
dechorionation on a high and low nutrient diet b) Microarray results for the genes 








Unlike many genome-wide studies, the results described in this chapter with the 
treatment egg dechorionation, had a small number of genes with a significant change in 
expression. The major observation was the change in abundance of immune transcripts 
which were decreased in flies derived from dechorionated eggs on both the high and low 
nutrient diet.  This change suggests that the depletion of bacteria at the embryo stage has 
resulted in a reduction in immune regulation.   The presence of bacteria would activate 
the immune system and suggests that the bacteria contribute to the regulation of the 
IMD pathway and the Toll pathway.  Furthermore, this result suggests that these 
pathways may be required to control the microbial symbionts found within the gut 
(Reynolds and Rolff, 2008).  This response is supported by Ren et al (2007) where a 
decrease in expression of antimicrobial peptides was observed in axenic flies.   
When dechorionation and control comparisons were made with the low nutrient diet, a 
smaller number of transcripts were identified compared with the high nutrient diet.  This 
suggests that the response to bacterial depletion was not as strong with the low nutrient 
diet as the response on the high nutrient diet.  This demonstrates that diet has an 
important role in the response of Drosophila to treatments and also shows that the 
difference in the response of Drosophila demonstrated by different research labs could 
be due to the use of different diets. 
The greatest change in adundance was observed in transcripts which were associated 
with immunity and not metabolism, suggesting that the dominant response to bacterial 
depletion was immune related and not metabolic.  The metabolic transcripts where the 
expression was significantly altered were part of different metabolic pathways and 
therefore, proved more difficult to discuss compared with the immune transcripts.  A 
decrease in the abundance of transcripts associated with carbohydrate metabolism, lipid 
metabolism, aminoacyl transferase activity and serine proteases have been shown to be 
down-regulated with dechorionation on the high nutrient diet.  This reduction in 
metabolism does suggest that the bacteria do play a role in the metabolism in Drosophila. 
These changes may occur as bacteria have been shown to aid nutrient degradation 
(Hooper, 2009; Savage, 1986) and the reduction in bacteria could result in changes in the 
quantity of nutrients available, leading to changes in metabolism.  
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The comparison between the control flies on a high and low nutrient diet showed that the 
transcripts which had a significant change in expression were mainly metabolic 
transcripts.  One example was the significant reduction in Fat body protein 1 which has a 
function of transporting proteins into the fat body.  The low nutrient diet contained 20 g 
L-1 of yeast but the high nutrient diet contained a much greater content of 80 g L-1 of 
yeast.  Therefore, the reduced availability of protein in the low nutrient diet could have 
resulted in a reduced store of protein and a reduction in the transport of proteins into the 
fat body.  Fat body protein 2 and Larval serum protein 1 beta (both act as a nutrient 
reservoir) also had a reduced abundance which would be expected on a low nutrient diet 
as less nutrients would be available to be stored.  Furthermore, a gene associated with 
the process of gluconeogenesis was increased in abundance in flies reared on the low 
nutrient diet.  The limited supply of carbohydrates in a diet such as the low nutrient diet 
could lead to the gluconeogenesis (a metabolic pathway providing glucose using a non-
carbohydrate, such as pyruvate) and is commonly increased in animals which are starved 
or on a low carbohydrate diet (Berg et al., 2002, p425-463 and Westman et al., 2007).  
However, the change in abundance of phosphoenolpyruvate carboxykinase (involved in 
gluconeogenesis) was not observed with qRT-PCR.  
Unlike the control flies, the comparison of dechorionation with a high and low nutrient 
diet demonstrated a significant difference in the expression of the immune genes 
including; Defensin and Diptericin.  All of which have a reduced transcript abundance with 
flies reared on a low nutrient diet.  This suggests that the immune system has responded 
greater on a high nutrient diet highlighting the role of diet in the response of Drosophila.  
A quarter of all the transcripts with a significant change in abundance were metabolic 
transcripts.  Genes that were identified with the control flies on the 2 diets were also 
identified with the flies derived from dechorionation.  These included the nutrient 
reservoir genes (Fat body protein 2 and Larval serum protein 1 beta) which were also 
identified to be down-regulated by 7-3.2 fold. The transcript levels of several genes 
associated with the tricarboxylic acid cycle were significantly up-regulated suggesting an 
increase in glycolysis in flies without symbionts on the low nutrient diet in comparison 
with the high nutrient diet.  This observation was different to the comparison of the 
control flies on the 2 diets.  The transcript level of Phosphoenolpyruvate carboxykinase 
was significantly changed in control flies using the microarray analysis but was not 
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significantly altered in abundance using qRT-PCR.  Therefore, the changes in glycolysis (all 
3 fold or less) with dechorionation on the 2 diets would need to be confirmed using qRT-
PCR. 
QRT-PCR has been proven to be an important tool to verify the results gained from the 
microarray. Out of 28 reactions, 21 correlated well with the microarray, however 7 did 
not.  The transcripts with large changes in abundance of greater than 4 fold change, did 
correlate well with the results gained through qRT-PCR.  This would suggest that 
transcripts with a fold change close to 2 may produce results that did not correspond as 
well with the results gained through qRT-PCR.  As shown by Morey et al (2006), 
transcripts exhibiting at least a 1.4 fold change and a p-value of 0.0001 or less show a 
strong correlation with microarray data however those with a lower significance should 
be approached with more caution when verifying microarray results using qRT-PCR.  The 
microarray analysis provides an overall overview of the changes in transcript levels 
however, to gain more accurate results qRT-PCR would be a preferred method of 
determining changes in expression. 
4.5 Conclusion 
The microarray has demonstrated that the major result of removing bacterial symbionts 
from Drosophila melanogaster is the depletion in the immune system, particularly 
transcripts associated with the Toll/IMD pathway.  This result suggests that the Toll/IMD 
pathway is involved in controlling the symbionts found within the insect gut.  Lastly, the 
microarray with bacterial depletion on a high and low nutrient diet has demonstrated 








Chapter 5: Minimal chlortetracycline concentrations with the RIDL® 
mosquito, LA513 and the impact of chlortetracycline on wild-type Aedes 
aegypti  
5.1 Introduction 
5.1.1 RIDL® Mosquitoes  
As described in Section 1.5, RIDL® has been used with Aedes aegypti. LA513A is an 
example of a RIDL® mosquito (Aedes aegypti) that has a late-acting dominant lethal 
genetic system which causes the death of both male and female mosquitoes at L4-pupal 
stage (Phuc et al., 2007, Section: 1.5).  This tetracycline-repressible genetic system 
requires the insects to be reared with chlortetracycline, which suppresses the expression 
of the lethal gene and allows rearing of the insects.  Oxitec Ltd currently rear LA513A in 
water supplemented with 30 µg ml-1 of chlortetracycline to suppress the expression of 
tTav.   
In this chapter the minimum concentration of chlortetracycline required to suppress the 
late-acting dominant lethal gene being expressed in LA513A was determined. This was 
conducted by rearing the mosquitoes with a range of chlortetracycline concentrations (0-
30 μg ml-1). The fitness was determined by measuring survival and development time to 
pupae/adulthood and the life-span of the adults. 
This experiment will allow reductions in the cost of chlortetracycline and waste during 
mass-rearing, which will limit the quantities of chlortetracycline being released into the 
environment.  Furthermore, a reduction in the concentration used during rearing of the 
mosquitoes could potentially reduce the impact on beneficial bacteria found within the 
mosquito and promote performance and fitness.  
5.1.2 Wild-type Aedes aegypti and  
To complement the experiments with LA513, studies were made to determine the impact 
of using chlortetracycline on the insect host and its microbiota. As described in Chapter 1, 
little is known about the diversity of the gut microbiota of Aedes aegypti.  Only one 
research group has published data regarding the diversity of the microbes found within 
the gut of Aedes aegypti.   What we do know from the published data is that Bacillus, 
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Asaia, Enterobacter, Klebsiella and Serratia are the dominant genera found in the gut of 
Aedes aegypti (Gusmão et al., 2007; Gusmão et al., 2010).  
The role of these individual gut symbionts to the insect host is still unknown however we 
do know what happens to the performance of the insect when all the bacteria in Aedes 
aegypti are eliminated.  Lang et al (1972) identified the effects of eliminating bacteria on 
the performance of Aedes aegypti.  It was suggested that the removal of bacteria did not 
affect of the development time, survival and protein content. Nevertheless, bacterial 
depletion did impact the lipid content, water content and extended the life-span of the 
insect.  This indicates that the performance of the mosquito was not compromised as 
much as shown in Drosophila melanogaster (Chapter 3) but the nutritional content of the 
insect was affected.  Furthermore, it was shown that bacteria-free mosquitoes had an 
extended life-span which is similar to Drosophila melanogaster where an extension was 
observed with antibiotic treated.   
There have not been any studies that have shown the impacts of chlortetracycline 
treatment on Aedes aegypti and the associated microbes.  Therefore, I determined the 
impacts of chlortetracycline on wild-type Asian Aedes aegypti, a strain which was reared 
at Oxitec Ltd and originally isolated from Malaysia in 1974 and wild-type Mexican Aedes 
aegypti reared at Cornell University since 2006.  The reason for the use of both strains 
was to determine whether there was a difference between a strain that may have had 
prior contact with chlortetracycline in the laboratory and one at Cornell University which 
had not.  Both strains were treated with a range of chlortetracycline concentrations (0-
100 μg ml-1).  Survival and development to pupae and adulthood, lifespan and the 
nutrition of the mosquitoes were measured.  454 pyrosequencing and 16S rRNA gene 
analysis was conducted to gain more insight into the diversity of bacteria within larvae 
and adult Aedes aegypti and to identify the changes in the diversity when the insects 





5.2 LA513 (Bisex-Lethal) performance with varying concentrations of 
chlortetracycline 
5.2.1 Survivorship to pupae and adulthood of LA513 
Survival to pupae and adult stages were measured using 6 replicates of 150 mosquito 
larvae.  The survival to pupae and adulthood varied significantly with chlortetracycline 
concentration: with very high mortality at 0 and 0.01 µg ml-1; and >80% survival at greater 
concentrations (Pupae - KW: H6 = 34.512, p<0.001; Adult - KW: H6 = 37.840, p<0.001) 
(Figure 5.1).  Pupae mortality was observed at 0.1 µg ml-1 with 29% of total pupae failing 
to emerge as adults.  At 0.5 µg ml-1 and above, the percentage that died was smaller, 
ranging from 11-20%.  Survival to adulthood was lower than survival to pupae, 
mosquitoes reared on 0.1 µg ml-1 showed the biggest decrease with only 58% surviving to 
adulthood.  Mosquitoes reared on 0.5 µg ml-1 and above showed a much greater survival 
of 75-91%.  
 
Figure: 5.1. Percent survival to pupae of mosquitoes treated with 0-30 μg ml-1 of 
chlortetracycline, number of replicates = 6 with 150 larvae per replicate (Methods 





5.2.2 Development time of LA513 
Development time to pupae and adulthood was measured for three reasons; 1) 
experiments with Drosophila showed extension of development time when treated with 
chlortetracycline (Chapter 3), 2) development time could be affected by the expression of 
the lethal gene and 3) the development time is important when mass rearing.  Any 
change in development time due to changes in chlortetracycline concentration need to be 
identified so the rearing schedule can be adjusted accordingly. 
The development time to pupae was determined using 6 replicates of 150 larvae and 
analysed using Kruskal-Wallis analysis.  This analysis demonstrated that development 
time to pupae was significantly different in males (KW: H4 = 103.073, p<0.001) and 
females (KW: H4 = 149.947, p<0.001) when treated with different concentrations of 
chlortetracycline. At 0.1 and 1 µg ml-1 the median development was the same for males 
(10 days) and females (11 days). However, at 10 and 30 µg ml-1 the median development 
time was reduced to 9 days in males but in females the development time remained the 
same from 0.1 to 30 µg ml-1 (Figure: 5.2). 
 
Figure: 5.2. Median development time to pupae of LA513 reared with 0.1-30 μg ml-1 of 
chlortetracycline, number of replicates = 6 with 150 larvae per replicate (Methods 





The development time to adulthood was also significantly different in males (KW: H4 = 
121.411, p<0.001 and females (KW: H4 = 130.528, P<0.001) when treated with different 
concentrations of chlortetracycline. At 0.1 µg ml-1 both male and female have the same 
median development time of 12 days, however above this concentration the 
development time reduced to 11 days in males and increased to 13 days in females 
(Figure: 5.3). 
 
Figure: 5.3. Median development time to adulthood with 0.1-30 μg ml-1 of 
chlortetracycline, number of replicates = 6 with 150 larvae per replicate (Methods 











5.2.3 Observations of DsRed fluorescence in LA513A treated with 0-10 µg ml-1 of 
chlortetracycline 
It has been suggested that the level of DsRed expression is affected by the 
chlortetracycline concentration and that DsRed expression may be enhanced by the 
positive feedback loop of the RIDL® system, linking the fluorescence expression with the 
RIDL® expression. Therefore, fluorescence images were taken to examine the expression 
of DsRed in LA513A.  DsRed expression was continually observed to have a more 
pronounced fluorescence in mosquitoes reared on 0 and 0.01 µg ml-1 of chlortetracycline 
(Table: 5.1). 
Table: 5.1. Fluorescence of LA513 reared on different concentrations of 
chlortetracycline.  
Chlortetracycline 
concentration (µg ml-1) 
Larvae viewed using the 
filters for red fluorescence 
(excitation 510-550, 
emission 590LP) 

















5.2.4 Life-span of LA513 
Life-span is an important measurement with both male and female LA513.  Male life-span 
needs to be long enough to ensure that the transgenic mosquitoes mate with the female 
mosquitoes in the wild. In addition female mosquitoes need to have a lifespan long 
enough in the mass rearing facility to mate with male mosquitoes and produce sufficient 
eggs for production needs.  Adult lifespan data varied significantly with chlortetracycline 
concentration in females (KW: H4 = 80.778, p<0.001) and in males (KW: H4 = 86.372, 
p<0.001), being shorter on 0.1 µg ml-1 chlortetracycline compared with treatments 0.5 µg 
ml-1 and above.   The difference was more pronounced in males (median lifespan 15 days 
on 0.1 µg ml-1 and 29 days on 0.5 µg ml-1 chlortetracycline) than in females (31 days and 
39 days, respectively) (Figure: 5.4, Figure: 5.5). 
 
Figure: 5.4. Life-span of male LA513 treated with 0.1-30 μg ml-1 of chlortetracycline, 
number of replicates = 6 with 20 adult mosquitoes per replicate (Methods Chapter; 
Section: 2.3.3, page 41-42). 
   
Figure: 5.5. Life-span of female LA513 treated with 0.1-30 μg ml-1 of chlortetracycline, 




5.3 The impacts of chlortetracycline treatment on WT Aedes aegypti 
The second section of this chapter will determine the impact of chlortetracycline on two 
wild-type strains of Aedes aegypti; Asian Aedes aegypti which was used to create LA513 
at Oxitec Ltd and secondly, Mexican Aedes aegypti.  
5.3.1 Survival of Asian Aedes aegypti treated with 0-100 μg ml-1 of chlortetracycline   
The survival of Asian wild-type (WT) was the first performance parameter to be measured 
using 7 replicates of 300 larvae. The percent survival to pupae and adult mosquitoes 
varied from 69-98% (Figure: 5.6).  Control mosquitoes had a survival to pupae and 
adulthood of 90% and 78% respectively.  Angular transformation of the percentage data 
was conducted and an ANOVA was used to identify the significance of the results; for 
pupae there was no significant effect on survival (F6, 34 = 1.186, p>0.05) between any of 
the chlortetracycline concentrations, this was also observed with adult data (F6, 41 = 1.359, 
p>0.05). 
 
Figure: 5.6. Percent survival to pupae and adulthood of Asian Aedes aegypti treated 
with 0-100 μg ml-1 of chlortetracycline, number of replicates = 7 with 300 larvae per 





5.3.2 Development time of Asian Aedes aegypti treated with chlortetracycline  
The development time to adulthood was assessed in male and female mosquitoes.  In 
male mosquitoes, control mosquito emergence peaked at 11 days.  Chlortetracycline 
treatments at the concentrations; 0.5, 10, 30 and 100 µg ml-1 also had a peak emergence 
of 11 days.  The treatments of 0.1 and 1 µg ml-1 had a pupation peak a day later at 12 
days (Figure: 5.7).  Statistical analysis showed that the development time was significantly 
different with chlortetracycline treatment for males (Kruskal-Wallis: H6 = 40.451, 
p<0.001).  
 
Figure: 5.7. Development curve to adulthood of male mosquitoes treated with 0-100 μg 
ml-1 of chlortetracycline, number of replicates = 7 with 300 larvae per replicate 
(Methods Chapter; Section: 2.3.3, page 41-42). 
For female mosquitoes pupation curves indicated a peak emergence of 14 days across all 
treatments, however statistical analysis suggested that chlortetracycline did significantly 




Figure: 5.8. Development curve to adulthood of female mosquitoes treated with 0-100 
μg ml-1 of chlortetracycline, number of replicates = 7 with 300 larvae per replicate 
(Methods Chapter; Section: 2.3.3, page 41-42). 
5.3.3 Life-span of Aedes aegypti 
A Cox’s regression statistical analysis was conducted with life-span data as the experiment 
was performed for a limited time and before all the mosquitoes died (50-55 days). The 
life-span of female mosquitoes was significantly affected by the treatment of 
chlortetracycline, compared with the control treatment of 0 µg ml-1 (p<0.001).  Control 
mosquitoes showed a reduction in life-span (median lifespan of 30 days) compared with 
other treatments (33-38.5 median lifespan) which suggests that chlortetracycline 
treatment could promote life-span (Figure: 5.9. and Table: 5.2.).  The life-span of male 
mosquitoes was not significantly altered with chlortetracycline treatment (median 




Figure: 5.9. Cumulative survival of female Asian Aedes aegypti treated with 0-100  µg 
ml-1 chlortetracycline, number of replicates = 5 with 30 adults per replicate (Methods 
Chapter; Section: 2.3.3, page 41-42). 
Table: 5.2. Results of Cox’s regression analysis of the life-span of female Asian Aedes 
aegypti treated with 0-100 µg ml-1 chlortetracycline.  For each treatment the estimated 
regression coefficient (B), experimental Exp(B), standard error (S.E), degrees of freedom 
(d.f) and Wald-Statistic are given. 
Covariate B Exp(B) S.E Wald 
Statistic 
d.f Significance 
Replicate -0.130 0.878 0.033 16.090 1 <0.001 
Chlortetracycline 
treatment 
   93.529 6 <0.001 
0.1 0.530 1.698 0.132 16.068 1 <0.001 
0.5 -0.323 0.724 0.150 4.672 1 <0.05 
1 -0.263 0.769 0.152 2.996 1 NS 
10 -0.485 0.616 0.132 13.579 1 <0.001 
30 -0.296 0.744 0.134 4.888 1 <0.05 





Figure: 5.10. Cumulative survival of male Asian Aedes aegypti treated with 0-100 µg ml-1 
chlortetracycline, number of replicates = 5 with 30 adults per replicate (Methods 
Chapter; Section: 2.3.3, page 41-42). 
Table: 5.3. Results of Cox’s regression analysis of the life-span of male Asian Aedes 
aegypti treated with 0-100 µ µg ml-1 of chlortetracycline.  For each treatment the 
estimated regression coefficient (B), experimental Exp(B), standard error (S.E), degrees 
of freedom (d.f) and Wald-Statistic are given. 
Covariate B Exp(B) S.E Wald 
Statistic 
d.f Significance 
Replicate 0.054 1.055 0.023 5.431 1 <0.05 
Chlortetracycline 
treatment 
   4.483 6 >0.05 
0.1 -0.111 0.895 0.120 0.862 1 >0.05 
0.5 0.038 1.039 0.124 0.093 1 >0.05 
1 -0.078 0.925 0.123 0.408 1 >0.05 
10 0.052 1.054 0.121 0.189 1 >0.05 
30 -0.145 0.865 0.122 1.411 1 >0.05 







5.3.4 Total lipid content of Asian Aedes aegypti treated with chlortetracycline 
The lipid content was consistently greater in males compared with female mosquitoes 
and the values ranged from 0.308 and 0.485 mg per mg of dry weight.  Chlortetracycline 
treatment did not have a significant effect on the lipid content of male and female 
mosquitoes (Table: 5.4).  A 2-way ANOVA showed that chlortetracycline does not have a 
significant effect on the lipid content within the mosquitoes (F6, 130 = 1.588, p>0.05) at the 
concentrations of chlortetracycline tested in this study.  This response to chlortetracycline 
treatment was observed in both males and females (F6, 130 = 0.907, p>0.05).  As described 
above, the lipid content between male and female mosquitoes was significantly different 
(F1, 130 = 147.245, p<0.001). 
Table: 5.4. Total lipid content of Asian Aedes aegypti treated with 0-100 μg ml-1 
chlortetracycline, number of replicates = 5 (Methods Chapter; Section: 2.5.6, page 48). 
Concentration 
of chlortetracycline (μg ml
-1
) 
Mean lipid content per mosquito (mg)  per mg
 
of dry weight ± s.e 
(n=10) 
Male Female 
0 0.453 ±0.017 0.319 ±0.015 
0.1 0.412 ±0.023 0.327 ±0.011 
0.5 0.433 ±0.013 0.338 ±0.020 
1 0.485 ±0.027 0.352 ±0.012 
10 0.431 ±0.012 0.335 ±0.017 
30 0.435 ±0.029 0.335 ±0.015 
100 0.449 ±0.010 0.308 ±0.006 
 
The dry weight of the mosquitoes ranged from 0.295 to 0.645 mg, with female 
mosquitoes having the greater weight.  This statistical test (ANOVA) showed a significant 
effect with chlortetracycline treatment (F6, 130 = 6.696, p<0.001) and sex (males smaller 
than females, F1, 130 = 569.426, p<0.001) and also a significant interaction between sex 
and chlortetracycline treatment (F1, 130 = 2.356, 0.05>p>0.01).  LSD (Least significant 
difference) post hoc test revealed that male mosquitoes had a significantly greater dry 
weight when treated with 100 µg ml-1 chlortetracycline than all other treatments.  In 
female mosquitoes the dry weight was significantly increased at 10 μg ml-1 (0.621 µg) and 




Table: 5.5. Dry weight of Asian Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline, number of replicates = 5 (Methods Chapter; Section: 2.5.6, page 48). 
Concentration 
of chlortetracycline (μg ml
-1
) 
Average dry weight per mosquito (mg) ± s.e (n=10) 
Male Female 
0 0.302 ± 0.003 0.526 ± 0.022 
0.1 0.299 ± 0.004  0.519 ± 0.026 
0.5 0.299 ± 0.004 0.569 ± 0.028 
1 0.295 ± 0.009 0.561 ± 0.026 
10 0.310 ± 0.010 0.621 ± 0.026 
30 0.310 ± 0.016 0.562 ± 0.030 
100 0.359 ± 0.010 0.645 ± 0.028 
5.3.5 Wing length of Asian Aedes aegypti treated with 0-100 μg ml-1 of chlortetracycline 
Wing length was used as another measure of size (Chapter 2) to compare different 
chlortetracycline treatments. Wing length of male and female mosquitoes ranged from 
1.422 to 2.177 mm, with females having longer wings compared with males (Table: 5.6).  
A 2-way ANOVA showed that the wing length did vary significantly with chlortetracycline 
treatment (F6, 331= 38.038, p<0.001), there was a significant difference between male and 
female mosquitoes (shorter in males than females, F1, 331 = 1.033, p<0.001) with no 
significant interaction between chlortetracycline and sex (F6, 331 = 1.784, p>0.05).  LSD 
post hoc analysis revealed that males reared with 0 and 100 µg ml-1 of chlortetracycline 
had significantly shorter wings (1.42 mm) than males reared with intermediate 
chlortetracycline concentrations.  A difference between treatments was obtained for 
females with a significantly smaller wing length at 0 and 100 μg ml-1 of chlortetracycline 
(Table: 5.6).   
 Table: 5.6. Wing length of Asian Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline, number of replicates = 5 (Methods Chapter; Section: 2.5.1, page 44). 
 
Concentration  
of chlortetracycline (μg ml
-1
) 
Average wing length (mm) ± s.e (n=6) 
Male Female 
0 1.425 ± 0.018 1.843 ± 0.017 
0.1 1.561 ± 0.070 2.083 ± 0.023 
0.5 1.685 ± 0.018 2.177± 0.023 
1 1.615 ± 0.083 1.916 ± 0.085 
10 1.663 ± 0.021 2.050 ± 0.080 
30 1.597 ± 0.023 2.107 ± 0.021 
100 1.422 ± 0.021 1.874 ± 0.035 
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5.4 Chlortetracycline effects on the performance of Mexican Aedes aegypti 
5.4.1 Survival of Mexican Aedes aegypti treated with 0-100 μg ml-1 of chlortetracycline 
The survival to pupae and adulthood was measured for the different chlortetracycline 
treatments, the percent survival to adults ranged from 51-79% (Figure: 5.11). The 
percentage data was angular transformed and an ANOVA was conducted. The statistical 
analysis showed that the mosquitoes were significantly affected by chlortetracycline 
treatment at pupae (F6, 35 = 4.246, p<0.01) and adulthood (F6, 35 = 7.372, p<0.001).  Pupal 
survival was significanty reduced at 0.1 and 100 μg ml-1 of chlortetracycline where 
survival reduced from 75% with control mosquitoes to 67% at 0.1 and 100 μg ml-1.  Adult 
survival showed a greater response to chlortetracycline than pupae, survival was 73% 
with control mosquitoes, however the survival was significantly reduced to 51% at 100 μg 
ml-1 of chlortetracycline.  
 
Figure: 5.11. Percent survival to pupae and adulthood of Mexican Aedes aegypti treated 
with 0-100 μg ml-1 of chlortetracycline, number of replicates = 6 with 150 larvae per 






5.4.2 Development time to adulthood of Mexican Aedes aegypti treated with 
chlortetracycline  
To assess the impact of chlortetracycline development rates were determined for male 
and female mosquitoes. 
For male mosquitoes, development curves demonstrate that adult emergence peaked at 
11 days for control mosquitoes and at 30-100 μg ml-1 of chlortetracycline.  Peak 
emergence of 0.1-10 μg ml-1 of chlortetracycline was reduced to day 10 (Figure: 5.12).   
Statistical analysis showed that the development time was significantly different with 
chlortetracycline treatment for males (Kruskal-Wallis: H6 = 36.459, p<0.001).  
 
Figure: 5.12. Development curves to adulthood of male mosquitoes treated with 0-100 
μg ml-1 chlortetracycline, number of replicates = 6 with 150 larvae per replicate 
(Methods Chapter; Section: 2.3.3, page 41-42). 
For female mosquitoes, development curves demonstrated an extension in the time to 
emergence in control mosquitoes, with a 12 and 13 day time period for adult emergence 
(Figure: 5.13).  A 12 day period was also observed for 10 and 100 μg ml-1 of 
chlortetracycline and a reduction to 11 days at 0.1, 0.5, 1, 30 μg ml-1 of chlortetracycline 
(Figure: 5.13).  Kruskal-Wallis analysis indicated that the development time was 
significantly different between treatments in female mosquitoes (Kruskal-Wallis: H6 = 




Figure: 5.13. Development curves to adulthood of female mosquitoes treated with 0-
100 μg ml-1 chlortetracycline, number of replicates = 6 with 150 larvae per replicate 
(Methods Chapter; Section: 2.3.3, page 41-42). 
5.4.3 Life-span of Mexican Aedes aegypti treated with chlortetracycline  
In females, the median life-span varied from 35.5 to 51.5 days (Figure: 5.14).  Statistical 
analysis showed that the life-span of female mosquitoes varied significantly with 
chlortetracycline treatment (KW: H6 = 89.545, p<0.001). With control mosquitoes, the 
median life-span was 51.5 days, however at 100 μg ml-1 the lifespan was significantly 
reduced to 40 days, with the lowest life-span being at 30 μg ml-1 (35.5 days). 
The life-span of male mosquitoes was also measured, the median life-span was similar to 
female mosquitoes of 35-58 days (Figure: 5.15).  A Kolmogorov-Smirnov (KS) test was 
conducted to assess the normality of the data for the male life-span data before the 
statistical analysis was conducted.  The distribution was not significantly different from 
the normal distribution (p>0.05), therefore a one-way ANOVA was conducted to 
determine whether there was a significant effect on the life-span of male mosquitoes. 
The life-span of male mosquitoes varied significantly with chlortetracycline treatment (F6, 
653 =11.382, p<0.001).  With control mosquitoes, the median life-span was 55.5 days, 
however at 100 μg ml-1, the lifespan was significantly reduced to 35 days, with the lowest 
life-span being at 30 and 100 μg ml-1. LSD post-hoc statistical test supported this result 
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and showed that at 0.5 to 100 μg ml-1 of chlortetracycline had a significantly different life-
span than the control treatment. 
 
Figure: 5.14. Median life-span of female Mexican Aedes aegypti treated with 0-100 μg 
ml-1 of chlortetracycline, number of replicates = 6 with 20 adults per replicate (Methods 
Chapter; Section: 2.3.3, page 41-42). 
 
Figure: 5.15. Median life-span of male Mexican Aedes aegypti treated with 0-100 μg ml-
1 of chlortetracycline, number of replicates = 6 with 20 adults per replicate (Methods 




5.5 Nutritional Status of Mexican Aedes aegypti 
The carbohydrate, lipid and protein content of the insect was analysed to determine how 
chlortetracycline treatment affected the nutrition of the insect.  Further measurements 
were conducted, including dry weight and wing length to determine the effects of 
chlortetracycline on the size of the insect. 
5.5.1 Wing length of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline. 
The size was inferred from the wing length of the mosquitoes and used for nutritional 
analysis.  The wing length of the mosquitoes varied from 2-2.8 mm, with females having a 
longer wing length (Table: 5.7). An ANOVA demonstrated that chlortetracycline had no 
significant effect on the wing length of either males or females (F6, 56 = 1.070, p>0.05). 
However, there was a significant difference between the sexes (F1, 56 = 198.910, p<0.001).  
The response of male and female mosquitoes to chlortetracycline was not significantly 
different (F6, 56 = 0.636, p>0.05).  
Table: 5.7. Wing length of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline, number of replicates = 5 (Methods Chapter; Section: 2.5.1, page 44). 
Concentration  
of chlortetracycline (μg ml
-1
) 
Mean wing length (mm) ± s.e (n=5) 
Male Female 
0 2.094 ± 0.038 2.703 ± 0.026 
0.1 2.104 ± 0.014 2.734 ±0.029 
0.5 2.112 ± 0.043 2.836 ± 0.055 
1 2.115 ± 0.041  2.807 ± 0.037 
10 2.132 ± 0.017 2.810 ± 0.039 
30 2.139 ± 0.049 2.705 ± 0.068 
100 2.151 ± 0.040 2.823 ± 0.039 
 
5.5.2 Glucose content of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline. 
The glucose content varied between 1.25 and 3.1 µg, with a greater glucose content 
observed in female mosquitoes (Table: 5.8).  To determine whether there was a 
significant effect of antibiotic treatment on the glucose content of mosquitoes, a 2-way 
ANCOVA was conducted with wing length used a size covariate. The statistical analysis 
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showed that wing length varied significantly (F1, 55 = 7.324, p<0.05).   Chlortetracycline 
appears to have a significant effect on the glucose content within the mosquitoes (F6, 55 = 
4.294, p<0.01), with a greater response in females.  Female glucose content reduced as 
the chlortetracycline concentration increased. There was also a significant difference 
between sexes (F1, 55 = 4.232, p<0.05), a greater content observed in females compared 
with males.  The response to chlortetracycline was shown to be different in male and 
female mosquitoes (F6, 55 = 5.344, p<0.001).  The glucose content of male mosquitoes did 
not significantly alter with treatment of chlortetracycline (F6, 28 = 1.933, p>0.05) (Table: 
5.8).  However, in females, the glucose content was significantly decreased at 30 μg ml-1 
of chlortetracycline where the mean glucose content decreased from 2.53 µg in control 
mosquitoes to 1.61 µg (F6, 28 = 9.416, p>0.001)  (Table: 5.8).   
Table: 5.8. Glucose content of mosquitoes treated with chlortetracycline (0-100 μg ml-1), 
number of replicates = 5 (Methods Chapter; Section: 2.5.4, page 46). 
Concentration  
of chlortetracycline (μg ml
-1
) 
Mean glucose content µg per fly ± s.e (n=5) 
Male Female 
0 1.42 ± 0.13 2.53 ± 0.22 
0.1 1.51 ± 0.09 3.09 ±0.24 
0.5 1.66± 0.13 3.10 ± 0.36 
1 1.75 ± 0.10 2.10 ± 0.21 
10 1.25 ± 0.06 2.44 ± 0.16 
30 1.63 ± 0.08 1.61 ± 0.05 
100 1.74 ± 0.07 2.46 ± 0.12 
 
5.5.3 Glycogen content of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline. 
Glycogen was quantified in both male and female mosquitoes, the glycogen content of 
the mosquitoes ranged on average between 2.70 and 5.73 µg (Table: 5.9). Male 
mosquitoes showed a greater content of glycogen compared with female mosquitoes. A 
2-way ANCOVA (wing length as the covariate) showed that wing length was statistically 
significantly different (F1, 54 = 4.202, p≤0.05).  Chlortetracycline concentration appears to 
have no significant effect on the glycogen content within the flies (F6, 54 = 1.752, p>0.05) 
but a significant difference was observed between sexes (F1, 54 = 26.630, p<0.001).  
Furthermore, there was a no significant interaction between chlortetracycline treatment 
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and sex (F6, 54 = 2.133 p>0.05), showing that the response was the same in both sexes.  
The content of glycogen of male mosquitoes ranged from 4.26 μg in control mosquitoes 
to 5.73 μg at 100 μg ml-1 of chlortetracycline.  Little change was observed in female 
mosquitoes, in control mosquitoes the glycogen content was 3.42 μg and at 100 μg ml-1 of 
chlortetracycline the quantity was 3.53 μg. 
Table: 5.9. Glycogen content of mosquitoes treated with chlortetracycline (0-100   μg 
ml-1), number of replicates = 5 (Methods Chapter; Section: 2.5.4, page 46). 
Concentration  
of chlortetracycline (μg ml
-1
) 
Mean glycogen content µg per fly ± s.e (n=5,*4) 
Male Female 
0 4.26 ±0.30  3.42 ± 0.21 
0.1 5.51 ± 0.18 4.59 ± 0.53 
0.5 5.72 ± 0.53 4.63 ± 0.47 
1 5.38 ± 0.75 3.12 ± 0.30* 
10 5.35 ± 0.59 4.00 ± 0.52 
30 5.60 ± 0.65 2.70 ± 0.32 
100 5.73 ± 0.26 3.53 ± 0.36 
 
5.5.4 Trehalose content of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline. 
The trehalose content varied from 1.81 to 5.66 µg, with similar trehalose content in male 
and female mosquitoes (Table: 5.10).   An ANCOVA was conducted to determine whether 
there was a significant impact of antibiotic treatment on the trehalose content of the 
mosquitoes.  Wing length was used as the covariate and was shown to be significantly 
different (F1, 54 = 5.257, p<0.05).  Chlortetracycline appears to have a significant effect on 
the trehalose content within the mosquitoes (F6, 54 = 9.091, p<0.001). There was no 
significant difference between the 2 sexes (F1, 54 = 0.033, p>0.05).  Furthermore, the same 
response to chlortetracycline was observed in both sexes (F6, 54 = 2.074, p>0.05). The 
trehalose content of male mosquitoes ranged from 4.65 μg in control mosquitoes to 3.96 
μg at 100 μg ml-1 of chlortetracycline, the lowest trehalose content was observed at 0.1 
μg ml-1 of chlortetracycline with 1.81 μg.  In control female mosquitoes, the trehalose 
content was 5.70 μg, however at 0.1-30 μg ml-1 of chlortetracycline the trehalose quantity 
was reduced to 3.75-4.14 μg. At 100 μg ml-1 of chlortetracycline the trehalose content 
was 5.66 μg, not significantly different to control mosquitoes.   
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Table: 5.10. Trehalose content of mosquitoes treated with chlortetracycline (0-100 μg 
ml-1), number of replicates = 5 (Methods Chapter; Section: 2.5.4, page 46). 
Concentration  
of chlortetracycline (μg ml
-1
) 
Trehalose content µg per fly ± s.e (n=5,*4) 
Male Female 
0 4.65 ± 0.17 5.70 ± 0.38 
0.1 1.81 ± 0.15 3.75 ± 0.23* 
0.5 2.60 ± 0.17 4.01 ± 0.52 
1 3.30 ± 0.29 4.10 ± 0.28 
10 3.55 ± 0.76 4.04 ± 0.72 
30 4.60 ± 0.23 4.14 ± 0.54 
100 3.96 ± 0.24 5.66 ± 0.35 
 
5.5.5 Total lipid content of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline. 
The total lipid content of male and female mosquitoes varied from 0.243 to 0.378 mg, 
with the greatest lipid content being in male mosquitoes (Table: 5.11). Using a 2-way 
ANOVA, chlortetracycline treatment appears to have a significant effect on the lipid 
content within the mosquitoes (F6, 56 = 3.129, p<0.05) with a significant difference 
between sexes (F1, 56 = 220.023, p<0.001).  However, there was a significant difference in 
the response to chlortetracycline by the 2 sexes (F6, 56 = 3.910, p<0.01).  In female 
mosquitoes, the lipid content was significantly different at 1 and 30 μg ml-1 of 
chlortetracycline, where the lipid content increased from 0.246 mg in control mosquitoes 
to 0.278-0.300 mg.  In males, the lipid content was shown to significantly increase from 
0.328 mg in control mosquitoes to 0.363-0.378 mg at 0.5, 10 and 30 μg ml-1 of 
chlortetracycline.  
Table: 5.11. Total lipid content of mosquitoes treated with 0-100 μg ml-1 of 
chlortetracycline, number of replicates = 5 (Methods Chapter; Section: 2.5.6, page 48). 
Concentration  
of chlortetracycline (μg ml
-1
) 
Mean lipid content per mg of dry weight (mg) per fly  ± s.e (n=5)  
Male Female 
0 0.328 ± 0.015 0.246 ± 0.003 
0.1 0.326 ± 0.013 0.249 ± 0.003 
0.5 0.378 ± 0.014 0.243 ± 0.008 
1 0.340 ± 0.015 0.300 ± 0.006 
10 0.363 ± 0.013 0.252 ± 0.017 
30 0.367 ± 0.011 0.278 ± 0.008 
100 0.362 ± 0.009 0.264 ± 0.017 
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5.5.6 Dry weight of Mexican Aedes aegypti treated with 0-100 μg ml-1 of chlortetracycline  
The dry weight of the mosquitoes varied from 0.298 mg to 0.572 mg, with females having 
the greater weight (Table: 5.12).  A 2-way ANOVA showed that chlortetracycline had a 
significant effect on the dry weight of the mosquitoes (F6, 56 = 4.133, p<0.01). There was 
also a significant difference between male and female mosquitoes as described above   
(F1, 56 = 321.540, p<0.001).  However, there was not a significant interaction between 
chlortetracycline treatment and sex (F6, 56 = 1.970, p>0.05), suggesting that the response 
to chlortetracycline was the same in both sexes.  In female mosquitoes, the weight range 
increased to 0.540-0.572 mg compared with control mosquitoes with a weight of 0.456 
mg.  In male mosquitoes, the dry weight also increased to 0.351 mg at 100 μg ml-1 of 
chlortetracycline compared with control mosquitoes with a dry weight of 0.304 mg.   
Table: 5.12. Dry weight of mosquitoes treated with 0-100 μg ml-1 of chlortetracycline, 
number of replicates = 5 (Methods Chapter; Section: 2.5.6, page 48). 
Concentration  




Mean dry weight (mg) per fly  ± s.e (n=5) 
Male Female 
0 0.304 ± 0.009 0.456 ± 0.015 
0.1 0.298 ± 0.008 0.493 ± 0.007 
0.5 0.374 ± 0.020 0.487 ± 0.033 
1 0.308 ± 0.028 0.544 ± 0.012 
10 0.349 ± 0.017 0.506 ± 0.036 
30 0.337 ± 0.008 0.540 ± 0.028 
100 0.351 ± 0.010 0.572 ± 0.026 
 
5.5.7 Protein content of Mexican Aedes aegypti treated with 0-100 μg ml-1 of 
chlortetracycline 
The protein content was quantified in male and female mosquitoes which varied from 79-
177 µg with females having a larger quantity than males (Table: 5.13).  Wing length was 
used as a size covariate.  The observed difference in protein content between male and 
female was supported by the ANCOVA statistical analysis (F1, 54 = 24.196, p<0.001).  The 
wing length was significantly different (F1, 54 = 11.768, p<0.05). The statistical analysis 
demonstrated that there was a significant effect of chlortetracycline treatment on protein 
content (F6, 54 = 2.792, p<0.05), however different responses were observed with the 2 
sexes (F6, 54 = 7.034, p<0.001).    In female mosquitoes, there does not appear to be a 
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trend with protein content and increasing concentration of chlortetracycline.  However, in 
males a decrease in protein content was observed in treated mosquitoes (1-100 μg ml-1) 
compared with control; the protein content reduced from 113.95 μg to 94.63-78.98 μg.  
Table: 5.13: Protein content of mosquitoes treated with 0-100 μg ml-1 of 
chlortetracycline, number of replicates = 5 (Methods Chapter; Section: 2.5.3, page 46). 
Concentration  
of chlortetracycline (μg ml
-1
) 
Mean protein content µg per fly ± s.e (n=5,*4) 
Male Female 
0 113.95 ± 5.53 124.28 ± 6.95 
0.1 86.55 ± 2.90 140.23 ± 5.09 
0.5 86.84 ± 6.35 157.35 ± 9.06 
1 78.98 ± 4.25 147.22 ± 10.52 
10 91.78 ± 5.31 177.34 ± 7.18* 
30 91.95 ± 5.30  126.15 ± 4.71 
100 94.63 ± 5.52 154.74 ± 6.25 
 
5.6 Impacts of chlortetracycline on the culturable bacterial numbers and 
diversity in WT Aedes aegypti  
The impact of chlortetracycline on the colony forming units and the diversity of the 
bacteria cultured from the larvae and water treated with chlortetracycline was assessed.  
454 pyrosequencing was used to gain an insight into the diversity of culturable and non-
culturable bacteria of larvae, adult male and adult female mosquitoes.  The diversity of 
bacteria within control adult males was also compared with chlortetracycline treated 
males at 30 µg ml-1 of chlortetracycline.  The diversity of the bacteria in chlortetracycline 
treated adult males was chosen rather than female mosquitoes as RIDL® male mosquitoes 
are released into the wild to compete with male mosquitoes in the wild. 
5.6.1 Impacts of chlortetracycline on the culturable bacterial numbers in Asian WT Aedes 
aegypti and the rearing water for Asian WT Aedes aegypti 
To investigate the impact of chlortetracycline treatment on the bacterial numbers in 
Asian WT, larvae reared with 0-100 μg ml-1 of the antibiotic and the rearing water were 
plated onto agar plates (+/- 50 μg ml-1 of chlortetracycline) with 5 dilution factors. The 
number of colony forming units (CFUs) varied from 103 to 108 per larva (Table: 5.14). The 
number of CFUs found in larvae and water at different concentrations of chlortetracycline 
was reduced at 30 and 100 µg ml-1 (100,000 times lower than other treatments).  Colonies 
grew on plates supplemented with 50 µg ml-1 of chlortetracycline indicating that the 
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larvae and water bore chlortetracycline-resistant bacteria. In addition, with larval and 
water samples the number of colonies was reduced by 100-1000 fold on chlortetracycline 
plates relative to chlortetracycline-free plates.  In water and larvae, the number of CFUs 
on antibiotic plates was similar to antibiotic-free plates at high chlortetracycline 
concentrations, 30-100 µg ml-1 (Table: 5.14). 
Table: 5.14. Log10 CFUs of Asian wild-type mosquito larvae and water treated with 0-100 
µg ml-1 of chlortetracycline, number of replicates = 1 (Methods Chapter; Section: 2.4.2, 
page 43). 
 
The culturable bacteria of Asian Aedes aegypti larvae and rearing water were sampled 
from the agar plates (+/- 50 μg ml-1 of chlortetracycline), up to 5 colonies with different 
morphology were identified from each treatment.   
In control larvae the bacteria identified included: Microbacteria (Actinobacteria), 
Chryseobacterium meningosepticum (Bacteroidetes), Serratia marcescens/Pseudomonas 
fluorescens (Proteobacteria) and Leucobacter (Actinobacteria) (Appendix: Table: 7.32, 
7.33).  The Genera/species that were continually identified in the larvae across all 
treatments and in the water samples were; Serratia marcescens (Proteobacteria), 
Leucobacter (Actinobacteria), Chryseobacterium meningosepticum (Bacteroidetes) and 
Microbacteria. Genera/species that were not commonly found in other treatments and 
were only found in water samples were; Bacillus cereus (Firmicutes) in control water and 
Delftia (Proteobacteria) found at 100 μg ml-1 of chlortetracycline rearing water (Appendix: 

















0 8.346 4.797 8.598 6.659 
0.1 7.226 4.178 8.742 6.483 
0.5 6.705 5.251 8.809 5.699 
1 7.267 6.426 8.812 5.813 
10 6.962 3.828 8.812 6.301 
30 3.951 3.085 6.124 5.494 
100 3.186 3.693 6.556 6.107 
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These results suggest that the bacterial diversity in larvae treated with different 
concentrations of chlortetracycline does not appear to significantly change.  
Nevertheless, the relative total number of bacteria was significantly lowered with 30 and 
100 ug ml-1 treatments of chlortetracycline. Water and larvae showed similar species 
diversity.  The results have demonstrated that Microbacteria (Actinobacteria), 
Leucobacter (Actinobacteria), Serratia marcescens (Proteobacteria) and Chryseobacterium 
meningosepticum (Bacteroidetes) are the dominant culturable species in Asian Aedes 
aegypti larvae and in the rearing water. 
5.6.2 Chlortetracycline effects on the culturable bacterial numbers in Mexican WT Aedes 
aegypti and the rearing water for Mexican WT Aedes aegypti 
During the performance studies with Mexican wild-type mosquitoes, the number of 
colony forming units (CFUs) was quantified in the mosquito larvae.  The number of colony 
forming units (CFUs) varied from 103 to 108 per larva (Table: 5.15), showing a similar 
number of CFUs measured with Asian WT (Table: 5.14). 
Table: 5.15. Log10 CFUs of Mexican wild-type mosquito larvae and water treated with 0-
100 µg ml-1 of chlortetracycline during the performance studies, number of replicates = 
1 (Methods Chapter; Section: 2.4.2, page 43). 
 
A smaller and separate experiment investigating the impact of chlortetracycline on the 
bacterial content in Mexican wild-type larvae was also conducted with replicates to 
confirm the above results.  
A  Kolmogorov-Smirnov (KS) test was performed for the Log10 CFU data of larvae and 



















0 8.028 2.263 8.602 4.283 
0.1 8.150 2.301 7.556 5.134 
0.5 6.368 3.222 6.00 4.477 
1 6.233 2.689 6.862 5.079 
10 4.590 3.699 6.903 5.079 
30 4.146 3.768 5.903 8.795 
100 4.865 4.768 5.326 5.903 
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different from the normal distribution (p<0.05), therefore the data was rank transformed 
before a Three-Way ANOVA was conducted.  It was shown that there was a significant 
effect of chlortetracycline (F6, 28 = 8.148, p<0.001) on the culturable bacterial content of 
mosquitoes and the water, with a significant difference between the presence and 
absence of chlortetracycline in the agar plates (F1, 28 = 184.254, p<0.001) (Table: 5.16).  A 
greater number of CFUs was observed with water samples at higher concentrations of 
chlortetracycline on antibiotic plates, with a 100 fold greater CFUs (Table: 5.16).   
Statistical analysis showed that there was a difference between the water and larvae 
samples (F1, 28 = 48.395, p<0.001).  The response of the water and larvae samples to 
chlortetracycline treatment was significantly different (F6, 28 = 3.337, p<0.05), the number 
of CFUs measured in larvae was reduced by 1000 fold, however, in water it was only 
reduced by 8 fold (Table: 5.16).  On chlortetracycline supplemented agar plates, the CFUs 
observed were significantly reduced to 106 in control samples (F1, 28 = 5.994, p<0.05) 
(Table: 5.16).  Furthermore, the difference between chlortetracycline supplemented agar 
plates and non-supplemented plates was less pronounced with treatments at higher 
concentrations of chlortetracycline (30-100 μg ml-1) with less than a 2 fold difference (F6, 
28 = 22.676, p<0.001).  Statistical analysis also showed that the three-way interaction 
(Treatment*Sample Type*+/-Chlortetracycline on agar plates) was not significantly 
different (H6, 28 = 49.244, p>0.05). 
Table: 5.16. Log10 CFUs of Mexican wild-type mosquito larvae and rearing water treated 
with 0-100 µg ml-1 of chlortetracycline, number of replicates = 2 (Methods Chapter; 




















0 8.199 ± 0.24 1.673 ± 0.15 8.846 ± 0.02 3.628 ± 1.15 
0.1 8.308 ± 0.13 3.184 ± 1.49 8.947 ± 0.07 5.396 ± 0.07 
0.5 7.539 ± 0.21 4.068 ± 0.60 8.375 ± 0.21 4.758 ± 0.06 
1 7.495 ± 0.001 4.885 ± 0.11 8.360 ± 0.34 4.690 ± 0.54 
10 7.689 ± 0.27 7.990 ± 0.06 8.322 ± 0.28 7.789 ± 0.06 
30 5.409 ± 0.56 5.588 ± 1.11 7.288 ± 0.39 6.681 ± 0.10 
100 4.539 ± 0.97 4.518 ± 0.78 7.906 ± 0.01 7.981 ± 0.06 
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The culturable bacteria were also sampled from the agar plates in which the numbers of 
CFUs were counted, up to 6 colonies were identified from each treatment, including both 
samples of water and larvae and on plates supplemented with chlortetracycline.  In 
control larvae the bacteria identified included: Microbacterium laevaniformans 
(Actinobacteria), Elizabethkingia meningoseptica (Bacteroidetes) and Serratia marcescens 
(Proteobacteria) (Appendix: Table: 7.34, 7.35).  The following Genera/species were 
continually identified in all treatments, Elizabethkingia meningoseptica (Bacteroidetes), 
Serratia marcescens (Proteobacteria) and Microbacteria. However, new Genera/species 
including Leucobacter (Actinobacteria) (0.1 μg ml-1 of chlortetracycline), Arthrobacter 
woluwensis (Actinobacteria) (0.5 μg ml-1 of chlortetracycline) and Klebsiella pneumoniae 
(Proteobacteria) (10 and 100 μg ml-1 of chlortetracycline) were also identified in other 
treatments (Appendix: Table: 7.34, 7.35).  In the water samples, the Genera/species that 
were identified were very similar to those identified in the larvae with the only difference 
being the identification of Ochrobactrum (Proteobacteria) and Delftia (Proteobacteria) 
found at 0.5 μg ml-1 of chlortetracycline and Chryseobacterium meningosepticum 
(Bacteroidetes) at 1 μg ml-1 of chlortetracycline (Appendix: Table: 7.34, 7.35). 
5.6.3 454 pyrosequencing analysis of Mexican WT Aedes aegypti 
The 454 pyrosequencing analysis of control Mexican WT larvae showed that the diversity 
of microbes found in the larvae were predominantly Actinobacteria with a low number of 
Proteobacteria (Appendix: Table: 7.36). The member of the phylum, Actinobacteria which 
made up 95% of the population was Microbacterium laevaniformans strain NML, this 
bacterium was also identified during culturable techniques (Appendix: Table: 7.34, 7.35).  
However, in adult male mosquitoes, the diversity was altered; the member of the phylum 
Bacteroidetes made up 93% of the sequence hits showing that the diversity of bacteria 
shifted from Actinobacteria (which was also identified using culturable techniques) to 
Bacteroidetes from larvae to adulthood (Appendix: Table: 7.37).  In adult females, a 
similar observation was observed with a majority of 80% of the reads belonging to the 
phylum Bacteroidetes with 15% belonging to Proteobacteria (Appendix: Table: 7.39).  
When the adult male mosquitoes were treated with chlortetracycline, the dominant 
bacterium present was a member of the phylum Proteobacteria with 76% of the total 




Preliminary experiments with LA513A treated with 0-100 µg ml-1 suggested that LA513 
were able to survive on 0.1 µg ml-1 and above.  The experiment was therefore repeated 
with 0.01-30 µg ml-1 to determine the minimal concentration.  Survival to pupae and 
adulthood suggest that 0.5 µg ml-1 and above of chlortetracycline was required to 
suppress the expression of tTAV.  However, at 0.1 µg ml-1 survival to pupae was high, 29% 
of the pupae failed to emerge as adults, suggesting that the tTAV was still expressed at a 
high enough level to cause lethality.  The fluorescence images of the expression of DsRed 
in the larvae showed a reduction in DsRed fluorescence in the mosquito larvae at 0.1 µg 
ml-1 and above. This may suggest that the level of DsRed expression is affected by the 
chlortetracycline concentration and that the DsRed expression may be enhanced by the 
positive feedback loop of the RIDL® system, which is being expressed in the absence of 
chlortetracycline, linking the fluorescence expression with the RIDL® expression. The link 
with fluorescence and the enhanced DsRed expression with the RIDL® system is also 
supported by the survival data which suggest that at concentrations below 0.1 µg ml-1 of 
chlortetracycline, poor survival is observed suggesting that the lethal gene is being 
expressed. 
As RIDL® mosquitoes will be released into the wild; life-span was considered an important 
performance assay to ensure that the RIDL® males will live long enough to mate with wild 
females.  Life-span results showed that 10 and 30 µg ml-1 of chlortetracycline gave the 
longest life-span.  Interestingly, in males 0.5-1 µg ml-1 of chlortetracycline doubled the life-
span compared with 0.1 µg ml-1.  This result supports the survival data measured during 
this study, where it was demonstrated that at 0.1 µg ml-1 of chlortetracycline the level of 
survival was not as high as at 0.5 µg ml-1 and above of chlortetracycline.  The life-span 
data also suggest that males are more sensitive to chlortetracycline concentration with a 
greater difference between 0.1 and 0.5 µg ml-1 and above compared with females.   
The conclusions made with the life-span data is also supported by the development data 
which showed that the development time of male mosquitoes to pupae and adulthood 
decreased to 9 days with 10-30 µg ml-1 of chlortetracycline and 11 days with 0.5-30 µg ml-
1 of chlortetracycline, respectively.  In females there was no difference in development 
time to pupae however, at 0.5 µg ml-1 and above an increase in development time to 
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adulthood was observed.  This response was not observed in Asian wild type mosquitoes 
at this concentration, therefore there could be an interaction between the transgene and 
chlortetracycline.   
As with Drosophila melanogaster, experiments with wild-type Aedes aegypti did indicate 
a significant impact on the time to peak emergence with chlortetracycline treatment.  
Experiments with Mexican Aedes aegypti indicated that control and high concentrations 
of chlortetracycline significantly extended peak emergence and low to medium 
concentrations of 0.1-10 µg ml-1 reduced the time to peak emergence in Mexican Aedes 
aegypti. This result suggests that chlortetracycline could promote development rates by 
removing deleterious bacteria.  Extension of peak emergence at high concentrations 
could be the result of the toxic effect of the antibiotic.  Unlike Mexican Aedes aegypti, 
Asian Aedes aegypti peak emergence did not show a trend with chlortetracycline 
treatment.   
The survival data to adulthood differed for Mexican and Asian mosquitoes; there was no 
significant effect of the survival with Asian WT but with Mexican WT a decrease in survival 
was observed at 100 µg ml-1 of chlortetracycline.  This result suggests that Mexican WT 
was more sensitive to chlortetracycline treatment unlike Asian WT which had previous 
exposure to chlortetracycline (through exposure from contaminated trays and water) and 
therefore was more tolerant to the antibiotic. 
Asian WT female mosquitoes had an extended life-span when treated with 
chlortetracycline, which suggests that the antibiotic could eliminate bacteria that are 
deletrious on the performance of the insect, this result is also supported by the findings 
of Lang et al (1972), which showed that the axenic mosquitoes had a greater life-span.  
Nevertheless, Mexican WT mosquitoes had a life-span that was significantly reduced in 
both sexes when treated with chlortetracycline (0.5-100 µg ml-1).   This suggests that the 
shortening of life-span could be due to the depletion of bacteria as the reduction was 
observed at concentrations of chlortetracycline where the bacterial CFUs were reduced 
from 108 to 103-7 in larvae.  Furthermore, the reduction was observed at low 
concentrations of chlortetracycline as well as high concentrations, which could eliminate 
toxicity as the main reason for the reduction.  Another reason for the reduction in life-
span may not necessarily be a due to a decrease in bacterial numbers but it could be due 
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to the change in diversity of the bacteria within the mosquito.  Mexican WT mosquitoes 
were recently isolated from Mexico (2006), therefore the greater sensitivity may be due 
to the fact that this strain has been reared in laboratory conditions for less time in 
comparison to Asian WT.  
Interestingly, wing length was significantly altered with Asian not Mexican mosquitoes.  In 
Asian mosquitoes, wing length was decreased at 100 µg ml-1 which would suggest that 
the high concentration of chlortetracycline had a negative impact on the insect.  
Furthermore, the wing length of control flies was significantly reduced which suggests 
that high bacterial numbers (108 CFUs in larvae) could have had a negative impact on the 
mosquito and the presence of a small amount of chlortetracycline could actually remove 
deleterious bacteria and promote mosquito performance.   
Chlortetracycline was established to have a significant impact on the dry weight of both 
Asian and Mexican mosquitoes.  In both of these strains, it was demonstrated that the 
mosquito dry weight was significantly increased when treated with chlortetracycline 
(Tables: 5.5, 5.12) in both male and female adults upon emergence.  This result was 
unexpected as the quantity of protein (in Mexican WT only) decreased in males with 
chlortetracycline treatment and lipid (Asian WT only) did not significantly alter in both 
male and female mosquitoes.  The reason for the decrease in protein content of male 
Mexican mosquitoes could be due to one or a combination of factors such as the removal 
of bacteria, a change in the diversity of the bacteria and toxicity of chlortetracycline. 
The lipid content of the mosquitoes were not significantly changed in Asian WT, and only 
significantly increased at 1 and 30 µg ml-1 of chlortetracycline with female Mexican WT 
and 0.5, 10 and 30 µg ml-1 of chlortetracycline with male Mexican WT.  The publication by 
Lang et al (1972) suggested that the percent lipid content of pupae was significantly 
reduced in axenic mosquitoes, however this change was not observed in the experiments 
described in this chapter using adult mosquitoes.  Chlortetracycline treatment in this 
study did not eliminate all the bacteria found in the mosquitoes and pupae were not 
sampled, therefore if the mosquitoes were produced axenically and different life-stages 
were sampled then a difference may have been identified.   
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Carbohydrate quantification results for chlortetracycline treated mosquito gave more 
variable results.  With glycogen, there was no significant effect of chlortetracycline 
treatment on the quantities within the insects of either sex.  The reason for this may be 
that chlortetracycline does not eliminate all the bacteria within the mosquitoes and 
experiments with axenic mosquitoes may show a stronger effect.  In general, the 
trehalose concentration was shown to be reduced in male and female mosquitoes when 
treated with chlortetracycline compared with control mosquitoes.  However, in female 
mosquitoes the decrease occurred with all concentrations of chlortetracycline except at 
100 µg ml-1 of chlortetracycline where the trehalose quantity was similar to control 
mosquitoes.  This increase of trehalose at this high chlortetracycline concentrations 
suggest that chlortetracycline itself may be causing the change as it does not follow the 
trend with the other concentrations of chlortetracycline.  The reduction in trehalose could 
also be explained by a change in diversity of the bacteria found within the mosquitoes 
which may not affect the glycogen levels but impact the concentration of trehalose 
circulating in the hemolymph. 
The experiments investigating the impact of the chlortetracycline treatment on the 
microbiota demonstrated that culturable bacteria (CFUs) were still found in Asian and 
Mexican Aedes aegypti even at high concentrations of chlortetracycline treatments.  
Furthermore, colonies grew on plates supplemented with 50 µg ml-1 of chlortetracycline 
suggesting that the larvae and water bore chlortetracycline-resistant bacteria and could 
explain why the impact of chlortetracycline on the mosquitoes was not as great when 
compared with Drosophila melanogaster treated with chlortetracycline. 
The culturable bacterial diversity in larvae in control and chlortetracycline treatment did 
not appear to alter, 454 analysis would provide data to confirm this result.  
Species/Genera such as Microbacteria, Elizabethkingia meningoseptica, Leucobacter and 
Serratia marcescens were continually identified in all samples.  The rearing water also 
contained similar species which does suggest that the mosquitoes gain the bacteria from 
the water.  One possibility is that the bacteria may originate from within the egg or on the 
egg surface and the introduction to water allows growth and replication of the bacteria, 
providing a food source.  Fish food was another possibility, which was fed to the larvae 
and may have provided the symbionts.  One argument against this hypothesis is that 
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similar bacteria have been found by other research groups with mosquitoes obtained 
from the wild and with other species of mosquitoes (Demaio et al., 1996; Gusmão et al., 
2010) suggesting that the fish food may not be solely responsible for the species found 
within the mosquitoes.       
The larval 454 data showed similarities with the data obtained with culturable data, which 
suggests that many of the bacteria found within the mosquitoes are culturable. 
Interestingly, the 454 data analysis with control versus chlortetracycline treated adult 
male mosquitoes demonstrated a change in bacterial diversity.  In control mosquitoes the 
major bacterium was Elizabethkingia meningoseptica and with chlortetracycline 
treatment Raoultella sp. was dominant and Elizabethkingia meningoseptica being the 
second most common species.  This change in diversity may be due to the reduction in 
chlortetracycline sensitive species which allows for the replication and growth of those 
which were resistant.   
The 454 and culturable bacterial analysis has shown that the majority of the microbes 
that inhabit the mosquitoes are common soil and water bacteria.  Klebsiella, Serratia, 
Enterobacter and Arthrobacter are such bacteria (Madigan et al., 2003, p379).  This would 
be expected as mosquitoes develop in rain water fed small pools of water.   
The presence of bacteria at 100 µg ml-1 of chlortetracycline does suggest that the 
microbes are antibiotic resistant.  This was perhaps not surprising with the strain reared 
at Oxitec Ltd, where both transgenic mosquitoes requiring chlortetracycline and wild-type 
mosquitoes were reared in the same room and in the same rearing trays, allowing wild-
type mosquitoes to be exposed to residual chlortetracycline.  In the Mexican WT 
mosquitoes resistant bacteria were also found, which was unexpected.  It has became 
apparent that this was not uncommon and even in areas where waste containing 
antibiotics was rare, such as the Arctic where low levels of Ampicillin resistance was 
observed in bacteria of Polar bear faeces (Glad et al., 2010).  Antibiotic resistance exists 
naturally but the excessive use of chlortetracycline in agriculture in countries such as the 
USA and Europe to promote health and growth of cattle has meant that the selection 
pressure has increased leading to bacterial resistant strains to tetracycline to rise 




Aedes aegypti are mainly colonised by bacteria commonly found in soil and water such as 
Klebsiella, Serratia and Arthrobacter (Madigan et al., 2003, p379).  The bacteria found in 
these mosquitoes show chlortetracycline resistance.  However, there does appear to be a 
distinct change in the diversity of the bacteria found in Mexican WT treated with 
chlortetracycline compared with control mosquitoes where the the dominant bacterium 
switched from Elizabethkingia meningoseptica to Raoultella sp with chlortetracycline 
treatment.   
Chlortetracycline affected the survival, life-span and the nutrition of wild-type Aedes 
aegypti. However, the chlortetracycline treatment did not entirely eliminate the 
microbiota and there were still negative impacts on performance.  This could be due to a 
reduction in the bacterial population, a change in diversity and/or due to the direct 
effects of chlortetracycline on the insects.  
The performance experiments with the transgenic line, LA513 demonstrate that these 
mosquitoes can be reared on chlortetracycline at concentrations lower than currently 
used (30 µg ml-1).  The results suggest that concentrations as low as 0.5 µg ml-1 can be 
used to rear LA513 nevertheless, the recommendation for rearing would be a 
concentration of 10 µg ml-1.  This concentration maintains an efficacy margin of more 
than an order of magnitude for error and accounts for chlortetracycline degradation 
(chlortetracycline is light sensitive) and the biodegradation of chlortetracycline by the 










Chapter 6: Discussion 
The research described in this thesis has demonstrated the deleterious impacts of 
chlortetracycline treatment on two dipteran insects; Drosophila melanogaster and Aedes 
aegypti.  Egg dechorionation was also used during this project, an alternative and 
preferable method of removing bacteria from Drosophila as it removes bacteria and does 
not damage the egg.  This method of eliminating bacteria in Drosophila improved the 
understanding of the impact of chlortetracycline and the result of eliminating bacteria. An 
alternative method of bacterial depletion in mosquitoes would also create a greater 
understanding of the role of the microbes found within this insect.   
6.1 The study of insect-microbe interactions in Drosophila melanogaster and 
Aedes aegypti 
The study of microbes within insects has become increasingly popular for several reasons; 
to increase the understanding of the insect-microbe interaction as a tool for the control 
of insect populations, and to increase the understanding of the role of gut microbes in 
humans.  The results gained from the experiments using Drosophila melanogaster and 
Aedes aegypti during this project can be used for different applications.   
Firstly, Drosophila can be used as a model for determining the role of gut microbes in 
humans. The experiments with Drosophila have improved our understanding of the role 
of bacteria in the nutrition and metabolism of the fly.  Drosophila is a suitable model to 
use as it has a very low diversity of bacteria in the gut (with the flies on the York diet 
consisting of mainly Acetobacter species), can be easily manipulated, the environment 
and diet can be tightly controlled, the whole genome has been sequenced (Adams et al., 
2000) and mutant flies can be produced with relative ease compared with other insects.   
In mice, mutants have been created to understand the relationship between the human 
gut and Bacteroides (Salyers and Pajeau 1989) and the role of bacteria in inflammatory 
diseases (Boivin et al., 1997).  Therefore, the creation of Drosophila mutants will: 1) 
identify the relationship between Acetobacter/Lactobacillus and the Drosophila host and 
their role in metabolism and growth and 2) identify the role of microbes in immunity and 
disease.  Mutant Drosophila may be useful in identifying the reason for the extension in 
development time when bacteria are depleted in the gut. This could be the result of 
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changes in the insulin/insulin-like growth factor signalling which has previously been 
shown to control the time to pupation and reach the critical weight for pupation (Edgar, 
2006; Bakker, 1959; Beadle et al., 1938; Moed et al., 1999; Robertson, 1963).  These 
changes can be confirmed using qRT-PCR and microarray data with first instar, second 
instar, third instar, prepupa and pupa.  Mutants could also be used to confirm the role of 
genes through inactivation and comparing the development of wild-type flies.  
Furthermore, the use of mutants could improve the understanding of the relationship 
between the host and gut bacteria and their role in the Drosophila immune system where 
a reduction in antimicrobial peptide gene expression has been demonstrated in this thesis 
and by Ren et al (2007) in bacteria depleted flies. 
Another major advantage of using Drosophila to examine the role of gut microbes is the 
differences in response to diet. The difference was emphasised in this thesis, by Ren et al 
(2007) and Brummel et al (2004).  As aging and metabolic studies using Drosophila have 
shown, diet impacts the fecundity and life-span of the fly (Chapter 1, Piper et al., 2005).  
The ratio of protein and carbohydrates have been demonstrated to be responsible for the 
changes in life-span (1:16 protein:carbohydrate ratio) and fecundity (1:2 
protein:carbohydrate ratio) and not dietary restriction (Lee et al., 2008 and Ja et al., 
2009).  Feeding behaviour was analysed by Ja et al (2009) to eliminate the difference in 
feeding rates for the reason for changes during dietary restriction.  One advantage with 
Drosophila, is that the development of the CAFE (Capillary feeder) assay by Ja et al (2007) 
has enabled the quantification and the monitor of feeding behaviour of the flies.  This 
technique could be used with antibiotic treated and dechorionated flies to determine 
whether the nutrition of the fly and extension in development time is of the result of 
bacterial depletion or changes in feeding behaviour.  The quantification of food intake will 
allow for an approximation of the concentration of chlortetracycline that the flies are 
consuming and not just exposed to. Furthermore, the difference in the response to diet 
by Drosophila will enable the study of microbe and diet interactions. 
With mosquitoes (mainly with Anopheles gambiae), research with bacterial symbionts has 
concentrated on a method of controlling the insect populations rather than using the 
insect as a model for human health.  The increasing interest in using bacteria to control 
insect pests is due to the limitations of other methods for reducing the mosquito 
164 
 
populations or prevalence of vector related diseases. An example is to genetically 
engineer resident microbes to express anti-plasmodium factors (Riehle et al., 2007) and 
to identify resident microbes which reduce the susceptibility to plasmodium infection 
(Dong et al., 2009).  
The relative ease (not as easy as Drosophila) to genetically transform Aedes aegypti could 
allow for potential methods to 1) gain increasing knowledge regarding the relationship 
between the mosquito host and the bacterial species found within the host and 2) 
manipulate the insect host to disrupt the beneficial relationship between the host and 
bacteria, allowing for a method of controlling the population of the insect. 
The identification of bacteria found within Aedes aegypti could allow for experiments 
involving the rearing of axenic mosquitoes. Infection studies with the identified bacterial 
species including Serratia have the potential to inform us about the role of bacteria in 
mosquitoes which would allow for manipulation of certain species that may play a key 
role in sugar and blood metabolism.  Targeting these bacteria could limit the metabolism 
of key nutrients, leading to the malaise of the insect host and eventual death, an effective 
method of controlling insect vectors of human diseases. 
6.2 The use of antibiotics and bacterial depletion  
The experiments using chlortetracycline to deplete bacterial communities within 
Drosophila melanogaster and Aedes aegypti have demonstrated that the two insects and 
their symbionts respond differently to the antibiotic treatment.  Drosophila melanogaster 
have been confirmed to not entirely depend on their gut symbionts, this was also 
observed by Brummel et al (2004), Ren et al (2007) and Bakula (1969).  This response is 
very different to aphids, where the elimination of its symbionts significantly reduces the 
size and fecundity of the insect (Houk and Griffiths, 1980; Mittler, 1971; Sasaki et al., 
1991).  In fact, Drosophila appears to have an improved survival and no reduction in 
fecundity and size.   
Unlike Drosophila, chlortetracycline treatment of Aedes aegypti did not eliminate all the 
bacteria within the insect (still containing several thousand colony forming units at 100 µg 
ml-1) suggesting that the use of chlortetracycline may not be a useful method to eliminate 
all the bacterial population within Aedes aegypti. A higher concentration of 
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chlortetracycline may have reduced the numbers further, however, a combination of 
antibiotics or rearing axenically (Lang et al., 1972) are other methods that could be used.  
As deleterious impacts of using an antibiotic have been identified during this project, it 
may be preferable to rear the mosquitoes axenically rather than using a combination of 
antibiotics.  
From this thesis it is demonstrated that chlortetracycline and dechorionation have 
produced different results, with the performance traits including fecundity, life-span and 
metabolism.  A significant impact of dechorionation with immune gene expression was 
observed in this thesis; however, the impact of chlortetracycline on the gene expression 
was not conducted.  This experiment would prove an important tool in explaining the 
differences between the 2 methods of dechorionation and chlortetracycline treatment 
and gain more information regarding the impact of chlortetracycline and an insight into 
the result of using certain methods of bacterial depletion. 
The elimination of entire populations of bacteria within the insect host is a crude method 
of developing our understanding of the role of microbes within the host. There are 
several considerations to be made when planning to eliminate bacteria as described 
previously, total elimination of bacteria can lead to a general malaise of the insect.  
Furthermore, the complete removal of bacteria provides information regarding the 
impact of eliminating the entire community but does not provide information regarding 
the role of each species of bacteria.  Introduction studies with axenic flies and exposure 
to bacterial symbionts such as Acetobacter will develop the understanding of the function 
of individual species within the gut.  Moreover, these experiments could be developed 
further by introducing a mix of bacterial symbionts to determine how certain bacterial 
communities impact the insect host.  Infection studies with symbionts and pathogens 
could also provide information regarding the role of these symbionts in the protection of 
the host against pathogens such as Serratia and Enterococcus (Flyg et al., 1980; Basset et 
al., 2000).  
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6.3 The treatment of insects with chlortetracycline and its implications for 
Oxitec Ltd  
This thesis has emphasized the implications of using antibiotics to deplete bacteria. As 
results have shown, chlortetracycline has a greater deleterious impact on Drosophila 
when compared with dechorionation. This has highlighted the implications of using 
chlortetracycline to conduct experiments where bacterial depletion is required or for the 
use of tetracycline on/off genetic expression systems. Whereas a lower number of 
deleterious impacts of chlortetracycline were observed on the performance of Aedes 
aegypti in comparison with Drosophila, other insects may respond in a similar manner to 
Drosophila.  Therefore, this implication should be acknowledged by companies who 
regularly use antibiotics such as Oxitec Ltd.   
For Oxitec Ltd, it is crucial to ensure that when comparisons between the performance of 
wild-type and transgenic insects are made, that a chlortetracycline treated wild-type and 
transgenic be included in the analysis to differentiate between the deleterious impacts of 
the insertion of a transgene and the treatment with chlortetracycline.  
The treatment of small insects with chlortetracycline by Oxitec Ltd, does need to be at a 
concentration which is high enough to suppress the transgene but low enough to limit the 
deleterious impact on the insect and bacterial symbionts.  As with the experiments 
conducted in this thesis, it was shown that 10 µg ml-1 of chlortetracycline was the advised 
quantity required for LA513 to suppress the bi-sex lethal gene.  This concentration was 
lower than 30-100 µg ml-1 where deleterious impacts were observed on wild-type 
mosquitoes.  One important fitness trait which was addressed was the life-span of the 
insect host when treated with chlortetracycline; this experiment suggested that high 
concentrations (30-100 µg ml-1) significantly reduced the life-span of the mosquitoes 
(Mexican only). 
Life-span is one of the most important performance measurements for Oxitec Ltd as they 
will require the mosquito to live long enough to mate with wild female mosquitoes.  If the 
life-span is significantly reduced then the release of transgenic mosquitoes to control 
mosquito populations will prove to be unsuccessful.  Another important performance 
trait is fecundity, experiments with Drosophila melanogaster did suggest that 
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chlortetracycline did significantly impact the fecundity of female flies. Time limitations 
prevented this experiment to be conducted with mosquitoes, however,  it may prove a 
crucial experiment for the assessment of transgenic mosquitoes.    
On the other hand, the deleterious impact of the antibiotic on the mosquito may have 
been proved to not significantly alter the fitness of the mosquito to the point where it is 
unable to perform as well as mosquitoes in the wild.  The recent successful field studies 
conducted by Oxitec Ltd with LA513 in Grand Cayman did show that the transgenic 
population successfully mated with mosquitoes in the wild and significantly reduced the 
population of the dengue carrying Aedes aegypti (http://www.oxitec.com/wp-
content/uploads/2010/11/Oxitec-MRCU-press-release.pdf, www.newscientist.com).  
Despite the fact that chlortetracycline-resistant bacteria in mosquitoes have limited the 
deleterious impact of the antibiotic on the mosquito, with Drosophila the deleterious 
impact of antibiotic treatment was an example where chlortetracycline could 
substantially impact the insect host.  Oxitec Ltd is also developing RIDL® in other insects 
including the Mediterranean fruit fly, Mexican fruit fly and the olive fly.  The olive fly 
(Bactrocera oleae) has been demonstrated to have a major symbiont, Acetobacter 
(Kounatidis et al., 2009).  This symbiont was also the major symbiont of the Drosophila 
used in the studies described in this thesis, therefore could the treatment of 
chlortetracycline remove the major symbiont of the olive fly and impact the performance 
of the insect? If so, it could prove more difficult for a RIDL® insect to be produced and 
compete successfully with insects in the wild.  In addition, Drosophila melanogaster could 
be used as model for investigating the impact of removing the major symbionts of 
Lactobacillus and Acetobacter from the host.  This research could improve the 
understanding of the role of these symbionts which could provide methods of pest 
control with insects where their major symbionts are Lactobacillus and Acetobacter.  If 
reminiscent of Drosophila, the olive fly could undergo changes in nutrition, metabolism 
and development and these symbionts could be used as a method to control these 
agricultural pests. 
As described previously and during this thesis, a difference in response to 
chlortetracycline was observed with mosquitoes and in Drosophila.  This result should be 
considered by groups including Oxitec Ltd when treating other insects with 
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chlortetracycline, it would be advised to determine the impact of this antibiotic on the 
performance on the insect before continuing with experiments and techniques such as 
RIDL®.  However, bacterial depletion in the 2 insects tested during this project were not 
affected as much as insects with a tight interaction such as aphids and tsetse flies, the use 
of antibiotics should be decided with caution as an insect may be suitable for RIDL® but 
the fitness may be compromised through the use of chlortetracycline. 
If the fitness of the insect was significantly compromised due to bacterial depletion 
through chlortetracycline treatment, the identification and culture of the beneficial 
symbionts could allow for the re-introduction of these symbionts into the insect host.  
Niyazi et al (2004) re-introduced two symbionts (Enterobacter agglomerans and Klebsiella 
pneumoniae) into Mediterranean fruit flies through feeding.  This introduction improved 
their survival and mating numbers, highlighting the importance of the gut microbes in the 
fitness of the host (Niyazi et al., 2004).  This re-introduction with insects used by Oxitec 
Ltd would be difficult as it would not be possible to provide the bacteria in the food which 
is also supplemented with an antibiotic.  However, when rearing transgenic mosquitoes 
such as the strain LA513, chlortetracycline treatment is only required at the larval to 
pupal stage and not at the adult stage. Therefore, bacteria could be re-introduced into 
the adult male populations before they are released into the wild to mate with females.  
6.4 The use of chlortetracycline, antibiotic resistance, the microbial 
community and its implications for Oxitec Ltd  
Species of bacteria were still present within Aedes aegypti treated with 0-100 µg ml-1 of 
chlortetracycline, suggesting the presence of chlortetracycline resistant strains within the 
mosquitoes. To ensure these bacteria were chlortetracycline resistant the bacteria were 
also cultured overnight in nutrient broth +/- chlortetracycline.  Further methods to detect 
chlortetracycline resistance by identifying the presence of different groups of tetracycline 
resistance genes including Tet(A), Tet(M) and Tet(O) using conventional polymerase chain 
reaction or multiplex PCR (Ng et al., 2001) would improve the understanding of the 
prevalence of tetracycline resistance.  
Chlortetracycline resistance was observed in mosquitoes reared at Oxitec Ltd and with a 
population with no prior contact with chlortetracycline in the laboratory.  This suggests 
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that wild populations of mosquitoes may already contain antibiotic resistant strains. The 
exposure to this antibiotic in the laboratory could promote the establishment of a gut 
microbiota dominated by bacterial populations that are already resistant to the antibiotic 
and therefore, treatment could change the overall diversity within the insect gut which 
was observed in adult male mosquitoes in Chapter 5. 
Not only should chlortetracycline be considered as an antibiotic, but also as a signalling 
molecule.  Antibiotics play a role in the communication between bacteria within complex 
bacterial communities (Yim et al., 2007).  The experiments with Aedes aegypti did not 
show a change in the number of bacteria at treatments of low concentrations of 
chlortetracycline. However, the community/diversity may still have altered through the 
introduction of this signalling molecule resulting in changes in the communication 
between bacteria within the insect gut (Yim et al., 2007). The introduction of these 
antibiotics could alter the maintenance of the community (Yim et al., 2007).  Celli and 
Trieu-Cuot (1998) demonstrated that exposure to tetracycline enhanced horizontal gene 
transfer.  Therefore, Oxitec Ltd should consider the environmental impacts when using 
large quantities of chlortetracycline, especially when using chlortetracycline water when 
rearing mosquito larvae.  Such volumes of chlortetracycline rearing water could be 
substantial when mass rearing mosquitoes. As demonstrated through the over-use of 
antibiotics in agriculture (Kümmerer et al., 2004) the release of the chlortetracycline into 
the water systems could increase chlortetracycline resistant bacteria within the 
environment, and the persistence of microbes with chlortetracycline resistance. 
Moreover, high usage of the antibiotic could result in increasing levels of gene transfer 
between bacterial communities and an alteration in the communication between 
bacterial communities found within the environment.   
To limit the release of chlortetracycline into the environment, Oxitec Ltd should consider 
treating the water with UV light and high temperatures, 2 conditions which 
chlortetracycline is sensitive.   In addition, limit the exposure of wild-type mosquitoes at 
Oxitec Ltd.  These insects should be kept separately from the transgenic mosquitoes and 
the rearing equipment should be thoroughly decontaminated to prevent unnecessary 
exposure to chlortetracycline and to chlortetracycline-resistant bacteria found within the 
mosquitoes.   
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Not only should the impact on the host and environment be considered but also the 
employees who work with the insects.  The antibiotic-resistant bacteria could be exposed 
to employees and if an infection was to occur, then treatment with antibiotics could 
prove to be more difficult.  Furthermore, the bacteria carrying chlortetracycline 
resistance genes within the mosquitoes could transfer chlortetracycline resistant genes to 
pathogens.  The development of chlortetracycline resistance could reduce the ability to 
treat infections within animals and humans if exposed to these mosquitoes in the 
laboratory and if/when they are released into the wild.  If Oxitec Ltd were to release 
mosquitoes carrying bacteria with the tetracycline resistance gene, these bacteria could 
be introduced into the environment and create problems with treating infections.   
Bacteria identified in Aedes aegypti have also been implicated in human diseases. One of 
the bacteria identified in Aedes aegypti was Chryseobacterium 
meningosepticum/Elizabethkingia meningiseptica. This continual identification of this 
bacterium by myself and by others (Dong et al., 2009) suggests that it is not a pathogen of 
mosquitoes, however, this bacterium has been documented to cause meningitis and 
sepsis in infants and immunocompromised individuals in Taiwan (Chui et al., 2000).  In 
addition, Serratia marcescens found in Aedes aegypti has been identified as an 
opportunistic pathogen infecting and causing death of individuals during an epidemic and 
also carrying antibiotic resistance (Schaberg et al., 1976).  The presence of pathogens and 
the suggestion that these bacteria are antibiotic resistant highlights the importance of 
ensuring that exposed individuals are prevented from being infected with these bacteria. 
6.5 Overall conclusion 
In conclusion, the work in this thesis has revealed the importance of host-symbiont 
interactions of Drosophila melanogaster and Aedes aegypti.  The deleterious effects of 
chlortetracycline treatment emphasise the implications of using antibiotics to control 
genetic systems for insect pest management and as a method to determine the impact of 
bacterial depletion.  Egg dechorionation with Drosophila melanogaster has provided an 
alternative tool to evaluate bacterial depletion and to determine the impact of 





7.1. Bacterial identification of culturable bacteria in Drosophila treated with 
and without chlortetracycline and the rearing food  
Table: 7.1.  Bacterial identities from 16S rRNA gene analysis in control Drosophila 
melanogaster and the food used to rear the insects. 
 
Larvae Food 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (97%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (98%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (94%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (98%) 
FJ227313.1 - Acetobacter pasteurianus strain 
bh12 16S ribosomal RNA gene, partial sequence 
(98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (98%) 
 
FN429074.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain ZJ362 (99%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (98%) 
 
EU807752.1 - Lactobacillus plantarum strain 
ML5-1 16S ribosomal RNA gene, partial 
sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (97%) 
 
DQ981282.1 - Uncultured bacterium clone 
thom_k16 16S ribosomal RNA gene, partial 
sequence (99%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (99%) 
NR_025512.1 - Acetobacter cerevisiae strain 
LMG 1625 16S ribosomal RNA, partial sequence  
(98%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (98%) 
HM562995.1 - Acetobacter cerevisiae strain T0-
PCP23 16S ribosomal RNA gene, partial 
sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (99%) 
 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (98%) 
 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (98%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (99%) 
FJ227313.1 - Acetobacter pasteurianus strain 
bh12 16S ribosomal RNA gene, partial sequence 
(98%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (98%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (97%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (99%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (99%) 
NR_025512.1 - Acetobacter cerevisiae strain LMG 
1625 16S ribosomal RNA, partial sequence (97%) 
FN429068.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain SX461 (98%) 
DQ981281.1 - Uncultured bacterium clone 






























FJ227313.1 - Acetobacter pasteurianus strain 
bh12 16S ribosomal RNA gene, partial sequence 
(97%) 
NR_025512.1 - Acetobacter cerevisiae strain LMG 
1625 16S ribosomal RNA, partial sequence  (99%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (99%) 
FN429074.1 - Acetobacter pasteurianus partial 
16S rRNA gene, strain ZJ362 (97%) 
EU096229.1 - Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (97%) 
FJ227313.1 - Acetobacter pasteurianus strain 
bh12 16S ribosomal RNA gene, partial sequence 
(99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (96%) 
GQ359863.1- Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (99%) 
GQ359863.1- Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (99%) 
EU096229.1- Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, partial 
sequence (99%) 
GQ359863.1- Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1- Acetobacter sp. 6-C-2 16S 
ribosomal RNA gene, partial sequence (99%) 
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Table: 7.2.  Bacterial identities from 16S rRNA gene analysis in Drosophila melanogaster 




EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359860.1 - Lactobacillus sp. 0-C-2 16S ribosomal RNA gene, 
partial sequence (96%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (97%) 
HM462422.1 - Lactobacillus plantarum strain ChR-I-str20 16S 
ribosomal RNA gene, partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (96%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA gene, 
strain SX461 (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S ribosomal 
RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (97%) 
GQ359860.1 - Lactobacillus sp. 0-C-2 16S ribosomal RNA gene, 
partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA gene, 
strain SX461 (96%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA 
gene, strain SX461 (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S 
ribosomal RNA gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA 
gene, strain SX461 (99%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S ribosomal 
RNA gene, partial sequence (98%) 
GU253891.1 - Lactobacillus pentosus strain N3 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359860.1 - Lactobacillus sp. 0-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
HM449702.1 - Micrococcus luteus strain PCSB6 16S 
ribosomal RNA gene, partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S ribosomal 
RNA gene, partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
GU369767.1 - Lactobacillus brevis strain JS-7-2 16S 
ribosomal RNA gene, partial sequence (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (99%) 
HM218620.1 - Acetobacter malorum strain NM156-4 16S 
ribosomal RNA gene, partial sequence (97%) 
FJ227317.1 - Lactobacillus brevis strain b4 16S ribosomal 
RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
AB494721.1 - Lactobacillus plantarum gene for 16S 
ribosomal RNA, partial sequence, strain: KL23 (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (99%) 
GU253891.1 - Lactobacillus pentosus strain N3 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (97%) 
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Table: 7.3.  Bacterial identities from 16S rRNA gene analysis in Drosophila melanogaster 
on nutrient agar plates supplemented with 50 µg ml-1. 
Control flies Drosophila treated with 50 µg ml-1 of chlortetracycline 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S 
ribosomal RNA gene, partial sequence (98%) 
HM218620.1 - Acetobacter malorum strain NM156-4 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
AB510752.1 - Lactobacillus plantarum gene for 16S ribosomal 
RNA, partial sequence, strain: I041715 (97%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
HM218620.1 - Acetobacter malorum strain NM156-4 16S 
ribosomal RNA gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
GQ359860.1 - Lactobacillus sp. 0-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA 
gene, strain SX461 (97%) 
FJ462692.1 - Lactobacillus sp. strain E-1 16S ribosomal RNA gene, 
partial sequence (99%) 
FN429074.1 - Acetobacter pasteurianus partial 16S rRNA 
gene, strain ZJ362 (96%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S ribosomal 
RNA gene, partial sequence (96%) 
FJ751793.1 - Lactobacillus plantarum strain DSPV 354T 16S 
ribosomal RNA gene, partial sequence (99%) 
EU789400.1 - Lactobacillus plantarum strain M01210 16S 
ribosomal RNA gene, partial sequence (97%) 
HM218620.1 - Acetobacter malorum strain NM156-4 16S 
ribosomal RNA gene, partial sequence (99%) 
HQ286594.1 - Lactobacillus plantarum strain H2 16S ribosomal 
RNA gene, partial sequence (98%) 
HM562999.1 - Lactobacillus plantarum strain T30-PCM02 
16S ribosomal RNA gene, partial sequence (99%) 
FJ751793.1 - Lactobacillus plantarum strain DSPV 354T 16S 
ribosomal RNA gene, partial sequence (98%) 
AB368905.1 - Lactobacillus plantarum gene for 16S rRNA, 
partial sequence, strain: T3-10 (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (99%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S 
ribosomal RNA gene, partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA 
gene, strain SX461 (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (99%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S 
ribosomal RNA gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (99%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
GU253891.1 - Lactobacillus pentosus strain N3 16S 
ribosomal RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA gene, 
partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (97%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S ribosomal 
RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (98%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (98%) 
GQ359863.1 - Acetobacter sp. 6-C-2 16S ribosomal RNA 
gene, partial sequence (99%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (98%) 
FN429068.1 - Acetobacter pasteurianus partial 16S rRNA gene, 
strain SX461 (96%) 
EU096229.1 - Acetobacter pomorum strain EW816 16S ribosomal 
RNA gene, partial sequence (98%) 
FJ227313.1 - Acetobacter pasteurianus strain bh12 16S ribosomal 
RNA gene, partial sequence (98%) 
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7.2. Bacterial identification using 454 pyrosequencing of Drosophila guts 
treated with and without chlortetracycline  
 









10909 100 CP001161 Buchnera aphidicola str. 5A 





2717 100 HM080051 Uncultured Actinomycetales bacterium 




2020 100 NR_025512 Acetobacter cerevisiae strain LMG 1625 
16S ribosomal RNA, partial sequence 
>gi|23892796|emb|AJ419843.1| 
Acetobacter cerevisiae 16S rRNA gene, 




2020 99.6 GQ477828 Uncultured bacterium clone MS-123 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1715 100 HM027569 Bacillus subtilis strain zj2008 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Firmicutes; Bacillales; 
Bacillaceae; Bacillus. 
312 99.6 AM087199 Asticcacaulis benevestitus partial 16S 




212 100 AB461807 Acinetobacter sp. M522 gene for 16S 





186 100 EU096229 Acetobacter pomorum strain EW816 16S 




  100 AB308058 Acetobacter pasteurianus gene for 16S 




171 99.6 AJ318114 Uncultured gamma proteobacterium 16S 
rRNA gene, clone BIci4 
Bacteria; Proteobacteria; 
Gammaproteobacteria; environmental 
82 100 AB050446 Spiroplasma sp. YR-2 gene for 16S rRNA, 
partial sequence 
Bacteria; Tenericutes; Mollicutes; 
Entomoplasmatales; Spiroplasmataceae; 
Spiroplasma. 
64 100 HM344691 Uncultured bacterium clone 
ncd1060g01c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples 
63 100 EF433462 Devosia sp. IPL18 16S ribosomal RNA 




57 98.9 AY673373 Streptomycetaceae bacterium Ellin7207 




55 96.0 AJ247194 Asticcacaulis excentricus partial 16S rRNA 






38 100 HM334791 Uncultured bacterium clone ncd991e01c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
34 100 HM337834 Uncultured bacterium clone 
ncd1107h11c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
25 100 HM344642 Uncultured bacterium clone 
ncd1060b08c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
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23 99.6 GQ206310 Wolbachia endosymbiont of Sogatella 
furcifera clone A3H1M1 16S ribosomal 





21 98.9 GQ988635 Uncultured bacterium clone GI_AR_U_G0 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
20 100 AF078368 Grassland soil clone sl2_508 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
14 100 HM335477 Uncultured bacterium clone 
ncd1004g08c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
14 99.6 HM333436 Uncultured bacterium clone 
ncd1098f07c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
14 100 GU635382 Uncultured bacterium clone RW0038 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
13 98.9 FJ665195 Uncultured bacterium clone BCSAS2P1C1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
13 100 FJ436049 Burkholderia vietnamiensis strain SIr-665 




Burkholderia cepacia complex 
12 99.6 HM322590 Uncultured bacterium clone ncd400a04c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
12 98.9 HM286801 Uncultured bacterium clone ncd634h05c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
11 99.3 HM278405 Uncultured bacterium clone ncd554d11c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
10 98.5 AF253413 Acidocella sp. LGS-3 16S ribosomal RNA 




8 94.97 DQ413077 Uncultured bacterium clone 18 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
8 100 GU643701 Uncultured bacterium clone RW8357 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
8 99.6 HM257287 Uncultured bacterium clone ncd103d11c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 




Micrococcineae; Micrococcaceae; Kocuria 
8 99.2 EU776263 Uncultured bacterium clone IR_aaa03d07 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
8 98.8 FJ897521 Pedobacter sp. N1d-b1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Bacteroidetes; Sphingobacteria; 
Sphingobacteriales;Sphingobacteriaceae; 
Pedobacter 
8 100 GU644300 Uncultured bacterium clone RW8956 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
7 99.6 AB271048 Microbacterium ginsengisoli gene for 16S 





7 100 EU630302 Uncultured Actinomyces sp. clone 







7 91.2 AF507713 Uncultured soil bacterium clone S166 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
7 88.9 FJ916286 Uncultured delta proteobacterium clone 




7 100 HM314555 Uncultured bacterium clone ncd425b11c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
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7 99.3 EF219646 Uncultured beta proteobacterium clone 
AI-1M_A05 16S gene, partial sequence 
Bacteria; Proteobacteria; 
Betaproteobacteria; environmental 
7 97.8 AM400943 Flavobacteriaceae bacterium JJ-2987 
partial 16S rRNA gene, isolate JJ-2987 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales;Flavobacteriaceae 





7 100 FJ797394 Comamonas sp. G4 16S ribosomal RNA 




6 98.5 AM988902 Chryseobacterium sp. AKB-2008-VA6 
partial 16S rRNA gene, strain AKB-2008-
VA6 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales;Flavobacteriaceae; 
Chryseobacterium 
6 100 GQ246690 Janibacter sp. M2T2B13 16S ribosomal 





6 97.8 AM396913 Carnobacterium sp. NJ-46 16S rRNA gene, 
strain NJ-46 
Bacteria; Firmicutes; Lactobacillales; 
Carnobacteriaceae; Carnobacterium 
6 98.0 AM936584 Uncultured candidate division TM7 
bacterium partial 16S rRNA gene, clone 
EMP2 
Bacteria; candidate division TM7; 
environmental samples 
6 100 AB538964 Methylomonas sp. Fw12E-Y gene for 16S 




6 100 HM338449 Uncultured bacterium clone 
ncd1119e03c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
5 97.8 AY332104 Microbacterium sp. GWS-BW-H145 16S 





5 100 EU440980 Sphingopyxis sp. 2PR58-1 16S ribosomal 




5 92.7 HM308241 Uncultured bacterium clone ncd893f05c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
5 99.6 GQ891704 Caulobacter leidyia strain W1 16S 





5 100 FM176596 Uncultured Acidimicrobiales bacterium 
partial 16S rRNA gene, clone CL5.H403 
Bacteria; Actinobacteria; 
Acidimicrobidae; Acidimicrobiales; 
5 99.2 GQ391570 Uncultured organism clone G07-1-PTM2 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
5 100 HM343804 Uncultured bacterium clone 
ncd1051a04c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
5 90.7 FJ475509 Uncultured delta proteobacterium clone 




5 100 HM079530 Uncultured Lactobacillaceae bacterium 
clone E105G12 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Firmicutes; Lactobacillales; 
Lactobacillaceae 
5 93.0 GQ339139 Uncultured bacterium clone IS-32 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
5 78.1 EU436157 Anaplasma phagocytophilum genotype 






5 97.8 HM057788 Uncultured bacterium clone A8W_114 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
5 99.6 EF061026 Uncultured Flavobacteria bacterium clone 
LiUU-22-10 16S ribosomal RNA gene, 
partial sequence 




4 98.9 EU876624 Uncultured Flavisolibacter sp. clone KL2-




Flavisolibacter; environmental samples 
4 99.6 HM340514 Uncultured bacterium clone 
ncd1057b08c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
4 100 EU300429 Uncultured Propionibacteriaceae 
bacterium clone GASP-KC3W1_F10 16S 






4 90.4 AF047568 Candidate division OP11 clone LGd1 16S 
ribosomal RNA gene, partial sequence 
Unknown classification 
4 98.5 FJ002227 Navicula sp. C21 16S ribosomal RNA gene, 
partial sequence; chloroplast 
Eukaryota; stramenopiles; 
Bacillariophyta;Bacillariophyceae;Bacillari
ophycidae; Naviculales; Naviculaceae; 
Navicula 
4 99.6 GU225981 Uncultured bacterium clone 192 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples.             
4 100 HM339571 Uncultured bacterium clone 
ncd1008e06c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
4 99.6 AB265906 Uncultured Chloroflexi bacterium gene for 
16S rRNA, partial sequence, clone: UH-12 
Bacteria; Chloroflexi; environmental 
samples 
4 100 GU408433 Leptotrichia sp. oral taxon 215 clone 
HU062 16S ribosomal RNA gene, partial 
sequence 
Bacteria; Fusobacteria; Fusobacteriales; 
Fusobacteriaceae; Leptotrichia 
4 93.4 DQ829135 Uncultured proteobacterium clone 
DOK_NOFERT_clone140 16S ribosomal 
RNA gene, partial sequence 
Bacteria; Proteobacteria; environmental 
samples 
4 98.5 GU473087 Uncultured Janthinobacterium sp. clone 






4 97.8 FJ200295 Streptomyces sp. CLS28 16S ribosomal 





4 82.5 GQ391003 Uncultured organism clone D01-5-410 16S 
ribosomal RNA gene, partial sequence 
Unknown classification 
4 82.3 AM040129 Uncultured delta proteobacterium partial 
16S rRNA gene, clone Sylt 33 
Bacteria; Proteobacteria; 
Deltaproteobacteria; environmental 
4 94.9 FJ598048 Lutibacter sp. S7-2 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales;   Flavobacteriaceae; 
Lutibacter. 
4 96.0 AY922021 Uncultured Bacteroidetes bacterium 
clone AKYG467 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Bacteroidetes; environmental 
samples 
4 96.3 FJ542898 Uncultured Microbacteriaceae bacterium 






4 99.6 GU415459 Streptococcus anginosus clone WW062 
16S ribosomal RNA gene, partial sequence 
Bacteria; Firmicutes; Lactobacillales; 
Streptococcaceae;Streptococcus; 
Streptococcus anginosus group 
4 99.6 FM176343 Uncultured candidate division SR1 
bacterium partial 16S rRNA gene, clone 
BF.A2 
Bacteria; candidate division SR1; 
environmental samples 
4 99.6 NR_029345 Staphylococcus condimenti strain F-2 16S 
ribosomal RNA, complete sequence 
>gi|2673873|emb|Y15750.1| 
Staphylococcus condimenti 16S rRNA 
gene, strain F-2 T, DSM 11674 T 
Bacteria; Firmicutes; Bacillales; 
Staphylococcus 
4 98.5 FN668139 Uncultured Flavobacterium sp. partial 16S 
rRNA gene, clone ZS-2-61 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales;Flavobacteriaceae; 
Flavobacterium; environmental samples 
4 99.6 GQ994674 Uncultured organism clone supp_mic9 
16S ribosomal RNA gene, partial sequence 




4 98.1 GQ402641 Uncultured bacterium clone PW134 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
4 98.1 HM308483 Uncultured bacterium clone ncd897d02c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
4 94.0 DQ676299 Uncultured Chlorobi bacterium clone 
MVP-23 16S ribosomal RNA gene, partial 
sequence 
Bacteria; Chlorobi; environmental 
samples 
4 84.6 AM943204 Uncultured bacterium partial 16S rRNA 
gene, isolate KA-001.0.36 
Bacteria; environmental samples 
4 95.6 GU643527 Uncultured bacterium clone RW8183 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
4 98.9 EU982453 Uncultured bacterium clone DYB14 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
4 98.2 GU929374 Uncultured Cellvibrio sp. clone 45d_B7 




Cellvibrio; environmental samples 
4 99.6 AY655732 Cellulomonas parahominis strain W7387 





4 99.3 FJ859687 Ochrobactrum pseudogrignonense strain 





3 99.3 FM872717 Uncultured bacterium partial 16S rRNA 
gene, clone FB01A04 
Bacteria; environmental samples 
3 97.0 HM307004 Uncultured bacterium clone ncd874f01c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
3 99.3 DQ337515 Microbacterium sp. BBDP82 16S 







FJ482172 Uncultured candidate division OD1 
bacterium clone Pav-OD9 16S ribosomal 
RNA gene, partial sequence 
Bacteria; candidate division OD1; 
environmental samples 
3 97.8 AM990702 Rhodobacteraceae bacterium MOLA 435 





3 87.8 FM176343 Uncultured candidate division SR1 
bacterium partial 16S rRNA gene, clone 
BF.A2 
Bacteria; candidate division SR1; 
environmental samples 
3 91.5 EU914095 Uncultured bacterium clone 
D6ENV_87G11 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
3 96.3 DQ827966 Uncultured Bacteroidetes bacterium 
clone DOK_BIODYN_clone272 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Bacteroidetes; environmental 
samples 
3 99.6 GU429487 Beta proteobacterium oral taxon B96 




3 99.3 HM270636 Uncultured bacterium clone ncd268g09c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
3 100 FM176037 Uncultured Rhodoblastus sp. partial 16S 





3 100 AY882019 Streptomyces yanglinensis strain 317 16S 





3 96.7 HM125151 Burkholderia sp. CPA4 16S ribosomal RNA 




3 100 EF668276 Uncultured Geobacteraceae bacterium 
clone M22_1608 16S ribosomal RNA 




Geobacteraceae; environmental samples 
3 80.3 GQ423809 Uncultured bacterium clone R1B24H 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
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3 100 GU181268 Variovorax sp. SGM1-15 16S ribosomal 




3 99.6 EF220978 Uncultured Bacteroidetes bacterium 
clone D04_SGPO01 16S gene, partial 
sequence 
Bacteria; Bacteroidetes; environmental 
samples 
3 100 FJ875714 Uncultured beta proteobacterium clone 
D-08-ClB03 small subunit ribosomal RNA 
gene, partial sequence 
Bacteria; Proteobacteria; 
Betaproteobacteria; environmental 
3 99.3 D84617 Variovorax sp. S23408 gene for 16S 




3 87.7 CU922275 Uncultured Acidobacteria bacterium 16S 
rRNA gene from clone QEDR1BF06 
Bacteria; environmental samples. 
3 87.6 GQ263674 Uncultured bacterium clone FW3_65C 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
3 100 GQ159514 Uncultured bacterium clone 16slp92-
01e03.q1k 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
3 91.6 FJ694279 Uncultured bacterium clone KL201F02 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
3 100 HM328779 Uncultured bacterium clone ncd499f12c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
3 100 EF121241 Microcystis aeruginosa strain SPC 777 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Cyanobacteria; Chroococcales; 
Microcystis 
3 93.4 FJ542953 Uncultured gamma proteobacterium 




3 100 GU956686 Uncultured Firmicutes bacterium clone 
LI3-309 16S ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; environmental 
samples 
3 95.1 AM940560 Uncultured alpha proteobacterium partial 
16S rRNA gene, clone A6-42 
Bacteria; Proteobacteria; 
Alphaproteobacteria; environmental 
3 94.9 EF639389 Hymenobacter sp. BSw20462 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Bacteroidetes; Cytophagia; 
Cytophagales; Cytophagaceae; 
Hymenobacter 
3 95.6 FM175743 Uncultured Rickettsia sp. partial 16S rRNA 
gene, clone CL2.C528 
Bacteria; Proteobacteria; 
Alphaproteobacteria; Rickettsiales; 
Rickettsiaceae; Rickettsieae; Rickettsia; 
environmental samples 
3 92.7 AY673182 Actinobacteridae bacterium Ellin7016 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Actinobacteria; Actinobacteridae 
3 99.6 FN554975 Chryseobacterium sp.R4-1A partial 16S 
rRNA gene, type strain R4-1AT 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales;Flavobacteriaceae; 
Chryseobacterium 
3 100 AB362615 Lactobacillus brevis gene for 16S rRNA, 
partial sequence, strain: NRIC 0134 
Bacteria; Firmicutes; Lactobacillales; 
Lactobacillaceae; Lactobacillus 
2 92.3 AY193185 Uncultured candidate division OD1 
bacterium clone DA23 16S ribosomal RNA 
gene, partial sequence 
Bacteria; candidate division OD1; 
environmental samples 
2 99.6 GQ404080 Uncultured bacterium clone BD289 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 92.6 DQ190785 Uncultured proteobacterium clone JAB 
NFA1 88 16S ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; environmental 
samples 
2 100 CU926027 Uncultured Unclassified bacterium 16S 
rRNA gene from clone QEDN7DE10 
Bacteria; environmental samples. 
2 93.4 AY395155 Uncultured actinobacterium clone E07ST 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 100 CP000721 Clostridium beijerinckii NCIMB 8052, 
complete genome 
Bacteria; Firmicutes; Clostridia; 
Clostridiales; Clostridiaceae; Clostridium 
2 93.0 FM176368 Uncultured Cystobacteraceae bacterium 





2 97.1 GU636726 Uncultured bacterium clone RW1382 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
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2 99.3 FM176093 Uncultured Pseudorhodobacter sp. partial 





2 97.3 DQ129127 Uncultured soil bacterium clone CWT 
SM03_G11 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
2 98.2 GQ397014 Uncultured bacterium clone AK1DE2_05G 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 100 GU643321 Uncultured bacterium clone RW7977 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 100 FN563432 Mesorhizobium sp. LSE1 partial 16S rRNA 




2 100 GU640437 Uncultured bacterium clone RW5093 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 93.0 CU923796 Uncultured Actinobacteria bacterium 16S 
rRNA gene from clone QEDP3BH09 
Bacteria; environmental samples. 
2 100 HM015669 Spiroplasma citri isolate UPM 16S 
ribosomal RNA gene, partial sequence; 
16S-23S ribosomal RNA intergenic spacer, 
complete sequence; and 23S ribosomal 
RNA gene, partial sequence 
Bacteria; Tenericutes; Mollicutes; 
Entomoplasmatales; Spiroplasmataceae; 
Spiroplasma 
2 97.0 GU643071 Uncultured bacterium clone RW7727 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 99.6 FM177077 Uncultured Rhodoferax sp. partial 16S 










2 99.6 GU385867 Paenibacillus sp. QT21 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Firmicutes; Bacillales; 
Paenibacillaceae; Paenibacillus 
2 94.5 FM176448 Uncultured Aquiflexum sp. partial 16S 
rRNA gene, clone CL5.H221 
Bacteria; Bacteroidetes; Cytophagia; 
Cytophagales;Cyclobacteriaceae; 
Aquiflexum; environmental samples 
2 96.3 AB365060 Nocardioides oleivorans gene for 16S 












FM176577 Uncultured Polyangiaceae bacterium 










2 100 EF612342 Methylobacterium sp. K6-11 16S 




2 99.3 EU558285 Paenibacillus sp. B3a 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Firmicutes; Bacillales; 
Paenibacillaceae; Paenibacillus 
2 90.8 FM176113 Uncultured Desulforegula sp. partial 16S 





2 97.8 GU643314 Uncultured bacterium clone RW7970 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 99.6 HM345221 Uncultured bacterium clone 
ncd1152d06c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
2 92.9 FJ620939 Uncultured soil bacterium clone 
FACE.R1.EC.C09 small subunit ribosomal 
RNA gene, partial sequence 
Bacteria; environmental samples. 
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2 97.8 AM988899 Chryseobacterium sp. AKB-2008-HE92 
partial 16S rRNA gene, strain AKB-2008-
HE92 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales; 
Flavobacteriaceae; Chryseobacterium 
2 90.4 FJ694279 Uncultured bacterium clone KL201F02 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
2 100 AY436793 Methylophilus sp. ECd4 16S ribosomal 




2 94.4 FM206085 Uncultured bacterium partial 16S rRNA 
gene, clone GW_7 
Bacteria; environmental samples. 
2 99.6 GQ284336 Arthrobacter nicotinovorans strain 






2 100 GU992398 Lactococcus lactis subsp. lactis strain 
RIBB1 16S ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; Lactobacillales; 
Streptococcaceae; 
Lactococcus 
1 99.6 GU902766 Uncultured bacterium clone PP254-b02 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 94.8 GQ354973 Uncultured Spirochaetales bacterium 
clone 4-217 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Spirochaetes; Spirochaetales; 
environmental samples 
1 100 HM333401 Uncultured bacterium clone 
ncd1098d02c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 80.2 EF663250 Uncultured proteobacterium clone GASP-
MA2W2_F07 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Proteobacteria; environmental 
samples 
1 91.2 DQ294012 Uncultured epsilon proteobacterium 





1 99.6 FJ827889 Uncultured actinobacterium clone 
ME012E8 16S ribosomal RNA gene, partial 
sequence 
Bacteria; Actinobacteria; environmental 
samples 
1 98.9 AB190066 Comamonas sp. N-31-25-4 gene for 16S 




1 92.7 GQ339250 Uncultured bacterium clone IS-195 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Proteobacteria; environmental 
samples 
1 90.5 AF069496 Trojanella thessalonices 16s ribosomal 




1 100 GQ157139 Uncultured bacterium clone 16slp101-
3h05.p1k 16S ribosomal RNA gene, partial 
sequence 
Bacteria; environmental samples. 
1 99.3 FJ827881 Uncultured actinobacterium clone 
ME011D4 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Actinobacteria; environmental 
samples 
1 97.8 GQ302554 Uncultured Gemmatimonadetes 
bacterium clone sw-xj18 16S ribosomal 
RNA gene, partial sequence 
Bacteria; Gemmatimonadetes; 
environmental samples. 
1 85.8 EU245242 Uncultured organism clone MAT-CR-H4-
F07 16S ribosomal RNA gene, partial 
sequence 
Unclassified; environmental samples. 
1 98.1 DQ453128 Comamonas odontotermitis strain Dant 3-





1 92.6 FM176882 Uncultured Waddlia sp. partial 16S rRNA 
gene, clone CL6-7.L258 
Bacteria; Chlamydiae; Chlamydiales; 
Waddliaceae; Waddlia; environmental 
samples 
1 87.5 AY988769 Uncultured soil bacterium clone L1A.3D03 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 92.7 GQ339243 Uncultured bacterium clone IS-186 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 97.8 FJ894731 Uncultured bacterium clone nbt40f08 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 95.9 FJ764216 Uncultured beta proteobacterium clone 







1 93.3 GU305806 Uncultured bacterium clone YHY25 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 90.5 HM269021 Uncultured bacterium clone ncd241g11c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 99.3 AY958085 Staurastrum punctulatum chloroplast, 
complete genome 
Eukaryota; Viridiplantae; Streptophyta; 
Zygnemophyceae; Desmidiales; 
Desmidiaceae; Staurastrum 
1 91.7 HM335512 Uncultured bacterium clone 
ncd1001d03c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 91.5 AY532578 Uncultured bacterium clone 1013-28-
CG38 16S ribosomal RNA gene, partial 
sequence 
Bacteria; environmental samples. 
1 84.7 FJ712836 Uncultured Rhizobium sp. clone Cvi12 16S 




group; Rhizobium environmental samples 
1 88.6 EU723941 Aeromonas sp. AE100 16S ribosomal RNA 




1 90.1 EU676408 Uncultured bacterium clone 44P1 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 93.9 HM341023 Uncultured bacterium clone 
ncd1005g12c1 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 97.0 FJ517700 Uncultured Bdellovibrionales bacterium 





1 100 EU117887 Uncultured actinobacterium clone RC1B2 
16S ribosomal RNA gene, partial sequence 
Bacteria; Actinobacteria; environmental 
samples 
1 94.5 FJ475456 Uncultured Acetobacteraceae bacterium 
clone AhedenP18 16S ribosomal RNA 





1 97.4 HM269134 Uncultured bacterium clone ncd243e10c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 85.6 EF018867 Uncultured bacterium clone 
Amb_16S_1350 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 94.9 EU979051 Uncultured delta proteobacterium clone 




1 89.7 DQ532275 Uncultured bacterium clone JSC9-H2 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 88.6 EU723933 Aeromonas sp. AE99 16S ribosomal RNA 




1 99.3 EU131002 Sphingomonas sp. BAC318 16S ribosomal 




1 97.7 FJ719670 Eutreptia viridis strain SAG1226-1c 16S 
ribosomal RNA gene, partial sequence; 
chloroplast 
Eukaryota; Euglenozoa; Euglenida; 
Eutreptiales; Eutreptia 
1 94.1 GQ859797 Uncultured bacterium clone AA105 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 
1 98.3 EF072459 Uncultured delta proteobacterium clone 
GASP-WA1W3_B08 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Proteobacteria; 
Deltaproteobacteria; environmental 
1 95.6 HM317816 Uncultured bacterium clone ncd328a02c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples. 






1 94.6 DQ676307 Uncultured candidate division OD1 
bacterium clone MVP-35 16S ribosomal 
RNA gene, partial sequence 




1 88.3 FM176464 Uncultured Polyangiaceae bacterium 





1 95.2 EU914095 Uncultured bacterium clone 
D6ENV_87G11 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples 
1 100 NR_025513 Acetobacter malorum strain LMG 1746 




1 93.0 AJ867896 uncultured betaproteobacterium partial 
16S rRNA gene, clone A3 
Bacteria; Proteobacteria; 
Betaproteobacteria; environmental 
1 96.3 DQ828676 Uncultured proteobacterium clone 
DOK_CONFYM_clone423 16S ribosomal 
RNA gene, partial sequence 
Bacteria; Proteobacteria; environmental 
samples 
1 99.3 FM173120 Corynebacterium lubricantis partial 16S 





1 99.3 AB264798 Chitinophaga ginsengisegetis gene for 16S 
rRNA, partial sequence 
Bacteria; Bacteroidetes; Sphingobacteria; 
Sphingobacteriales; Chitinophagaceae; 
Chitinophaga 
1 94.8 DQ501318 Uncultured Bacteroidetes bacterium 
clone FSW11-13 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Bacteroidetes; environmental 
samples 
1 95.2 AY673182 Actinobacteridae bacterium Ellin7016 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Actinobacteria; 
Actinobacteridae. 
1 96.7 AY268295 Uncultured bacterium clone A2 16S small 
subunit ribosomal RNA gene, partial 
sequence 
Bacteria; environmental samples 
1 98.4 AY731468 Uncultured Cellulomonadaceae bacterium 






1 96.0 AM935633 Uncultured Sphingomonas sp. partial 16S 





1 98.5 EU423300 Nocardioides sp. LnR5-15 16S ribosomal 





1 88.7 FJ673881 Uncultured bacterium clone 130-6J1 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 99.6 GU642496 Uncultured bacterium clone RW7152 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 99.6 FM173386 Flavobacterium sp. CL1.3 partial 16S rRNA 
gene, isolate CL1.3 
Bacteria; Bacteroidetes; Flavobacteria; 
Flavobacteriales; Flavobacteriaceae; 
Flavobacterium 
1 91.6 FJ936832 Uncultured bacterium clone kab115 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 97.8 DQ501338 Uncultured beta proteobacterium clone 




1 98.1 GU416464 Streptococcus cristatus clone VF065 16S 
ribosomal RNA gene, partial sequence 
Bacteria; Firmicutes; Lactobacillales; 
Streptococcaceae; Streptococcus 
1 92.2 CU922275 Uncultured Acidobacteria bacterium 16S 
rRNA gene from clone QEDR1BF06 
Bacteria; environmental samples 
1 92.3 EU135203 Uncultured bacterium clone FFCH1186 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 96.0 FM175683 Uncultured Micromonosporineae 






1 94.5 EF540429 Uncultured soil bacterium clone MK27b 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 94.1 EF470923 Uncultured bacterium clone 156-21F 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
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1 99.3 AM884298 Mycobacterium gordonae partial 16S 







FJ793551 Alcaligenes sp. GR24-5 16S ribosomal RNA 




1 94.1 EF020290 Uncultured bacterium clone 
Elev_16S_1827 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples 
1 99.6 GU642018 Uncultured bacterium clone RW6674 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 99.6 AF125877 Dehydroabietic acid-degrading bacterium 





1 98.1 AB184555 Streptomyces mucoflavus gene for 16S 






1 97.8 DQ521555 Uncultured bacterium clone ANTLV9_C10 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 100 AB252938 Uncultured Nitrospirae bacterium gene 
for 16S rRNA, partial sequence, clone: 480 





















Table: 7.5. 454 Sequencing results of bacterial identities for Drosophila guts treated with 










29544 100 NR_025512 Acetobacter cerevisiae strain LMG 
1625 16S ribosomal RNA, partial 
sequence 
>gi|23892796|emb|AJ419843.1| 
Acetobacter cerevisiae 16S rRNA 
gene, strain LMG 1625 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Rhodospirillales; Acetobacteraceae; 
Acetobacter. 
314 100 EU096229 Acetobacter pomorum strain 
EW816 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Rhodospirillales; Acetobacteraceae; 
Acetobacter. 
54 100 CP001161 Buchnera aphidicola str. 5A 





12 100 HM334791 Uncultured bacterium clone 
ncd991e01c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
2 100 GQ246723 Lactobacillus sp. M3T1B5 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; Lactobacillales; 
Lactobacillaceae;Lactobacillus 
2 100 HM344642 Uncultured bacterium clone 
ncd1060b08c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
2 96.3 EF668276 Uncultured Geobacteraceae 
bacterium clone M22_1608 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Deltaproteobacteria; 
Desulfuromonadales;Geobacteraceae; 
environmental samples 
2 97.4 FJ444721 Uncultured Sinorhizobium sp. clone 
4h-12 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Rhizobiales; Rhizobiaceae; 
Sinorhizobium/Ensifer group; Sinorhizobium; 
 environmental samples 
2 97.4 EU839288 Soil bacterium 05G-03 16S 
ribosomal RNA gene, partial 
sequence 
Soil bacterium 
2 97.0 DQ153941 Brevibacterium sp. SK8B10 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales;Micrococcineae; 
Brevibacteriaceae; Brevibacterium 
2 100 FJ887890 Bacillus malacitensis strain TP12 
16S ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; Bacillales; Bacillaceae; 
Bacillus 
2 98.1 FJ654577 Uncultured alpha proteobacterium 
clone 012_E03_06-017477 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Alphaproteobacteria; 
environmental 
2 98.9 GU129070 Porphyromonadaceae bacterium 
62bF 16S ribosomal RNA gene, 
partial sequence 
Bacteria; Bacteroidetes; Bacteroidia; 
Bacteroidales;Porphyromonadaceae; 
unclassified Porphyromonadaceae 
2 99.6 HM328284 Uncultured bacterium clone 
ncd491c09c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
1 100 HM027569 Bacillus subtilis strain zj2008 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; Bacillales; Bacillaceae; 
Bacillus. 
1 100 GQ246660 Brevundimonas sp. M1T2B6 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Caulobacterales;Caulobacteraceae; 
Brevundimonas 
1 91.2 AF507713 Uncultured soil bacterium clone 
S166 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
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1 100 FJ875714 Uncultured beta proteobacterium 
clone D-08-ClB03 small subunit 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Betaproteobacteria; 
environmental 
1 98.2 AB252934 Uncultured alpha proteobacterium 
gene for 16S rRNA, partial 
sequence, clone: 225 
Bacteria; Proteobacteria; Alphaproteobacteria; 
environmental 
1 99.3 GU208440 Uncultured prokaryote clone Fr3-5 
16S ribosomal RNA gene, partial 
sequence 
Bacteria; environmental samples. 
1 99.6 GU902766 Uncultured bacterium clone PP254-
b02 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 96.7 NR_025512 Acetobacter cerevisiae strain LMG 
1625 16S ribosomal RNA, partial 
sequence 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Rhodospirillales; Acetobacteraceae; 
Acetobacter. 
1 97.0 GU916225 Uncultured bacterium clone 
F5K2Q4C04IIOUV 16S ribosomal 
RNA gene, partial sequence 
Bacteria; environmental samples. 
1 98.9 EU982453 Uncultured bacterium clone DYB14 
16S ribosomal RNA gene, partial 
sequence 
Bacteria; environmental samples. 
1 100 GU124493 Arthrobacter sp. endosymbiont of 
Nilaparvata lugens clone A300 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales;Micrococcineae; 
Micrococcaceae; Arthrobacter 
1 90 AY988665 Uncultured soil bacterium clone 
L1A.1H04 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 81.4 FM176408 Uncultured candidate division OD1 
bacterium partial 16S rRNA gene, 
clone BF.A2 
Bacteria; candidate division OD1; 
environmental samples 
1 97.8 GU643314 Uncultured bacterium clone 
RW7970 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 100 EU004565 Paenibacillus sp. HM06-03 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; Bacillales; 
Paenibacillaceae; Paenibacillus 
1 95.2 GU472572 Uncultured Rhodocyclaceae 
bacterium clone Rh60A4 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Betaproteobacteria; 
Rhodocyclales;Rhodocyclaceae; environmental 
samples 
1 86.7 EF020290 Uncultured bacterium clone 
Elev_16S_1827 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
1 100 HM333643 Uncultured bacterium clone 
ncd1107g12c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
1 99.6 HM336914 Uncultured bacterium clone 
ncd1087f06c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
1 95.2 GQ023532 Uncultured bacterium clone 
nbu319g02c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
1 99.6 HM146606 Uncultured bacterium clone SD102-
3_d06 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 99.6 HM332517 Uncultured bacterium clone 
ncd991c11c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental samples. 
1 93.0 HM099641 Lachnospiraceae bacterium oral 
taxon F15 strain UY038 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Firmicutes; Clostridia; Clostridiales; 
Lachnospiraceae 
1 99.3 FN646601 Brachybacterium sp. SS-2009-
PON14 partial 16S rRNA gene, 
strain PON14 





1 89.7 EU803767 Uncultured bacterium clone 
5C231389 16S ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
1 99.3 FJ482194 Uncultured candidate division OP11 
bacterium clone Pav-OP27 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; candidate division OP11; 
environmental samples 
1 99.6 EU775345 Uncultured bacterium clone 
gir_aah93g05 16S ribosomal RNA 
gene, partial sequence 
environmental 
1 98.1 AF236006 Beta proteobacterium A0618 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Betaproteobacteria 
1 99.3 AY876630 Uncultured Gemmatimonadetes 
bacterium clone Nsp8b 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Gemmatimonadetes; environmental 
samples 
1 91.6 FJ155589 Methylobacterium sp. SW08-7 16S 
ribosomal RNA gene, partial 
sequence 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Rhizobiales;Methylobacteriaceae; 
Methylobacterium 
1 99.6 NR_025512 Acetobacter cerevisiae strain LMG 
1625 16S ribosomal RNA, partial 
sequence  
Bacteria; Proteobacteria; Alphaproteobacteria; 
Rhodospirillales; Acetobacteraceae; 
Acetobacter. 
1 95.6 AF141504 Uncultured gamma 
proteobacterium clone CRE-PA17 




1 93.1 AB079644 Green non-sulfur bacterium AK-6 
gene for 16S ribosomal RNA, partial 
sequence 
Bacteria; Chloroflexi. 
1 93.1 AB079639 Kouleothrix aurantiaca gene for 16S 
rRNA, partial sequence, 
strain:MYSI-A 
Bacteria; Chloroflexi; Kouleothrix 
1 100 HM329712 Uncultured bacterium clone 
ncd980d04c1 16S ribosomal RNA 
gene, partial sequence 
















7.3 Microarray transcripts with 2 fold or more change in abundance (p<0.05) 
Table: 7.6.   Dechorionation on the high nutrient diet: Immune transcripts 















Defence response to fungus 
Defence response to bacterium 
Extracellular region 
Extracellular space 
Antibacterial humoral response 
Defence response to Gram-negative 
bacterium 
Defence response to Gram-positive 
bacterium 







Antibacterial humoral response 
Antifungal humoral response 
Defence response 
Defence response to fungus 
Defence response to Gram-negative 
bacterium 
Defence response to Gram-positive 
bacterium 
Extracellular region 




Antibacterial humoral response 
Defence response to Gram-negative 
bacterium 
CG10794 Diptericin b Down 14.94 GO:0019731 
GO:0005576 
Antibacterial humoral response 
Extracellular region 






Antibacterial humoral response 
Defence response to Gram-positive 
bacterium 
Defence response to bacterium 
Positive regulation of biosynthetic 
process of antibacterial peptides 
active against gram-positive bacteria 






Antibacterial humoral response 
Defence response to Gram-negative 
bacterium 
Defence response to bacterium 
Innate immune response 
Extracellular region 





Antibacterial humoral response 
Defence response 
Extracellular space, 
Defence response to bacterium 
Extracellular region 
CG15678 Poor imd 
response upon 
knock-in 







Response to symbiotic bacterium 
Protein binding 
Receptor binding 
Negative regulation of immune 
response 
Negative regulation of innate 
immune response 
Negative regulation of 
peptidoglycan recognition protein 
signalling pathway 






















Integral to plasma membrane 

























Defence response,  
Phototransduction, 
Phototransduction, visible light, 
Phototransduction, UV 
Rhodopsin biosynthetic process 
Cell adhesion 
Integral to plasma membrane 
carotenoid transport 
Scavenger receptor activity 
Defence response 
Membrane 





Defence response to Gram-negative 
bacterium 
Defence response to Gram-positive 
bacterium 
Peptidoglycan recognition protein 
signalling pathway 
Positive regulation of peptidoglycan 















Integral to plasma membrane 
Innate immune response 




Peptidoglycan binding activity 
Extracellular region  

















GO:0000270   
GO:0005887 
Protein binding, 





amidase   
Peptidoglycan binding activity 
Defence response 
Detection of bacterium 
Immune response 
Peptidoglycan catabolic process   
Peptidoglycan metabolic process 
Integral to plasma membrane 






C, type I 










Polysaccharide binding  
Scavenger receptor activity 
Defence response 




response to bacterium 




Table: 7.7.   Dechorionation on the high nutrient diet: Binding and transport transcripts 
Gene 
Number 













Up 2.48 GO:0016021 
GO:0005488 
 GO:0006810 
Integral to membrane 
Transport 
Binding 
CG10943 Viral a-type 
inclusion 
protein 
Down 2.39 GO:0005488 Binding 
BT025105 Class vii 
uncontrol 
myosin 









Down 2.24 GO:0005507 
GO:0006875 
Copper ion binding 
Cellular metal ion homeostasis 
CG4950 Carboxypeptida
se n subunit 2 
Down 2.14 GO:0005515 Protein binding 
CG33192 Metallothionein 
D 
Down 2.14 GO:0046872 Metal ion binding 
CG4139 Karl (isoform a) Down 2.05 GO:0005488  Binding 
 
Table: 7.8.   Dechorionation on the high nutrient diet: Metabolic transcripts 
Gene 
Number 





















Glutathione biosynthetic process 
Glutathione metabolic process 














Protein amino acid prenylation 
Protein farnesyltransferase 
complex 




Down 3.99 GO:0001676 
GO:0007498 
GO:0004467 





CG14205 - Down 3.61 GO:0016747 Transferase activity, transferring 
acyl groups other than amino-
acyl groups 






Chitin metabolic process 
structural constituent of 
peritrophic membrane 




Nucleotide and nucleic acid 
metabolic process  
DNA binding 


















Central nervous system 
development 
Dorsal closure 
Intestinal cholesterol absorption 
Hedgehog receptor activity 
Integral to membrane 
Plasma membrane 
Peripheral nervous system 
development 
CG11512 Glutathione s 
transferase d4 
Down 2.94 GO:0004602 
GO:0006979 
GO:0004364 
Glutathione peroxidase activity 
Response to oxidative stress 
Glutathione transferase activity 
CG15533 Acid 
sphingomyelinase 





Sphingomyelin catabolic process 
Sphingomyelin metabolic 
process 
CG10814 - Down 2.72 GO:0008336  
GO:0055114 
Gamma-butyrobetaine 
dioxygenase activity  
Oxidation reduction 




ATP biosynthetic process 
Cation transport 
Membrane  
ATPase activity, coupled to 
transmembrane movement of 
ions, phosphorylative 
mechanism 




Sphingomyelin catabolic process 
CG12766 Aldo-keto 
reductase 





Aldehyde reductase activity 






Carbohydrate metabolic process 
Cation binding 























Nucleoside diphosphate kinase 
activity 
EC216908 Synaptic vesicle 
membrane protein 
vat-1 homolog-like 
Up 2.33 GO:0008270 
GO:0055114 
GO:0016491 
Zinc ion binding 
Oxidation reduction 
Oxidoreductase activity 





CG12242 Glutathione s 
transferase d5 
Down 2.22 GO:0004602 
GO:0006979 
GO:0004364 
Glutathione peroxidase activity 
Response to oxidative stress 
Glutathione transferase activity 










CG14219 - Down 2.19 GO:0016747 Transferase activity, transferring 
acyl groups other than amino-
acyl groups 
CG34357 CG34357 Down 2.19 GO:0005524 
GO:0004383 
ATP binding 






















Protein kinase activity 
cGMP biosynthetic process 
Intracellular signalling pathway 
Protein amino acid 
phosphorylation 
EC216839 Bifunctional purine 
biosynthesis 
protein 






IMP cyclohydrolase activity 
IMP biosynthetic process 
CG9989 Mitochondrial 
endonuclease 
Down 2.12 GO:0046872 
GO:0003676 
GO:0016787 
Metal ion binding 
Nucleic acid binding  
Hydrolase activity 























Electron carrier activity 
Heme binding 
Ecdysone biosynthetic process 
Molting cycle, chitin-based 
cuticle 
Oxidation-reduction process 






























































Transcription activator activity 




Genital disc anterior/posterior pattern formation 
Heart formation 
Neuron development 
Labial disc development 
Oogenesis 
Positive regulation of epithelial cell differentiation 
Positive regulation of S phase of mitotic cell cycle 
Positive regulation of transcription from RNA 
polymerase II promoter 
Regulation of mitotic cell cycle 
Segment polarity determination 
Smoothened signalling pathway 
Spiracle morphogenesis, open tracheal system 
Wing disc anterior/posterior pattern formation 
Cytoplasm 




Transcription factor activity 
Transcription repressor activity 
Zinc ion binding 
Blastoderm segmentation 
Negative regulation of transcription from RNA 
polymerase II promoter 
Ovarian follicle cell development 
Regulation of transcription 

















Juvenile hormone binding 
Protein heterodimerization activity 
Protein homodimerization activity 
Transcription regulator activity 
Regulation of developmental process 
Regulation of transcription, DNA-dependent 
Nucleus 
Sequence-specific DNA binding transcription factor 
activity 
Signal transducer activity 








snRNP U1-CFB  
Nucleus  
Nuclear mRNA splicing, via spliceosome 
Negative regulation of striated muscle development 
 







Nuclear exosome (RNase complex) 
Nucleic acid binding 







Table: 7.10.   Dechorionation on the high nutrient diet: Miscellaneous transcripts 
Gene 
Number 

















Structural molecule activity 
BP553587 
(CG17082) 















Structural molecule activity 










3',5'-cyclic-AMP phosphodiesterase activity 
3',5'-cyclic-GMP phosphodiesterase activity 
cAMP metabolic process 











































Protein tyrosine phosphatase activity 
Axon guidance 
Cellular response to hypoxia 
Germ-band extension 
Cellular response to hypoxia 
Germ-band extension 
Mitotic cell cycle 




Regulation of protein localization 
Regulation of protein stability 
Cytoplasm 
Nucleus 

















Table: 7.11.   Dechorionation on the high nutrient diet: Tentative consensus sequences 
and Expression Sequence Tags with no assigned gene ontology. 
Sequence Number Sequence description Up/Down regulation Absolute fold change 
EC265593 (CG14322) Expression sequence tag Down 40.33 
TC218200 (Imaginal discs, 
adulthead, larval-pupal stage) 
Tentative consensus sequence Down 9.01 
TC212147 (Head) Tentative consensus sequence Down 4.04 
TC213322 Tentative consensus sequence Down 3.50 
TC217958 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 3.13 
TC212294 (Adult male and 
female heads) 
Tentative consensus sequence Up 2.91 
TC219398 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.00-2.85 
TC207643 (Larval and early 
pupal stage) 
Tentative consensus sequence Up 2.69 
TC211395 (Head) Tentative consensus sequence Down 2.64 
CO340976  Expression sequence tag Up 2.60 
TC218608 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.52 
TC220267 Tentative consensus sequence Down 2.50 
TC217746 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.49 
TC202144 Tentative consensus sequence Down 2.47 
TC198329 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.39 
EC251496 Expression sequence tag Down 2.37 
TC217470 Tentative consensus sequence Up 2.36 
TC216814 Tentative consensus sequence Down 2.30 
EC251372  Expression sequence tag Up 2.30 
TC214127 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.29 
TC218787 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.29 
TC216582 Tentative consensus sequence Up 2.28 
TC221202 Tentative consensus sequence Up 2.27 
AT28783 Expression sequence tag Down 2.25 
TC215744 Tentative consensus sequence Down 2.24 
TC219887 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.20 
TC217326 (Embryo) Tentative consensus sequence Down 2.20 
TC216236 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Down 2.19 
TC204335 (Larval early pupae) 
 
Tentative consensus sequence Down 2.19 
TC201532 Tentative consensus sequence Up 2.18 
TC218281 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.13 
CK133206  Expression sequence tag Up 2.10 
CA806439  Expression sequence tag Up 2.09 
CA805541 (CG43139) Expression sequence tag Up 2.06 
CO335149  Expression sequence tag Down 2.06 
LP20693 Expression sequence tag Down 2.06 
TC214720 Tentative consensus sequence Down 2.05 
TC216455 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.04 
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TC220402 (Embryo) Tentative consensus sequence Up 2.03 
TC215707 (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.02 
TC215821  (Mixed stage 
embryos, adult heads and 
imaginal discs) 
Tentative consensus sequence Up 2.02 
EL871925  Expression sequence tag Up 2.01 
EC265111  Expression sequence tag Down 2.00 
CO300471  Expression sequence tag Down 2.00 
 
 
Table: 7.12.   Dechorionation on the high nutrient diet: Sequences with no assigned gene 
ontology. 
Gene/Sequence Number Up/Down regulation Absolute fold change 
CG32185 Down 118.89 
CG34143 (Ionotropic receptor 10a) Up 7.00 
CG18273-RA Down 4.80 
CG18273 Up 3.81 
CG33553-RF Down 4.61 
CG16775 Down 3.82 
CG31711-RA Down 3.59 
CG41233 Down 3.41 
CG12998 Down 3.01 
NM_168143 (CG32408) Down 2.86 
NM_167853 (CG9094) Up 2.86 
CG31410 (Niemann-Pick type C-2e) Down 2.72 
CG33460 Down 2.71 
CG13641 Down 2.65-2.74 
CG18539 Up 2.62 
CG14639 (TwdlF) Down 2.42 
CG31698 Up 2.41 
CG7953 Down 2.28 
CG31554 Up 2.28 
CG7968 Down 2.26 
CG13640 Down 2.15 
NM_144221 Down 2.02 
CG40137 Up 2.01 



































Defence response to 
Gram-negative 
bacterium 
Defence response to 
bacterium 
Innate immune response 
Extracellular region 












Defence response to 
fungus 
Defence response to 
Gram-negative 
bacterium 
Defence response to 
Gram-positive bacterium 
Extracellular region 































alanine amidase activity 










Table: 7.14.   Dechorionation on the low nutrient diet: Binding and transport transcripts. 







NM_001015210 Zinc c3hc4 type (ring finger) 
domain protein 
Down 3.26 GO:0003676 
GO:0008270 
GO:0005515 
Nucleic acid binding 
Zinc ion binding 
protein binding 
CG11123 Mgc69156 protein Up 3.09 GO:0003723 RNA binding 
 










COPI vesicle coat 
Structural molecule 
activity 





















Integral to membrane 
Plasma membrane  
 
CG3250 Os-C  Down 2.09 GO:0005550 Pheromone binding 
 











Sensory perception of 
chemical stimulus  
Transport 
 
















Response to ethanol 
Sensory perception of 
chemical stimulus 


















Table: 7.15.   Dechorionation on the low nutrient diet: Metabolic transcripts. 




















CG2259 Glutamate-cysteine ligase 
catalytic subunit 
























CO334625 Cholesterol transporter 
tart1 
Up 2.74 GO:0017127 Cholesterol 
transporter activity 















Zinc ion binding 
Proteolysis 
 
Table: 7.16.   Dechorionation on the low nutrient diet: DNA/RNA replication/transcription 
transcripts. 
 







































Table: 7.17.   Dechorionation on the low nutrient diet: Tentative consensus sequences 
and Expression sequence tags with no assigned gene ontology. 
Sequence Number Sequence 
description 
Up/Down regulated Absolute fold change 
EC265593  Expression 
sequence tag 
Down 16.36 
TC218200 ( Larval early pupal) Tentative consensus 
sequence 
Down 11.09 












TC213314 (Embryo) Tentative consensus 
sequence 
Down 3.67 
TC203290 (Adult testis) Tentative consensus 
sequence 
Up 2.89 
TC218479 (mixed stage embryos, imaginal 





TC221383 Tentative consensus 
sequence 
Up 2.45 
TC196107 (Embryo) Tentative consensus 
sequence 
Down 2.32 
TC217326  (Embryo) Tentative consensus 
sequence 
Down 2.28 
TC220675 Tentative consensus 
sequence 
Up 2.28 
EC235662  Expression 
sequence tag 
Down 2.20 
TC217270 (Male and female adult head) Tentative consensus 
sequence 
Up 2.18 
TC212583 (Embryo) Tentative consensus 
sequence 
Down 2.17 
CK133206  Expression 
sequence tag 
Up 2.11 
TC221392 Tentative consensus 
sequence 
Down 2.07 







Table: 7.18.   Dechorionation on the low nutrient diet: Sequences with no assigned gene 
ontology. 
Gene/Sequence Number Up/Down regulated Absolute fold change 
CG32185 (BT023614) Down 35.34 
CG13445 Down 3.11 
CG34336 (RT07405p) Up 2.18 






Table: 7.19.   Control flies on the high and low nutrient diet: Binding and transport 
transcripts. 










CG40343 Up 4.20 GO:0003676 
GO:0008270 
Nucleic acid binding 
Zinc ion binding 
































Sensory perception of 
chemical stimulus  
Transport 
Salivary gland cell 





Autophagic cell death 
CO265995 Secis-binding 
protein 2 
Down 2.70 GO:0046872 Metal ion binding 































Integral to membrane 
EL882428 Isoform b Down 2.33 GO:0016021 
GO:0006814 
GO:0005215 
Integral to membrane 
Sodium ion transport 
Transporter activity 














Integral to membrane 
CG12944 Odorant-binding 
protein 47a 




Sensory perception of 
chemical stimulus 
Odorant binding 














































Apposition of dorsal 
and ventral imaginal 
disc-derived wing 
surfaces 
mRNA 3'-UTR binding 
























Muscle thin filament 
tropomyosin 





























Clathrin coat assembly 
Neurotransmitter 
secretion 













Cell adhesion mediated 
by integrin 










Muscle tendon junction 
Protein complex     
Calcium ion binding 
 
 
Table: 7.20.   Control flies on the high and low nutrient diet: Metabolic transcripts 
Gene 
Number 





Gene Ontology (GO) 
number 
GO term 




Oxygen transporter activity 
Protein transporter activity 
Lipid particle 
Storage protein import into fat body 
CG3763 Fat body protein 2 Down 23.54 GO:0055114 
GO:0004022  
GO:0045735 
 GO:0005488  
GO:0005811  
Oxidation reduction 
Alcohol dehydrogenase (NAD) 
activity 
Nutrient reservoir activity 
Binding 
Lipid particle 






Chitin metabolic process 
structural constituent of peritrophic 
membrane 
CG4178 Larval serum 
protein 1 beta 





Oxygen transporter activity 
Larval serum protein complex 
Nutrient reservoir activity 
Lipid particle 
Transport 


















(GTP) activity Mitochondrion 
CG33467 - Down 3.27 GO:0004672 
GO:0006468 
GO:0005524 
Protein kinase activity 
Protein amino acid phosphorylation 
ATP binding 




Electron carrier activity 
Heme binding 
Iron ion binding 
Monooxygenase activity 
CG32464 l(3)82Fd Up 2.83 GO:0016998 Cell wall macromolecule catabolic 
process 




Phospholipase A2 activity  
Anesthesia-resistant memory 
Regulation of heart contraction 
Olfactory learning 
CG13744 Serine protease Down 2.54 GO:0006508 
GO:0004252 
Proteolysis 
Serine-type endopeptidase activity 
CG41624 Spookier 
 







Electron carrier activity 
Heme binding 
Ecdysone biosynthetic process 
Molting cycle, chitin-based cuticle 
Oxidation-reduction process 




ATPase activity, coupled to 





GO:0016021 Transporter activity 
ATP-binding cassette (ABC) 
transporter complex 
Integral to membrane 
TC207646 - Down 2.38 GO:0051018 
GO:0008104 
Protein kinase A binding  
Protein localization 





Chitin metabolic process 
TC209811 Lectin type C Up 2.39 GO:0005534 Galactose binding 





Structural molecule activity 
Proteolysis 
Serine-type endopeptidase activity 
CG30098 tpa_inf: hdc06756 Down 2.28 GO:0006508 
GO:0004252 
Proteolysis 
Serine-type endopeptidase activity 
BT022430 tpa_inf: hdc06756 Down 2.25 GO:0006508 
GO:0004252 
Proteolysis 
Serine-type endopeptidase activity 
EL876446 CG11126-pa Down 2.17 GO:0016787 
GO:0009166 
Hydrolase activity 























TC209893 CG9444-PA Up 2.08 GO:0005427 
GO:0004550 
Proton-dependent oligopeptide 
secondary active transmembrane 
transporter activity 
Nucleoside diphosphate kinase 
activity 









Chitin catabolic process 




























CG41130 MIP04163p  Up 2.47 GO:0045449 
GO:0030528 
GO:0005634 
Regulation of transcription 











Nuclear exosome (RNase complex) 
3'-5'-exoribonuclease activity 
Cytoplasmic exosome (RNase complex) 
RNA binding 
RNA processing 
















Transcription activator activity 
Delamination 
Dendrite morphogenesis 
Embryonic pattern specification 
Eye-antennal disc development 
Imaginal disc-derived wing expansion 
Positive regulation of Wnt receptor 
signalling pathway 
Transcription, DNA-dependent 
Wing disc morphogenesis 
Wnt receptor signalling pathway 
Wnt receptor signalling pathway, calcium 
modulating pathway 
Nucleus 




































Salivary gland histolysis  
Salivary gland cell autophagic cell death 
Regulation of transcription, DNA-
dependent  
Regulation of development 
Metamorphosis 
Ecdysone-mediated induction of salivary 
gland cell autophagic cell death 
Cell death 
Zinc ion binding 
Specific RNA polymerase II transcription 
factor activity 
Transcription factor activity Response to 
symbiont  
Response to ecdysone  
Regulation of development, heterochronic 
Heterochronic progression of 
morphogenetic furrow involved in 
compound eye morphogenesis  
Oogenesis 
Muscle fiber development  
Male genitalia morphogenesis    
Larval central nervous system 
remodelling 
Eclosion 
Compound eye photoreceptor fate 
commitment   
Autophagy 







Table: 7.22.   Control flies on the high and low nutrient diet: Miscellaneous transcripts. 
Gene 
Number 










Down 9.11 GO:0042302 Structural constituent of cuticle 





Down 4.60 GO:0008011 Structural constituent of pupal chitin-
based cuticle 




Positive regulation of multicellular 
organism growth 
ARF guanyl-nucleotide exchange 
factor activity Regulation of ARF 
protein signal transduction 
Intracellular     
CO181664 - Up 3.06 GO:0040018 Positive regulation of multicellular 
organism growth 
TC215268 CG7941-PA Up 2.61 GO:0005214 
GO:0008010 
Structural constituent of chitin-based 
cuticle 
Structural constituent of chitin-based 
larval cuticle 
CG13586 Ion transport 
peptide 





Neuropeptide hormone activity 
Neuropeptide signalling pathway 
Extracellular region  
 
Table: 7.23.   Control flies on the high and low nutrient diet: Tentative consensus 
sequences and expression sequence tags with no assigned gene ontology number. 
Sequence Number Sequence description Up/Down 
regulation 
Absolute fold change 
TC198490   Tentative consensus sequence Down 17.05 
TC216174  (Embryo, imaginal 
disks and head) 
Tentative consensus sequence Up 3.86 
TC212147 (Head) Tentative consensus sequence Down 3.76 
TC212413 (Head) Tentative consensus sequence Down 3.73 
TC215541 (Embryo, imaginal 
disks and head) 
Tentative consensus sequence Up 2.86 
TC217270  (Adult head) Tentative consensus sequence Down 2.79 
TC221252 (Embryo, imaginal 
disks and head) 
Tentative consensus sequence Down 2.73 
BI568522  Expression sequence tag Down 2.66 
TC211303 (S2 cell) Tentative consensus sequence Up 2.64 
TC220055 
(Embryo, imaginal disks and 
head) 
Tentative consensus sequence Up 2.63 
CO183923  Expression sequence tag Down 2.49 
CO184327  Expression sequence tag Down 2.41 
TC215981 (Salivary glands) Tentative consensus sequence Up 2.38 
TC216561 (Embryo, imaginal 
disks and head) 
Tentative consensus sequence Up 2.36 
BP553587  Expression sequence tag Up 2.36 
TC219436 Tentative consensus sequence Up 2.35 
TC217125 (Embryo, imaginal 
disks and head) 
Tentative consensus sequence Up 2.27 
TC209931 (Head) Tentative consensus sequence Down 2.20 
TC219340 (Head) Tentative consensus sequence Down 2.19 
TC211084 (Head) Tentative consensus sequence Down 2.17 
208 
 
TC217379 (Head) Tentative consensus sequence Up 2.15 
TC215879 (Head) Tentative consensus sequence Down 2.10 
TC210443 (Embryo) Tentative consensus sequence Up 2.08 
TC221262 Tentative consensus sequence Down 2.07 
TC217757 Tentative consensus sequence Up 2.04 
AI517949 Expression sequence tag Up 2.01 
TC218077 (Embryo, imaginal 
disks and head) 
Tentative consensus sequence Down 2.01 
 
Table: 7.24.   Control flies on the high and low nutrient diet: Sequences with no assigned 
gene ontology number. 
Gene/Sequence Number Up/Down 
regulation 
Absolute fold change 
CG11370 Down 4.50 
CG13962 Down 4.31 
CG40203 Up 3.59 
CG13445 Up 2.71 
GM04319 Down 2.61 
BT028806 Down 2.37 
AT28783 Down 2.29 
CG14563 Down 2.20 
CG32182 Down 2.18 
CG15212 Up 2.04 
CG30395 Up 2.02 
CG41581 Up 2.00 
 
Table: 7.25.   Dechorionation on the high and low nutrient diet: Immune transcripts. 



















Cell wall macromolecule catabolic process 
Antimicrobial humoral response 
Lysozyme activity 






Antibacterial humoral response 
Defence response to Gram-negative 
bacterium 
Defence response to bacterium 
Innate immune response 
Extracellular region 






Antibacterial humoral response 
Defence response to Gram-positive 
bacterium 
Defence response to bacterium 
Positive regulation of biosynthetic process 
of antibacterial peptides active against 
Gram-positive bacteria 
























Phototransduction, visible light 
Phototransduction, UV 
Rhodopsin biosynthetic process 
Cell adhesion 
Integral to plasma membrane 
carotenoid transport 
Scavenger receptor activity 
Defence response 
Membrane 
CG6124-RA - Up 2.61 GO:0051635 
GO:0006910 
Bacterial cell surface binding 
Phagocytosis, recognition  
SD22390 Cg6124- 
partial 
















Protein homodimerization activity  
Hemolymph coagulation  
Hemostasis 
Melanization defence response 
Wound healing 




Chitin metabolic process 





Wnt receptor signalling pathway 



























Antimicrobial humoral response 
Border follicle cell migration 
Compound eye development 
Dorsal closure 
Establishment of planar polarity 
Imaginal disc fusion, thorax closure 
 JNK cascade 
Ovarian follicle cell migration 
R3/R4 cell fate commitment 
Regulation of cyclin-dependent protein 
kinase activity involved in G2/M 
Regulation of transcription, DNA-dependent 
Response to wounding 
Second mitotic wave involved in compound 
eye morphogenesis 
Synaptic growth at neuromuscular junction 






Protein dimerization activity 
Protein heterodimerization activity 
RNA polymerase II transcription factor 
activity Sequence-specific DNA binding 
Sequence-specific DNA binding transcription 
factor activity 
Specific RNA polymerase II transcription 
factor activity 
Transcription factor binding 






Actin filament  
Cytosol  
Extracellular region  
Actin binding  






C, type I 






Polysaccharide binding  
Scavenger receptor activity 
Defence response 










response to bacterium 
Integral to plasma membrane 
membrane  
 
Table: 7.26.   Dechorionation on the high and low nutrient diet: Transport and binding 
transcripts. 
















Sensory perception of 
chemical stimulus  
Odorant binding 
CG4950 Carboxypeptidase n 
subunit 2 
Up 3.24 GO:0005515 Protein binding 
CG32975 Nicotinic Acetylcholine 
Receptor α 34E 
















CG4139 Karl  Up 3.11 GO:0005488 Binding 





Sensory perception of 
chemical stimulus 
U02542 Odorant-binding protein 
83a 







Sensory perception of 
chemical stimulus 
Phenylalkylamine binding  
Transport 
















binding protein (A5) 



























Wing disc dorsal/ventral 
pattern formation 




Regulation of cell shape 
















Sister chromatid cohesion 
Lipid particle 
Granule 
Spermatid development  
Nucleic acid binding 
Actin binding 
Adenylate cyclase binding 
Instar larval development 
Bristle morphogenesis 




Actin polymerization or 
depolymerization 
Vinculin binding 
CG11748 Odorant-binding protein 
19a 








 Response to pheromone 




CA805378 Odorant-binding protein 
99b 







Odorant binding  
Sensory perception of 
chemical stimulus  
Transport 
Salivary gland cell  
Autophagic cell death 
Response to pheromone 
Extracellular region 
Olfactory behaviour 




Heat shock protein 
binding 
Unfolded protein binding 
CG10436 Pheromone-binding 
protein-related protein 1 






Odorant binding Transport 
Phenylalkylamine binding 
Pheromone binding 
Sensory perception of 
chemical stimulus 
Extracellular region 
BT029288 Zinc finger protein Down 2.51 GO:0003676 
GO:0005622 
GO:0008270 
Nucleic acid binding 
Zinc ion binding 
Intracellular 
CG3250 Os-C  Down 2.51-2.86 GO:0005550 Pheromone binding 
 









Cell adhesion mediated by 
integrin 




Muscle tendon junction 
Protein complex     
Calcium ion binding 
CG15279 Sodium shloride 
dependent amino acid 
transporter 





















receptor protein signalling 
pathway  







Olfactory receptor activity 
Response to stimulus 
Odorant binding  
Plasma membrane  
Sensory perception of 
smell 
Membrane 









Dibutyl phthalate binding 
Olfactory behaviour 
Response to pheromone 
Odorant binding  
Response to ethanol 
Sensory perception of 
chemical stimulus 





CG5670 Na pump α subunit 
(Atpalpha) 





































Determination of adult 
lifespan 
Embryonic development 




Regulation of cell shape 
Regulation of tube 
diameter, open tracheal 
system 
Response to mechanical 
stimulus 
Septate junction assembly  









ATP biosynthetic process  
Cation transport  
Monovalent inorganic 
cation transport  
Regulation of tube 
architecture, open 




complex                 




Integral to membrane 
Transporter activity 
CG1176 Pheromone-binding 
protein isoform a 






Extracellular region  
Pheromone binding 
Sensory perception of 







AA141263 AA141263 Down 2.19 GO:0005515 Protein binding 
CG8497 Rhophilin Up 2.17 GO:0017049 
GO:0007165 
GO:0005622 
GTP-Rho binding  
Signal transduction  
Intracellular 
EL881596 EL881596 Down 2.15 GO:0005267 
GO:0006813 
GO:0016020 
Potassium channel activity 
Potassium ion transport    
Membrane  
CG41520 CG41520 Up 2.14 GO:0005102 
GO:0007165 
Receptor binding 
 Signal transduction  






















Mesodermal cell fate 
determination 
Protein amino acid 
phosphorylation 
Larval visceral muscle 
development 
Pole cell migration 
Regulation of cell shape  
Regulation of calcium ion 
transport via store-
operated calcium channel 
activity 
Lymph gland development 
Muscle fiber development 
Integral to membrane  
Gonadal mesoderm 
development 
Ventral cord development 
Glial cell migration  
Pericardial cell 
differentiation  
Fibroblast growth factor 







Fibroblast growth factor 
receptor signalling 
pathway 














transporter activity  
Lipid particle 
Mitochondrial transport  
Calcium ion binding  
Integral to membrane 





Sensory perception of 
smell 
Olfactory receptor activity 
Odorant binding 















Actin binding  
Structural constituent of 
muscle  
Locomotion  
Mesoderm development  
Mitotic chromosome 
condensation 
Muscle attachment    
Myoblast fusion 
Sarcomere organization 











Skeletal muscle tissue 
development  
Condensed nuclear 





exchange factor activity 
Muscle organ 
development 
Regulation of Rho protein 
signal transduction  



























Gene Ontology (GO) 
number 
GO term 
CG17285 Fat body 
protein 1 




Oxygen transporter activity 
Protein transporter activity 
Lipid particle 
Storage protein import into 
fat body 






Chitin metabolic process 
structural constituent of 
peritrophic membrane 
CG3763 Fat body 
protein 2 








Nutrient reservoir activity 
Binding 
Lipid particle 
CG4178 Larval serum 
protein 1 
beta 





Oxygen transporter activity 
Larval serum protein 
complex 





















CG2559 Larval serum 
protein 1 
alpha 






Oxygen transporter activity 
Larval serum protein 





















































































Hexokinase activity  
Group III metabotropic 
glutamate receptor activity 
Metallopeptidase activity 




PDZ domain binding 
Polynucleotide 
adenylyltransferase activity  
UDP-N-acetylglucosamine 2-




dehydrogenase activity  

























receptor, adenylate cyclase 
inhibiting pathway 
Learning and/or memory 











Tricarboxylic acid cycle 
4 iron, 4 sulfur cluster 
binding 
Aconitate hydratase activity 
Mitochondrion 
Tricarboxylic acid cycle 








Nucleic acid binding 
Catalytic activity 
Intracellular 
Zinc ion binding 
Lipid metabolic process 
Triglyceride lipase activity 



















Insulin receptor signalling 
pathway 
Female mating behavior 
Insulin receptor binding 






ATP-binding cassette (ABC) 
transporter complex 
Transporter activity 
































Glycolysis, tricarboxylic acid 
cycle 
Mitochondrial oxoglutarate 
dehydrogenase complex    
BT025118 Serine 
protease 





















Chitin metabolic process 
CG3725  Calcium 
ATPase at 
60A 













Protein binding  
Neuromuscular synaptic 
transmission 








ATP biosynthetic process 
Calcium ion transport 
Endoplasmic reticulum 
membrane 
Integral to membrane 








































































Chitin-based larval cuticle 
pattern formation 
Chitin-based embryonic 
cuticle biosynthetic process  
Oocyte localization during 
germarium-derived egg 
chamber formation 
Cell-cell adhesion  
Neuroblast proliferation 




Negative regulation of Wnt 
receptor signalling pathway 
Head involution 









Imaginal disc pattern 
formation 
Nucleus 




Syncytial nuclear migration 
Cytokinesis 







































cyclohydrolase activity ATP 
binding 
Cellular amino acid 
biosynthetic process  
Formate-tetrahydrofolate 
ligase activity 
Folic acid and derivative 





TC206789 CG6865-PA Down 2.34 GO:0004295 
GO:0006508 


































































Hexokinase activity  
Group III metabotropic 
glutamate receptor activity- 
Metallopeptidase activity 




PDZ domain binding 
Polynucleotide 
adenylyltransferase activity  
UDP-N-acetylglucosamine 2-




dehydrogenase activity  



























receptor, adenylate cyclase 
inhibiting pathway 
Learning and/or memory 
Negative regulation of 
glutamate secretion 
N-acetylneuraminate 
metabolic process  














Fatty acid biosynthetic 
process 
Lipid metabolic process  
Oxidation reduction     
BT022319 Glutathione s 
transferase 









CO194525 CG7900  Down 2.28 GO:0016884 Carbon-nitrogen ligase 












le carboxylase activity 






















Glutamate catabolic process 
Synapse assembly 
Neurotransmitter receptor 
metabolic process Glutamine 
biosynthetic process 
CG17525 Glutathione s 
transferase 
e4 






Down 2.18 to 
2.30 
GO:0004091 Carboxylesterase activity 











CG7910 - Up 2.17 GO:0016884 
GO:0017064 
Carbon-nitrogen ligase 
activity, with glutamine as 
amido-N-donor 
Fatty acid amide hydrolase 
activity 




Metabolic process  














cGMP biosynthetic process 
Protein amino acid 
phosphorylation 
Protein tyrosine kinase 
activity 
ATP binding 
Guanylate cyclase activity 
CG3001 Hexokinase 
(Hex-A) 



















Electron carrier activity 






















Pyruvate metabolic process  
Signal transduction  















Magnesium ion binding 
NAD or NADH binding 








Up 2.06 GO:0003676 
GO:0044238 
GO:0003824 
Nucleic acid binding 
Primary metabolic process 
Catalytic activity 






ATP binding  
Guanylate cyclase activity  
Protein kinase activity  
 cGMP biosynthetic process  
Intracellular signalling 
pathway  
Protein amino acid 
phosphorylation  
CG3979 I'm not dead 
yet 









transporter activity   
Succinate transmembrane 
transporter activity   
Determination of adult 
lifespan 






Sodium ion transport 
 Transmembrane transport       




ATP biosynthetic process 
ATP binding 
Membrane 








GTP binding  
Phosphoenolpyruvate 
carboxykinase (GTP) activity 
Gluconeogenesis  
Mitochondrion  
CG6784 Tissue factor 
pathway 
inhibitor 2 
















Protein kinase activity 
ATP binding 





CG33103 Papilin Up 2.02 to 2.23 GO:0005201 
GO:0030198 
Extracellular matrix 














inhibitor activity  




























Table: 7.28.   Dechorionation on the high and low nutrient diet: RNA/DNA 
replication/transcription transcripts. 
 







TC219369 Reverse transcriptase Down 4.06 GO:0003723 
GO:0003964 
GO:0006278 
















,mRNA cleavage and 
polyadenylation  
Specificity factor complex 
mRNA 3'-UTR binding,  
Protein binding 
mRNA cleavage 





RNA polymerase II 
transcription factor 
activity 
Nucleic acid binding 
Nucleus 
Zinc ion binding 
Intracellular 























Integral to endoplasmic 
















Nucleic acid binding 
Nucleus 




















Nucleus   
Transcription factor 
activity 













transcription from RNA 
polymerase II promoter 
Zinc ion binding  
Neuron fate commitment  
Dendrite morphogenesis 
Nucleus 




Nucleic acid binding 
Intracellular 














RNA polymerase II 
transcription factor 
activity 




Nucleus       
Transcription factor 
activity 






















Regulation of alternative 






Glial cell migration 
Embryonic development 
Axon ensheathment 
Apposition of dorsal and 
ventral imaginal disc-
derived wing surfaces 













































































RNA polymerase II 
transcription factor 

























DNA bending activity 
Cytoplasm 




















Response to ether 
Generation of precursor 
metabolites and energy 
Odontogenesis of 
dentine-containing teeth 
Positive regulation of 
transcription from RNA 
polymerase II promoter 
Feeding behavior 
Adult behaviour 
Positive regulation of 
calcium ion transport 
Response to toxin 
Regulation of 
transcription from RNA 







Elevation of cytosolic 
calcium ion concentration 
CG6103 Cyclic-AMP response 
element binding protein B 
at 17A 



























Positive regulation of 
gene-specific 
transcription from RNA 














Learning or memory 
Locomotor rhythm 
Regulation of circadian 





Table: 7.29.   Dechorionation on the high and low nutrient diet: Miscellaneous transcripts. 








CG33519 Unc-89 Up 5.02 GO:0005524 
GO:0004674 






ATP binding  
Protein serine/threonine 
kinase activity  
Rho guanyl-nucleotide 
exchange factor activity 
Protein amino acid 
phosphorylation 
Regulation of Rho protein 
signal transduction 
Intracellular   





Odorant receptor 47 a Down 4.66 GO:0005214 
GO:0008010 
Structural constituent of 
chitin-based cuticle 
Structural constituent of 
chitin-based larval cuticle 






Small GTPase mediated 
signal transduction 
Membrane 






Structural constituent of 
cytoskeleton 
Calmodulin-dependent 
protein kinase activity 






Myosin light chain kinase 
activity 
ATP binding 
Response to acidity 
Vascular endothelial 
















Autophagic cell death  
Axon extension involved in 









phosphatase activity   




Extrinsic to membrane    
TC219478 - Up 2.48 GO:0005634 Nucleus 
BT030162 
 








exchange factor activity 
Regulation of ARF protein 
signal transduction 











Nuclear mRNA splicing via 
spliceosome 
Regulation of alternative 
nuclear mRNA splicing, via 
spliceosome 
Embryonic development 










Regulation of cell 
proliferation 
Learning or memory 
LD02307 Isoform b Up 2.15 GO:0005576 
GO:0008083 
Extracellular region 
Growth factor activity 
CG31004 CG31004 Up 2.10 GO:0007160 Cell-matrix adhesion 
CG33960 CG33960 Up 2.10 GO:0007411 
GO:0005886 
Axon guidance, 
Plasma membrane  





Cell death  
Head involution 
Negative regulation of 
growth  
Negative regulation of 
signal transduction  
Cytoplasm  
CG8927 Isoform a Up 2.08 GO:0042302 Structural constituent of 
cuticle 





Protein kinase activity 
Tau-protein kinase activity 







































Border follicle cell 
delamination 
Border follicle cell 
migration 
Establishment of imaginal 








organization involved in 





localization involved in 
oocyte Dorsal/ventral axis 
specification 
Ovarian follicle cell 
development 
Pole plasm protein 
localization 
Regulation of cell shape 
Regulation of pole plasm 
oskar mRNA localization 






Germline ring canal 
Neuromuscular junction 















Pole plasm oskar mRNA 
localization 
Protein amino acid 
phosphorylation 
Regulation of Wnt 
receptor signalling 
pathway 









Extracellular region  









protein kinase activity  






GO:0006468 ATP binding 
Protein serine/threonine 
kinase activity 
Structural constituent of 
cytoskeleton 
Protein amino acid 
phosphorylation   
 
 
Table: 7.30.   Dechorionation on the high and low nutrient diet: Tentative consensus 
sequences and expression sequence tags with no assigned gene ontology. 
Sequence Number Sequence description Up/Down 
regulation 
Absolute fold change 
TC217285 (Embryo) Tentative consensus sequence Up 10.07 
TC218367 (Embryo) Tentative consensus sequence Up 4.57 
TC198490 (Lsp1α-
PA) 
Tentative consensus sequence Down 4.50 
TC201533 Tentative consensus sequence Down 4.44 
TC214613 Tentative consensus sequence Down 4.31 
TC219844 Tentative consensus sequence Up 3.85 
TC212659 (Head) Tentative consensus sequence Down 3.45 
AW944513 
(CG6340) 
Expression sequence tag Down 3.35 
TC216377 (Head) Tentative consensus sequence Down 3.35 
TC201327(CG4757-
RA) 
Tentative consensus sequence Down 3.13 
TC221143 (Embryo) Tentative consensus sequence Up 2.91 
TC218749 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.86 
TC215215 (3rd instar 
larvae challenged 
with gram+/- 
bacteria in fat body) 
Tentative consensus sequence Down 2.73 
TC219201 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.66 
TC203290 Tentative consensus sequence Up 2.66 
TC213534 (Head) Tentative consensus sequence Up 2.62 
BI568522  Expression sequence tag Down 2.60 
TC215821 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Down 2.54 
TC213341 (Head) Tentative consensus sequence Up 2.51 
TC214171 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.47 
TC216854 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.44 
TC213388 (Head) Tentative consensus sequence Up 2.43 
TC217757 Tentative consensus sequence Up 2.42 
TC215541 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.34 
CB305266  Expression sequence tag Down 2.33 
TC219559 Tentative consensus sequence Up 2.32 
228 
 
TC220354 Tentative consensus sequence Up 2.32 
TC211303 (S2 cells) Tentative consensus sequence Up 2.29 
TC217125 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.27 
TC220379 Tentative consensus sequence Up 2.27 
TC216368 Tentative consensus sequence Up 2.24 
TC210404 (Head) Tentative consensus sequence Down 2.22 
TC216551 (Head) Tentative consensus sequence Up 2.20 
CA805541 
(CG43139) 
Expression sequence tag Down 2.20 
TC213188 (Embryo) Tentative consensus sequence Up 2.16 
TC213947 (Salivary 
glands) 
Tentative consensus sequence Down 2.15 
TC219494 Embryo 
and S2 cell culture) 
Tentative consensus sequence Up 2.13 
TC218163 (Ovary) Tentative consensus sequence Up 2.13 
TC218584 Tentative consensus sequence Up 2.12 
TC220906 Tentative consensus sequence Up 2.10 
TC209214 (Head) Tentative consensus sequence Up 2.10 
CO280900  Expression sequence tag Up 2.10 
TC215995 Tentative consensus sequence Up 2.06 
TC217151 (Embryo 
and S2 cell culture) 
Tentative consensus sequence Up 2.05 
TC210032 (Head) Tentative consensus sequence Down 2.05 
TC212461 (Head, 
ovary and embryo) 
Tentative consensus sequence Up 2.05 
TC212954 (Head) Tentative consensus sequence Up 2.03 
TC218875 (Embryos, 
imaginal disks and 
adults) 
Tentative consensus sequence Up 2.02 














Table: 7.31.   Dechorionation on the high and low nutrient diet: Sequences with no 
assigned gene ontology. 
Gene/Sequence Number Up/Down regulation Absolute fold change 
CG4996 Up 3.81 
CG34206 Down 3.79 
CG17761-RA Up 3.42 
CG40119-RA Down 2.91 
l(2)01289 Up 2.91 
CG40119 Up 2.80 
CG6544 (Fau) Up 2.79 
CG31008 Up 2.69 
NM_001015169 (CG41063) Up 2.51 
CG15597 Down 2.47 
NR_003123 Down 2.44 
pncr015:3L Down 2.42 
nimB5 Up 2.40 
CG34394 Up 2.37 
CG7502-RA Up 2.37 
CG17944 Down 2.32 
CG41130 Up 2.27 
CG41581 Up 2.26 
CG40626 Up 2.25 
CG11592 Up 2.23 
CG17839 Up 2.21 
CG34383 Up 2.18 
CR42217 Up 2.16 
CG32564 Down 2.16 
CG40137 Down 2.14 
AT10144 Down 2.12 
CG3246 Up 2.12 
CG14406 Up 2.08 
CG14066-RB Up 2.06 
CG31526 Down 2.05 
CG30296 Up 2.05 
BT024213 Up 2.05 
NM_001015218  (CG40159) Up 2.04 
CG41529 Up 2.04 






7.4 Bacterial identities of culturable bacteria in Asian and Mexican Aedes 
aegypti larvae and water samples at 0-100 µg ml-1chlortetracycline  
Table: 7.32. Bacterial identities found in Asian Aedes aegypti larvae and water samples at 
the different chlortetracycline concentrations (0-100 µg ml-1) (percent identity). 
 Chlortetracycline 







HQ113217.1 - Microbacterium sp. Z5 16S 
ribosomal RNA gene, partial sequence (98%) 
 
FJ652595.1 - Pseudomonas fluorescens strain PSY-11 
16S ribosomal RNA gene, partial sequence 
AY514432.1 - Serratia marcescens strain N1.8 16S 
ribosomal RNA gene, partial sequence (99%) 
HQ236076.1 - Bacillus cereus strain TBD3-2 
16S ribosomal RNA gene, partial sequence 
(99%) 
AJ704545.1 - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 51720 (99%) 
GQ504012.1 - Leucobacter sp. NAL101 16S 
ribosomal RNA gene, partial sequence (97%) 
GQ504012.1 - Leucobacter sp. NAL101 16S ribosomal 
RNA gene, partial sequence (97%) 
EU346911.1 - Leucobacter chironomi strain 
MM2LB 16S ribosomal RNA gene, partial 
sequence (98%) 
HQ113217.1 - Microbacterium paraoxydans strain 
CL-9.11a 16S ribosomal RNA gene, partial sequence 
(98%) 
HM573359.1 - Bacillus sp. EB353 16S 
ribosomal RNA gene, partial sequence 
GQ504012.1 - Leucobacter sp. NAL101 16S ribosomal 




AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
GQ504012.1 - Leucobacter sp. NAL101 16S ribosomal 
RNA gene, partial sequence (97%) 
HM820111.1 - Uncultured bacterium clone 
nby372d11c1 16S ribosomal RNA gene, 
partial sequence (98%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (99%) 
HM303366.1 - Uncultured bacterium clone 
ncd819f12c1 16S ribosomal RNA gene, 
partial sequence, Comamonas sp. N19-3 16S 
ribosomal RNA gene, partial sequence (99%) 
EU879962.1 - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence 
(98%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 




EU346911.1 - Leucobacter chironomi strain 
MM2LB 16S ribosomal RNA gene, partial 
sequence (97-98%) 
HQ113217.1 - Microbacterium paraoxydans strain 
CL-9.11a 16S ribosomal RNA gene, partial sequence 
(98%) 
HQ246280.1 - Enterobacter sp. 7A18S4 16S 
ribosomal RNA gene, partial sequence (97%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
GQ504012.1 - Leucobacter sp. NAL101 16S ribosomal 
RNA gene, partial sequence (99%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
GQ504012.1 - Leucobacter sp. NAL101 16S ribosomal 




HM820111.1 - Uncultured bacterium clone 
nby372d11c1 16S ribosomal RNA gene, 
partial sequence (99%) 
  
  
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
HQ113217.1 - Microbacterium paraoxydans strain 
CL-9.11a 16S ribosomal RNA gene, partial sequence 
(98%) 
EU346911.1 - Leucobacter chironomi strain MM2LB 




FJ652595.1 - Pseudomonas fluorescens 
strain PSY-11 16S ribosomal RNA gene, 
partial sequence,  
AY514432.1 - Serratia marcescens strain 
N1.8 16S ribosomal RNA gene, partial 
sequence(98%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720  (99%) 
HQ113217.1 - Microbacterium paraoxydans strain 






























AJ704542.1  - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 




EU302858.1 - Serratia marcescens strain 
DAP33 16S ribosomal RNA gene, partial 
sequence (98%) 
GU481093.1 - Chryseobacterium sp. RBT 16S 
ribosomal RNA gene, partial sequence (96%) 
J870662.1  - Chryseobacterium sp. pp2f 16S 
ribosomal RNA gene, partial sequence (99%) 
HQ113217.1 - Microbacterium paraoxydans strain 
CL-9.11a 16S ribosomal RNA gene, partial sequence 
(99%) 
FJ870662.1 - Chryseobacterium sp. pp2f 16S 




HM003215.1 - Delftia tsuruhatensis strain 
WYLW2-1 16S ribosomal RNA gene, partial 
sequence (99%) 
EF035134.1 - Serratia marcescens strain N4-5 16S 
ribosomal RNA gene, partial sequence (99%) 
HM003215.1 - Delftia tsuruhatensis strain 
WYLW2-1 16S ribosomal RNA gene, partial 
sequence (99%) 
  
AJ704545.1 - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 51720 (99%) 
EU302852.1 - Serratia marcescens strain DAP27 16S 
ribosomal RNA gene, partial sequence (99%) 
EF035134.1 - Serratia marcescens strain N4-5 16S 
ribosomal RNA gene, partial sequence (98%) 
  AM942043.1 - Ochrobactrum anthropi partial 16S 
rRNA gene, strain PH-03 (99%) 
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Table: 7.33. Bacterial identities found in Asian Aedes aegypti larvae and water samples at 
the different chlortetracycline concentrations (0-100 µg ml-1) and grown on nutrient agar 
supplemented with 50 µg ml-1 of chlortetracycline (percent identity). 
 
 Chlortetracycline 







AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
AJ704545.1 - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 51720 (98-99%) 
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
AJ704545.1 - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 51720 (99%) 
EF426425.1  - Elizabethkingia meningoseptica 
strain 2.5 16S ribosomal RNA gene (99%) 
DQ298759.1  - Bacterium 7C2 16S ribosomal RNA 
gene, partial sequence (99%) 
 EF426425.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
AJ704542.1  - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 13255 (100%) 
EF426425.1 - Elizabethkingia meningoseptica 
strain 2.5 16S ribosomal RNA gene, partial 
sequence (99%) 
DQ298759.1  - Bacterium 7C2 16S ribosomal RNA 
gene, partial sequence (100%) 
AJ704542.1 - Chryseobacterium meningosepticum 




AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
FJ652595.1 - Pseudomonas fluorescens strain PSY-11 
16S ribosomal RNA gene, partial sequence 
AY514432.1 -  Serratia marcescens strain N1.8 16S 
ribosomal RNA gene, partial sequence (99%) 
FP929040.1 - Enterobacter cloacae subsp. 
cloacae NCTC 9394 draft genome and 
uncultured bacteria (97-98%) 
 
AJ704545.1 - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 51720 (99%) 
FJ816020.1 - Elizabethkingia meningoseptica 
strain G3-1-08 16S ribosomal RNA gene, 
partial sequence (99%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 




FJ816020.1 - Elizabethkingia meningoseptica 
strain G3-1-08 16S ribosomal RNA gene, 
partial sequence (99%) 
FJ816020.1 - Elizabethkingia meningoseptica strain 
G3-1-08 16S ribosomal RNA gene, partial sequence 
(99%) 
AB244457.1 -  Enterobacter cloacae gene for 
16S rRNA, partial sequence, strain: An20-1 
(98%) 
GU481093.1 - Chryseobacterium sp. RBT 16S 
ribosomal RNA gene, partial sequence (99%) 
GU481093.1 - Chryseobacterium sp. RBT 16S 
ribosomal RNA gene, partial sequence (99%) 
AJ704545.1 - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 51720 (98%) 
AB244457.1 - Enterobacter cloacae gene for 16S 
rRNA, partial sequence, strain: An20-1 (98%) 
GU481093.1 - Chryseobacterium sp. RBT 16S 




AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
AB244457.1 - Enterobacter cloacae gene for 16S 
rRNA, partial sequence, strain: An20-1 (98%) 
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (98%) 
FJ405359.1- Microbacterium sp. GE1017 16S 
ribosomal RNA gene, partial sequence (97%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (99%) 
HM171926.1 - Microbacterium sp. Z5 16S ribosomal 




AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
HM171926.1  - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
GU180606.1- Elizabethkingia meningoseptica 
strain EKMS1 16S ribosomal RNA gene, partial 
sequence (94%)  
HQ113217.1 - Microbacterium paraoxydans strain 




AY335554.1 - Enterobacter aerogenes strain 
HK 20-1 16S ribosomal RNA gene, partial 
sequence (99%) 
HM171926.1  - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (98%) 
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (98%) 
HM171926.1  - Microbacterium sp. Z5 16S ribosomal 
RNA gene, partial sequence (99%) 
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AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
FJ870662.1 - Chryseobacterium sp. pp2f 16S 
ribosomal RNA gene, partial sequence (97-99%) 
EF035134.1 - Serratia marcescens strain N4-5 16S 
ribosomal RNA gene, partial sequence (98%) 
100 
  
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
EF035134.1 - Serratia marcescens strain N4-5 16S 
ribosomal RNA gene, partial sequence (99%) 
AJ704545.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 51720 (99%) 
GU481093.1 - Chryseobacterium sp. RBT 16S 
ribosomal RNA gene, partial sequence (98%) 
EF035134.1 - Serratia marcescens strain N4-5 
16S ribosomal RNA gene, partial sequence 
(99%) 
FJ652595.1 - Pseudomonas fluorescens strain PSY-11 
16S ribosomal RNA gene, partial sequence 
EU302856.1 - Serratia marcescens strain DAP31 16S 
ribosomal RNA gene, partial sequence (91%) 
FJ870662.1 - Chryseobacterium sp. pp2f 16S 
ribosomal RNA gene, partial sequence (99%) 
FJ662869.1 - Serratia nematodiphila strain P36 16S 
ribosomal RNA gene, complete sequence 
FJ662868.1 - Serratia marcescens strain P32 16S 
ribosomal RNA gene, complete sequence (99%) 
FJ662869.1 - Serratia nematodiphila strain P36 16S 
ribosomal RNA gene, complete sequence 
FJ662868.1 - Serratia marcescens strain P32 16S 



















Table: 7.34. Bacterial identities found in Mexican Aedes aegypti larvae and water samples 
at the different chlortetracycline concentrations (0-100 µg ml-1) (percent identity).   
Chlortetracycline 






EU346911.1 -  Leucobacter chironomi 
strain MM2LB 16S ribosomal RNA gene, 
partial sequence (98%) 
EU879962.1 - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (97%) 
GU180606.1 - Elizabethkingia meningoseptica strain 
EKMS1 16S ribosomal RNA gene, partial sequence 
(98%) 
EF035134.1  - Serratia marcescens strain N4-5 16S 
ribosomal RNA gene, partial sequence (99%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (99%) 
GU180606.1 - Elizabethkingia meningoseptica strain 





EU302852.1 -  Serratia marcescens strain 
DAP27 16S ribosomal RNA gene, partial 
sequence (99%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (98%) 
GU180606.1 -  Elizabethkingia 
meningoseptica strain EKMS1 16S 
ribosomal RNA gene, partial sequence 
(98%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (97%) 
AJ704541.1 -  Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 13254 (99%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (97%) 
HM063035.1 -  Microbacterium sp. CRRI-
13 16S ribosomal RNA gene, partial 
sequence (96%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (98%) 
EU879962.1  - Microbacterium 
laevaniformans strain NML 16S 
ribosomal RNA gene, partial sequence 
(97%) 
EU346911.1 - Leucobacter chironomi strain MM2LB 
16S ribosomal RNA gene, partial sequence (98%) 
EF035134.1  - Serratia marcescens strain 
N4-5 16S ribosomal RNA gene, partial 
sequence (99%) 
AM040493.1  - Leucobacter iarius 40 16S rRNA gene, 




HM159984.1 -  Ochrobactrum sp. OTU29 
16S ribosomal RNA gene, partial 
sequence (98%) 
EU302852.1 - Serratia marcescens strain DAP27 16S 
ribosomal RNA gene, partial sequence (99%) 
HM587796.1  - Delftia sp. MV01 16S 
ribosomal RNA gene, partial sequence 
(99%) 
AB244483.1 - Arthrobacter woluwensis gene for 16S 
rRNA, partial sequence, strain: limp 5-2 (98%) 
FJ816020.1 - Elizabethkingia 
meningoseptica strain G3-1-08 16S 
ribosomal RNA gene, partial sequence 
(98%) 
GU180606.1 - Elizabethkingia meningoseptica strain 
EKMS1 16S ribosomal RNA gene, partial sequence 
(99%) 
GU180606.1 - Elizabethkingia 
meningoseptica strain EKMS1 16S 
ribosomal RNA gene, partial sequence 
(98%) 
EF035134.1 - Serratia marcescens strain N4-5 16S 




HQ436416.1 - Elizabethkingia sp. dS13-
11 16S ribosomal RNA gene, partial 
sequence (98%) 
FJ652595.1 - Pseudomonas fluorescens strain PSY-11 
16S ribosomal RNA gene, partial sequence 
EU302855.1 - Serratia marcescens strain DAP30 16S 
ribosomal RNA gene, partial sequence (98%) 
FJ816020.1  - Elizabethkingia 
meningoseptica strain G3-1-08 16S 
ribosomal RNA gene, partial sequence 
(99%) 
AJ704541.1  - Chryseobacterium meningosepticum 
partial 16S rRNA gene, strain ATCC 13254 (99%) 
FJ816020.1 - Elizabethkingia 
meningoseptica strain G3-1-08 16S 
ribosomal RNA gene, partial sequence 
(99%) 
GQ351502.1 - Serratia marcescens strain N80 16S 
ribosomal RNA gene, partial sequence (99%) 
AJ704541.1 - Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
GQ165511.1 - Bacterium S119(2009) 16S ribosomal 










strain ATCC 13254 (99%) 
AJ704541.1 -  Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 13254 (99%) 
GU180606.1 -  Elizabethkingia meningoseptica strain 
EKMS1 16S ribosomal RNA gene, partial sequence 
(98%) 
 GU272355.1  - Microbacterium sp. LP2ME 16S 
ribosomal RNA gene, partial sequence (98%) 
 HQ436416.1 -  Elizabethkingia sp. dS13-
11 16S ribosomal RNA gene, partial 
sequence (98%) 
EU931562.1 - Klebsiella pneumoniae subsp. 
pneumoniae strain ZFJ-7 16S ribosomal RNA gene, 




FJ816020.1 -  Elizabethkingia 
meningoseptica strain G3-1-08 16S 
ribosomal RNA gene, partial sequence 
(98%) 
EU302852.1 -  Serratia marcescens strain DAP27 16S 
ribosomal RNA gene, partial sequence (99%) 
GU183606.1 -  Uncultured bacterium 
clone NMG46 16S ribosomal RNA gene, 
partial sequence (97%) 
HQ436416.1 - Elizabethkingia sp. dS13-11 16S 
ribosomal RNA gene, partial sequence (98%) 
GU180606.1 -  Elizabethkingia 
meningoseptica strain EKMS1 16S 
ribosomal RNA gene, partial sequence 
(97%) 
GU180606.1 -  Elizabethkingia meningoseptica strain 
EKMS1 16S ribosomal RNA gene, partial sequence 
(98%) 
AJ704541.1 -  Chryseobacterium 
meningosepticum partial 16S rRNA gene, 
strain ATCC 13254 (98%) 
HQ436416.1 -  Elizabethkingia sp. dS13-11 16S 
ribosomal RNA gene, partial sequence (98%) 
HQ436416.1 -  Elizabethkingia sp. dS13-11 16S 
ribosomal RNA gene, partial sequence (97%) 
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FJ652595.1 -  Pseudomonas fluorescens 
strain PSY-11 16S ribosomal RNA gene, 
partial sequence  
EU302855.1 -  Serratia marcescens strain 
DAP30 16S ribosomal RNA gene, partial 
sequence (98%) 
EU302852.1 - Serratia marcescens strain DAP27 16S 
ribosomal RNA gene, partial sequence (95%) 
EU302852.1 - Serratia marcescens strain DAP27 16S 




GQ351502.1  - Serratia marcescens 
strain N80 16S ribosomal RNA gene, 
partial sequence (97%) 
EU931562.1 -  Klebsiella pneumoniae subsp. 
pneumoniae strain ZFJ-7 16S ribosomal RNA gene, 
partial sequence (99%) 
GQ351502.1  - Serratia marcescens 
strain N80 16S ribosomal RNA gene, 
partial sequence (99%) 
AB548592.1 - Mycobacterium massiliense gene for 16S 
ribosomal RNA, partial sequence, strain: A1 (99%) 
EU879962.1 -  Microbacterium 
laevaniformans strain NML 16S 
ribosomal RNA gene, partial sequence 
(97%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (98%) 
EU879962.1  - Microbacterium 
laevaniformans strain NML 16S 
ribosomal RNA gene, partial sequence 
(98%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (98%) 
AF287752.1 -  Microbacterium sp. oral 
strain C24KA 16S ribosomal RNA gene, 
partial sequence (97%) 
EU879962.1  - Microbacterium laevaniformans strain 
NML 16S ribosomal RNA gene, partial sequence (99%) 
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Table: 7.35. Bacterial identities found in Mexican Aedes aegypti larvae and water samples 
at the different chlortetracycline concentrations (0-100 µg ml-1) on chlortetracycline 
supplemented agar plates (percent identity).   
 
Chlortetracycline 






EF035134.1 - Serratia marcescens strain 
N4-5 16S ribosomal RNA gene, partial 
sequence (99%) 
HQ436416.1 -  Elizabethkingia sp. dS13-11 16S 
ribosomal RNA gene, partial sequence (98%) 
EU302852.1 - Serratia marcescens strain 
DAP27 16S ribosomal RNA gene, partial 
sequence (98%) 
HQ436416.1 - Elizabethkingia sp. dS13-11 16S 
ribosomal RNA gene, partial sequence (98%) 
EU302852.1 - Serratia marcescens strain 
DAP27 16S ribosomal RNA gene, partial 
sequence (98%) 
HM130055.1 - Elizabethkingia meningoseptica 
strain S3 16S ribosomal RNA gene, partial sequence 
(99%) 
EF440614.1 - Delftia tsuruhatensis strain 
WXZ-1 16S ribosomal RNA gene, partial 
sequence (96%) 
GQ504012.1 - Leucobacter sp. NAL101 16S 
ribosomal RNA gene, partial sequence (97%) 
EF035134.1 - Serratia marcescens strain 
N4-5 16S ribosomal RNA gene, partial 
sequence (99%) 
EU302852.1 - Serratia marcescens strain DAP27 
16S ribosomal RNA gene, partial sequence (98%) 
EF035134.1 - Serratia marcescens strain 
N4-5 16S ribosomal RNA gene, partial 
sequence (98%) 
EF035134.1 - Serratia marcescens strain N4-5 16S 




HM771025.1 - Leucobacter sp. 
INBio2553H 16S ribosomal RNA gene, 
partial sequence (99%) 
FJ816020.1 - Elizabethkingia meningoseptica strain 
G3-1-08 16S ribosomal RNA gene, partial sequence 
(98%) 
DQ311007.1 - Agromyces sp. Xb-3 16S ribosomal 
RNA gene, partial sequence (98%) 
AF316618.1 - Mycobacterium fuerth 16S ribosomal 
RNA gene, partial sequence (99%) 
0.5 Samples and PCR completed, sequencing 
did not work 
AF316618.1 - Mycobacterium fuerth 16S ribosomal 
RNA gene, partial sequence (99%) 
 
1 Samples and PCR completed, sequencing 
did not work 
Samples and PCR completed, sequencing did not 
work 
 HQ436416.1 - Elizabethkingia sp. dS13-11 
16S ribosomal RNA gene, partial sequence 
(98%) 
AF535159.1 -  Microbacterium laevaniformans LA 




EU931562.1 - Klebsiella pneumoniae 
subsp. pneumoniae strain ZFJ-7 16S 
ribosomal RNA gene, partial sequence 
(96%) 
HM159984.1 - Ochrobactrum sp. OTU29 16S 
ribosomal RNA gene, partial sequence (99%) 
FJ816020.1 - Elizabethkingia 
meningoseptica strain G3-1-08 16S 
ribosomal RNA gene, partial sequence 
(99%) 
AB363526.1 - Uncultured bacterium gene for 16S 
ribosomal RNA, partial sequence, clone: 3-4-9 
(95%) 
EU931562.1 - Klebsiella pneumoniae 
subsp. pneumoniae strain ZFJ-7 16S 
ribosomal RNA gene, partial sequence 
(98%) Klebsiella pneumoniae subsp. 
pneumoniae strain ZFJ-7 16S ribosomal 




EU302852.1 - Serratia marcescens strain 
N4-5 16S ribosomal RNA gene, partial 
sequence (98%) 
 
EF035134.1 - Serratia marcescens strain 
N1.6 16S ribosomal RNA gene, partial 
sequence (98%) 
EF035134.1 - Serratia marcescens strain 




























GQ351502.1 -  Serratia marcescens strain 
N80 16S ribosomal RNA gene, partial 
sequence 
FJ652595.1 - Pseudomonas fluorescens 
strain PSY-11 16S ribosomal RNA gene, 
partial sequence (98%) 
EU536491.1 - Uncultured bacterium clone 
nbt214f11 16S ribosomal RNA gene, partial 
sequence (99%) 
FJ652595.1 -  Pseudomonas fluorescens 
strain PSY-11 16S ribosomal RNA gene, 
partial sequence 
EF035134.1 - Serratia marcescens strain 
N4-5 16S ribosomal RNA gene, partial 
sequence (99%) 
GQ351502.1 - Serratia marcescens strain N80 16S 
ribosomal RNA gene, partial sequence (98%) 
EU302852.1 - Serratia marcescens strain DAP27 
16S ribosomal RNA gene, partial sequence (98%) 
AY514432.1 - Serratia marcescens strain N1.8 16S 
ribosomal RNA gene, partial sequence (98%) 
238 
 
7.5. 454 pyrosequencing of bacteria in Mexican Aedes aegypti larvae, female 
adults and male adults with and without 30 µg ml-1chlortetracycline  




% Identity Accession 
number 
Identity Lineage 
31731 100.0 EU879962 Microbacterium 
laevaniformans strain 
NML 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Microbacterium.  
1101 100.0 EU714377 Microbacterium 
paraoxydans strain 76 
16S ribosomal RNA 
gene, partial sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Microbacterium. 
552 100.0 AM040493 Leucobacter iarius 40 
16S rRNA gene, type 
strain 40T 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Leucobacter 
59 96.0 EU717745 Microbacteriaceae 
bacterium ACTS123 16S 
ribosomal RNA gene, 
partial sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Microbacterium. 
49 97.8 DQ490450 Microbacteriaceae 
bacterium KVD-unk-03 
16S ribosomal RNA 
gene, partial sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Microbacterium. 
48 96.3 EU879962 Microbacterium 
laevaniformans strain 
NML 16S ribosomal RNA 
gene, partial sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Microbacterium. 
10 97.0 DQ490450 Microbacteriaceae 
bacterium KVD-unk-03 
16S ribosomal RNA 
gene, partial sequence 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Microbacteriaceae; 
Microbacterium. 
10 99.6 AB244483 Arthrobacter woluwensis 
gene for 16S rRNA, 
partial sequence, strain: 
limp 5-2 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Micrococcaceae; 
Arthrobacter 
1 97.8 AJ247194 Asticcacaulis excentricus 
partial 16S rRNA gene 
for 16S ribosomal RNA, 
strain DSM 4724(T) 
Bacteria; Proteobacteria; Alphaproteobacteria; 
Caulobacterales;Caulobacteraceae; Asticcacaulis 
1 98.9 DQ814374 Uncultured bacterium 
clone aab67f12 16S 
ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples 
1 100.0 GU428943 Comamonadaceae 
bacterium oral taxon 
A82 clone SV044 16S 
ribosomal RNA gene, 
partial sequence 
Bacteria; Proteobacteria; Betaproteobacteria; 
Burkholderiales; Comamonadaceae 
1 95.6 AB244483 Arthrobacter woluwensis 
gene for 16S rRNA, 
partial sequence, strain: 
limp 5-2 
Bacteria; Actinobacteria; Actinobacteridae; 
Actinomycetales; Micrococcineae; Micrococcaceae; 
Arthrobacter 
1 99.3 AB377177 Peptostreptococcaceae 
bacterium SK031 gene 
for 16S ribosomal RNA, 
partial sequence 





Table: 7.37. 454 Sequencing results of bacterial identities for male adult Mexican Aedes 
aegypti  
Number 
of reads  
% Identity Accession 
number 
Identity Lineage 
26723 100 GU180606 Elizabethkingia meningoseptica strain EKMS1 




2024 100 DQ365580 Erwinia persicina strain GS04 16S ribosomal 




 Enterobacteriaceae; Erwinia 
14 100 HM342703 Uncultured bacterium clone ncd1034b08c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 





 Enterobacteriaceae; Erwinia 
5 100 HM057713 Uncultured beta proteobacterium clone 





5 100 GQ360067 Acinetobacter sp. pp2a 16S ribosomal RNA 





3 100 EU714377 Microbacterium paraoxydans strain 76 16S 






3 100 NR_025643 Jeotgalicoccus halotolerans strain YKJ-101 16S 
ribosomal RNA, partial sequence  
Bacteria; Firmicutes; Bacillales; 
Jeotgalicoccus 
3 91.2 NR_025917 Acetivibrio cellulolyticus strain CD2 16S 
ribosomal RNA, partial sequence  
Bacteria; Firmicutes; Clostridia; 
Clostridiales; Ruminococcaceae; 
Acetivibrio 






2 100 HM329229 Uncultured bacterium clone ncd957e02c1 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
2 100 FJ859692 Sphingobacterium spiritivorum strain BIHB 





2 99.6 GU429487 Beta proteobacterium oral taxon B96 clone 











2 100 HM332804 Uncultured bacterium clone ncd1061e06c1 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
2 97.8 AJ247194 Asticcacaulis excentricus partial 16S rRNA 






2 100 GQ157223 Uncultured bacterium clone 16slp101-
1f11.w2k 16S ribosomal RNA gene, partial 
sequence 
Bacteria; environmental samples 





2 99.6 GU642046 Uncultured bacterium clone RW6702 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
2 98.4 DQ365580 Erwinia persicina strain GS04 16S ribosomal 





2 94.5 EU305584 Uncultured Pedobacter sp. clone 3-C 16S 




aceae; Pedobacter; environmental 
samples 





1 99.6 GQ891705 Caulobacter leidyia strain X 16S ribosomal 





1 92.31 AY193185 Uncultured candidate division OD1 bacterium 
clone DA23 16S ribosomal RNA gene, partial 
sequence 
Bacteria; candidate division OD1; 
environmental samples 
1 97.8 DQ801310 Uncultured bacterium clone RL388_aao93g08 
16S ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 93.0 AB480775 Erwinia tasmaniensis gene for 16S ribosomal 





1 97.4 EF667911 Uncultured Bdellovibrionales bacterium clone 






1 97.0 NR_024786 Delftia tsuruhatensis strain T7 16S ribosomal 
RNA, partial sequence 
>gi|17974274|dbj|AB075017.1| Delftia 











1 99.6 GU727800 Uncultured bacterium clone A196 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 97.0 FJ828944 Variovorax sp. enrichment culture clone 13.4 




e; Variovorax; environmental 
samples 
1 100 HM267307 Uncultured bacterium clone ncd212e06c1 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 98.5 AB294175 Alkalibacterium olivapovliticus gene for 16S 





1 100 HM269911 Uncultured bacterium clone ncd257e09c1 16S 
ribosomal RNA gene, partial sequence 
Bacteria; environmental samples 
1 92.3 GQ250436 Xanthomonas sp. MJ10 16S ribosomal RNA 






1 100 AB195767 Aquatic bacterium R1-B35 gene for 16S 




1 100 EF469609 Pseudacidovorax intermedius strain CC-CC21 






1 97.4 AY162048 Alpha proteobacterium PI_GH2.1.D7 small 
subunit ribosomal RNA gene, partial sequence 
Bacteria; Proteobacteria; 
Alphaproteobacteria. 
1 89.4 AY468464 Chryseobacterium sp. FRGDSA 4034/97 16S 







Table: 7.38. 454 Sequencing results of bacterial identities for male adult Mexican Aedes 
aegypti treated with 30 µg ml-1 of chlortetracycline 
 
Number of reads  % Identity  Accession Number ID Name  Lineage 
21392 98.9 FJ784637 Raoultella sp. Z2NS-91 16S 






4867 100 GU180606 Elizabethkingia 
meningoseptica strain 
EKMS1 16S ribosomal RNA 





1687 100 HM057713 Uncultured beta 
proteobacterium clone 
D8W_30 16S ribosomal 





65 98.4 GQ284560 Serratia marcescens strain 
A2.4bii 16S ribosomal RNA 





49 91.1 FN297940 Uncultured 
Enterobacteriales 
bacterium partial 16S 






44 98.1 GU640749 Uncultured bacterium 
clone RW5405 16S 
ribosomal RNA gene, 
partial sequence 
Bacteria; environmental samples. 
30 93.7 GU410540 Achromobacter 
xylosoxidans clone FH043 






22 99.5 HM130059 Elizabethkingia 
meningoseptica strain S7 








19 89.9 FJ184330 Uncultured soil bacterium 
clone B5_4 16S ribosomal 
RNA gene, partial 
sequence 
Bacteria; environmental samples. 
17 96.7 GU180606 Elizabethkingia 
meningoseptica strain 
EKMS1 16S ribosomal RNA 





11 98.8 GU180606 Elizabethkingia 
meningoseptica strain 
EKMS1 16S ribosomal RNA 





6 97.0 FJ607964 Uncultured Serratia sp. 
clone LF8 16S ribosomal 







6 95.6 DQ304115 Streptomyces sp. DA01013 








5 92.4 AB274281 Enterobacter sakazakii 
gene for 16S rRNA, partial 




Enterobacteriaceae;  Cronobacter 
4 100 FJ859692 Sphingobacterium 
spiritivorum strain BIHB 
346 16S ribosomal RNA 






2 97.4 GU180606 Elizabethkingia 
meningoseptica strain 
EKMS1 16S ribosomal RNA 





2 88.0 GQ284560 Serratia marcescens strain 
A2.4bii 16S ribosomal RNA 





2 92.7 HM130059 Elizabethkingia 
meningoseptica strain S7 






1 95.6 GQ284560 Serratia marcescens strain 
A2.4bii 16S ribosomal RNA 





1 95.6 EU834233 Pseudomonas sp. RZ 16S 









1 95.6 DQ417330 Pseudomonas fluorescens 
strain 3B 16S ribosomal 









Table: 7.39. 454 Sequencing results of bacterial identities for female adult Mexican Aedes 
aegypti  
 
Number of reads  % Identity   Accession 
Number 
Identity Lineage 
458 100 GU180606 Elizabethkingia meningoseptica 
strain EKMS1 16S ribosomal 






44 100 DQ365580 Erwinia persicina strain GS04 








39 98.9 FJ784637 Raoultella sp. Z2NS-91 16S 








2 100 AB238051 Uncultured bacterium gene for 




2 98.2 GQ500800 Uncultured bacterium clone 
MACA-EFT33 16S ribosomal 
RNA gene, partial sequence 
Bacteria; environmental 
samples 
2 98.2 AB252934 Uncultured alpha 
proteobacterium gene for 16S 






2 98.1 GQ348782 Uncultured alpha 
proteobacterium clone 
SHAB715 16S ribosomal RNA 





2 92.3 GQ988711 Uncultured bacterium clone 
FW_C02fw20 16S ribosomal 
RNA gene, partial sequence 
Bacteria; environmental 
samples 
2 92.3 GQ988710 Uncultured bacterium clone 
FW_H06fw32 16S ribosomal 
RNA gene, partial sequence 
Bacteria; environmental 
samples 
2 100 AJ536464 Melosira varians chloroplast 








2 99.3 EF580977 Uncultured bacterium clone 
CM132 16S ribosomal RNA 





2 99.6 EU850384 Uncultured Rhodocyclaceae 
bacterium clone F5 16S 








1 99.6 GU902766 Uncultured bacterium clone 
PP254-b02 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental 
samples 
1 100 FN691990 Pseudomonas sp. NR6 partial 







1 93.0 GQ339139 Uncultured bacterium clone IS-




1 100 AY957928 Uncultured bacterium clone 
B3NR69D13 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental 
samples 
1 100 EU580492 Uncultured bacterium clone 
D44 39 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental 
samples 
1 96.0 AY989122 Uncultured soil bacterium 
clone L1A.8D09 16S ribosomal 
RNA gene, partial sequence 
Bacteria; environmental 
samples 
1 100 HM251894 Uncultured bacterium clone 
ncd22a07c1 16S ribosomal RNA 
gene, partial sequence 
Bacteria; environmental 
samples 
1 99.3 AY947930 Uncultured Bacteroidetes 
bacterium clone IRD18D04 16S 




















7.6 Application for RIDL® 
7.6.1 Introduction 
The RIDL® technique involves the release of male mosquitoes into the wild.  Successful 
field trials in Grand Cayman involved the release of 3.3 million male mosquitoes into the 
wild over a period of 6 months (www.newscientist.com, http://www.oxitec.com/wp-
content/uploads/2010/11/Oxitec-MRCU-press-release.pdf). Only male mosquitoes are 
released therefore, mosquitoes need to be sexed before release.   
Mosquitoes can be sexed at the pupal stage.  Mosquito pupae differ by the shape of the 
genital lobe or by the size (females tend to be larger than males).  The only methods used 
to sex the pupae are: the use of a light microscope and sexing by hand and secondly, 
using a grid which separates the pupae by size with a 97% success rate (Sharma et al., 
1972).  These methods work well but only to a certain scale of rearing.  For a RIDL® 
control program millions of pupae will have to be sexed and the above methods are far 
too labour intensive for this. Therefore new and faster methods of sorting males from 
females are required. 
A female L4-pupae marker was proposed as a method to sort males and females to allow 
an easy identification of females.  The L4-pupae larvae can then be sorted so that only 
male pupae emerge, potentially saving time on sorting larvae from pupae and then sexing 
the pupae.  
To create a female-specific L4 marker, the female-specific splicing region for the Actin-4 
gene was used.  The Aedes Actin-4 gene was shown to be expressed in only female Aedes 
aegypti (Muñoz et al., 2004; Fu et al., 2010).  The Actin-4 gene is expressed in the indirect 
flight muscles in females (Muñoz et al., 2004).  This female-specific protein is generated 
by sex-specific splicing; the intron found between exons 1 and 2 is completely spliced in 
females (Fu et al., 2010).  However, in males the intron is partially spliced out producing a 
second version that is 244 bp longer (Figure: 7.1) (Fu et al., 2010).  This 244 bp region 
contains stop codons and therefore, prevents the expression of the Actin-4 gene in males 
(Fu et al., 2010).  When the intron is completely removed there are no stop codons 
present and therefore the expression of the Actin-4 continues and the protein is 
produced (Fu et al., 2010).  DsRed was used as the marker with the promoter Hr5IE1 
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(immediate-early promoter) which is a ubiquitous promoter.  Therefore, the DsRed 
fluorescence should be expressed in females only.  Transformed mosquitoes were 
identified by expression of cyan fluorescence in the eyes and anal papillae. 
 
Figure: 7.1. Illustration of the splicing region for the Actin-4 gene.  In males the intron is 
only partially spliced out, whereas in females and in some males the intron is 








7.6.2 Methods: Production and analysis of transgenic mosquitoes – Female-specific 
marker for mass rearing 
A female specific marker (OX4272) was created (designed by Guoliang Fu), for sex 
separation during mass rearing of Aedes aegypti. This plasmid (OX4272) will allow all over 



























Figure: 7.2. a) Summary of the DNA produced to create female-specific expression of 
DsRed in wild-type Asian Aedes aegypti.  DsRed expression under the control of the 
HR5IE1 promotor with spliced intron of AeAct4, the plasmid also contains an AmCyan 
fluorescent marker under the control of the 3XP3 promoter resulting in expression in 
the optic nerve b) the plasmid of OX4272. 
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7.6.2.1 Plasmid Construction 
The 3 PCR reactions of DsRed, HR5IE1 and 3xP3AmCyan involved the primers Table: 7.40.  
PCR amplification of DsRed (from OX3604, Figure: 7.3) and HR5IE1 (from OX3778, Figure: 
7.4) was performed in 50 µl of a mix containing 1X Herculase polymerase buffer, 2 mM 
MgCl2, 0.3 mM of each deoxynucleoside triphosphate, 0.33 µM of each primer, 1 µL of 
template DNA and 0.025 U of Herculase II Fusion DNA polymerase (Stratagene, Agilent 
Technologies).  The PCR mixtures were incubated for 70 seconds at 94 °C, followed by 2 
cycles of 30 seconds at 58 °C, 68 °C for 60 seconds, 2 cycles of 10 seconds at 94 °C, 30 
seconds at 55 °C, 68 °C for 60 seconds and 20 cycles of 10 seconds at 94 °C, 30 seconds at 
52 °C and 60 seconds at 68 °C with a final incubation of 6 minutes at 68°C.   The predicted 
sizes were 0.9 and 1.5 kb for DsRed and HR5IE1, respectively. 
PCR amplification of 3xP3AmCyan from OX3604 (Figure: 7.3) was performed in 50 µl of a 
mix containing 1X Taq DNA polymerase buffer, 2 mM MgCl2, 0.3 mM of each 
deoxynucleoside triphosphate, 0.33 µM of each primer, 1 µL of template DNA and 0.025 
U of Taq DNA polymerase (New England Biolabs).  The PCR mixtures were incubated for 
70 seconds at 94 °C, followed by 2 cycles of 30 seconds at 58 °C, 68 °C for 90 seconds, 2 
cycles of 10 seconds at 94 °C, 30 seconds at 55 °C, 68 °C for 90 seconds and 20 cycles of 
10 seconds at 94 °C, 30 seconds at 52 °C and 90 seconds at 68 °C with a final incubation of 
6 minutes at 68 °C.  The predicted size was 1.632kb. 
Table: 7.40. Primers used to amplify the sequences required in the female-specific 
marker. 
Sequence 
(Size of band) 




























































































Figure: 7.4.  The plasmid of OX3778. 
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The OX4272 PB(3xP3-AmCyan-HR5-IE1-Actin4intron-DsRed) construct was made by 
modifying OX3778 PB(HRIE-DR-vp16-TetO-Act4Pi-ubi-tTav2) (Figure: 7.4) by removing 
Ttav2.  The Ttav2 was removed using PmlI and XbaI (New England Biolabs), amplified 
DsRed was then inserted into the PmlI/XbaI site to create OX3778 PB(HRIE-DR-vp16-TetO-
AeActPi-ubi-DsRed).  HRIE-DR-VP16-TetO-AeActP was removed from OX3778 PB(HRIE-DR-
vp16-TetO-AeActPi-ubi-DsRed) using PacI and RsrII and HR5IE1 was inserted into the 
PacI/RsrII site to create OX3778 PB(HR5IE1-Act4i-ubi-DsRed).  Amplified 3xP3-AmCyan 
and OX3778 PB(HR5IE1-Act4i-ubi-DsRed) were then digested with PacI and NgomIV and 
3xP3-AmCyan was inserted into the PacI/NgomIV site of OX3778 PB(HR5IE1-Act4i-ubi-
DsRed) to create OX4272 PB(3xP3-AmCyan-HR5IE1-Act4intron-ubi-DsRed). 
All PCR and digest reactions were run on 0.8% agarose gel at 120V for 30 minutes and 
visualized using ethidium bromide under UV light.  Digestion bands and PCR reactions 
were purified using QIAquick Gel extraction kit (Qiagen, Crawley, West Sussex, UK) or 
using QIAquick PCR purification kit (Qiagen, Crawley, West Sussex, UK) eluted in 15 µl and 
30 µl of elution buffer, respectively.   
Products were ligated together using T4 DNA ligase (New England Biolabs) and cloned 
into XL-10-Gold Ultra-competent Cells (Stratagene, Agilent Technologies).  Bacterial 
colonies were PCR screened and individual colonies picked for screening were also used 
to inoculate LB broth with 100 µg ml-1 ampicillin and grown in a shaking incubator for 
several hours at 37 °C.  Six positive colonies were selected, 20 µl of the positive inoculate 
was used to inoculate 3 ml of LB with 100 µg ml-1 ampicillin.  The bacteria were grown 
overnight at 37 °C in a shaking incubator. 
DNA was extracted from 1 ml of the cultures by using the GeneJetTM Plasmid Miniprep kit 
(Fermentas, York, UK) and eluting in 50 µl of elution buffer.  Digestion of the plasmids was 
used to determine the correct insertion.  Positive digestions were sequenced using GATC 
Biotech (Germany). 
Bacteria expressing the final construct were used to inoculate 3 ml of LB with 100 µg ml-1 
of ampicillin.  The cultures were grown for 8 hours at 37 °C at 200 rpm, these cultures 
were then was used to inoculate 250 ml of LB with 100 µg ml-1 of ampicillin and grown 
overnight at 37 °C at 200 rpm.  DNA was extracted from 1 ml of the culture by using the 
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GeneJetTM Plasmid Miniprep kit and eluting in 50 µl of elution buffer and 1 ml was 
removed for a glycerol stock.  DNA was extracted from the remaining bacterial cells using 
the Endofree Plasmid Maxiprep kit (Qiagen, Crawley, West Sussex, UK) and eluting in 50 
µl of endotoxin-free water.  
Data was analysed using VectorNTi (Invitrogen). 
7.6.2.2 Microinjection of Asian WT Aedes aegypti mosquito eggs 
Asian WT Aedes aegypti mosquitoes were reared at 28 °C with 80% humidity.  The 
mosquitoes were blood fed 4 days before egg collection.  On the day of egg collection, 
damp filter papers (FisherBrand) were placed into cages and the cages placed in the dark.  
Eggs were allowed to mature and aligned for preparation for injections.  The eggs were 
then stuck to a cover slip using double sided tape, left to desiccate for 1-2 minutes and 
covered with halocarbon oil.  Eggs were injected (into the syncytial mass) with the 
injection solution (containing the 300 ng µl-1 of plasmid DNA, 700 ng µl-1 of helper mRNA, 
injection buffer [5 mM KCl and 0.1 mM NaH2PO4 pH 6.8] and water) using an Eppendorf 
microinjector.  Injected eggs were placed in water and transferred into a humidity box 
stored at 28 °C with 80% humidity to allow for recovery.  Eggs were hatched under a 
vacuum for 1 hour 3-5 days after injection with 2 droplets of Liquifry No 1 (Aquatics 
Warehouse).  Surviving mosquitoes were back-crossed with Asian WT, females were 
blood fed and the resulting eggs were hatched and screened.   
7.6.2.3 Genomic analysis of Aedes aegypti injected with OX4272 using PCR 
Only the transformation marker (3XP3AmCyan) was observed in the injected mosquitoes, 
therefore molecular analysis was conducted to determine why the transformation marker 
was visualized but not the sex-specific expression of DsRed. 
Two PCR reactions were performed each using 1 μl of genomic DNA (extracted using 
Nucleospin® Tissue kit) from male and female pupae and 24 μl of master mix.   
The master mix for the first PCR reaction consisted of 1X DreamTaq Buffer (Fermentas), 
7.5 pmole of the Act4intronF (5’-GAAGTTCTGATTCAGAACCATCTCTCATG-3’) forward and 
SeqRed2R (5’-CGATGAACTTCACCTTGTAGATGAAG-3’) reverse primer, 0.2 mM of each 
deoxynucleoside triphosphate and 1.5 U of DreamTaq ™ DNA polymerase (Fermentas).  
The second PCR reaction consisted of of 1X DreamTaq Buffer (Fermentas), 7.5 pmole of 
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the Act4intronF (5’-GAAGTTCTGATTCAGAACCATCTCTCATG-3’) primer and Red2midR (5’-
CCGTCCTCGAAGTTCATCACG-3’) reverse primer, 0.2 mM of each deoxynucleoside 
triphosphate and 1.5 U of DreamTaq ™ DNA polymerase (Fermentas). 
Both PCR mixtures were incubated for 60 seconds at 94 °C, followed by 3 cycles of 15 
seconds at 94 °C, 40 seconds at 58 °C, 72 °C for 60 seconds, 3 cycles of 15 seconds at 94 
°C, 40 seconds at 55 °C, 72 °C for 60 seconds and 35 cycles of 15 seconds at 94 °C, 45 
seconds at 52 °C and 60 seconds at 72 ° C with a final incubation of 6 minutes at 72 °C.   
7.6.2.4 Transcript analysis: Production of cDNA from RNA samples using SuperScript™ II 
RT (Invitrogen)  
RNA was extracted from OX3604 and OX4272 (injected 10/2/09 and injected 13/2/09) 
male and female pupae using TRI Reagent® according to the manufacturer’s instructions 
(Applied Biosystems).  Samples were kept at -80 °C.  The samples were treated with 
DNase to remove contaminating DNA from the samples.  After DNase treatment, the 
mixture consisting of 500 μg ml-1 of Oligo (dT), 5 μg of RNA and 12.5 pmole of dNTPs 
(made up in sterile distilled water) was heated to 65 °C for 5 minutes and chilled to 4 °C.  
First-Strand Buffer (1X), 0.01M DTT and RNaseOUT™ (40 U μl-1) were added and gently 
mixed and incubated at 25 °C for 2 minutes. Two hundred units of SuperScript™ II RT was 
added and mixed by pipetting.  The sample was then incubated at 25 °C for 10 minutes, 
followed by incubation at 42 °C for 50 minutes and a heat inactivation step of 15 minutes 
at 70 °C.  The cDNA was stored at -20 °C.   
7.6.2.5. Transcript analysis: Determination of DsRed expression using reverse 
transcriptase PCR and sequencing (assisted by Andrea Miles, Oxitec, Ltd). 
The RT-PCR reactions were performed using 1 μl of cDNA and 24 μl of Master mix.  The 
master mix consisted of 1X DreamTaq Buffer (Fermentas), 7.5 pmole of the ActRsR (5’-
GGTACAGTCGGACCGCCACCATGGAACCGAGGATAACGAGAAG-3’) forward and Red2midR 
(5’-CCGTCCTCGAAGTTCATCACG-3’) reverse primers, 0.2 mM of each deoxynucleoside 
triphosphate and 1.5 U of DreamTaq ™ DNA polymerase (Fermentas).  The PCR mixtures 
were incubated for 60 seconds at 94 °C, followed by 3 cycles of 15 seconds at 94 °C, 40 
seconds at 58 °C, 72 C° for 60 seconds, 3 cycles of 15 seconds at 94 °C, 40 seconds at 55 
°C, 72 C° for 60 seconds and 35 cycles of 15 seconds at 94 °C, 45 seconds at 52 °C and 60 
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seconds at 72 ° C with a final incubation of 6 minutes at 72 °C.  The predicted size was 1.1 
kb.   
Twenty micro litres of the PCR reactions were run on a 0.8% ethidium bromide agarose 
gel at 120V for 30 minutes.   
The correct bands were extracted using Qiagen QIAquick Gel extraction kit and eluted in 
10 µl of Buffer EB (Qiagen, Crawley, West Sussex, UK).  Pjet 1.2/Blunt cloning vector 
(Fermentas) and the PCR product were ligated together using T4 DNA ligase (New England 
Biolabs) at RT for 5 minutes.  The ligated product was then cloned into XL-10-Gold Ultra-
competent Cells (Stratagene, Agilent Technologies).   Bacterial colonies were PCR 
screened using the PjetFP2 (ATCAACTGCTTTAACACTTGTGC) forward primer and PjetRP2 
(AAAGAAGAACATCGATTTTCCATG) reverse primer by randomly removing individual 
colonies and dipping into the PCR mixture consisting of: 1X DreamTaq Buffer, 5 pmole of 
forward and reverse primers, 0.2 mM of each deoxynucleoside triphosphate and 2.5 U of 
DreamTaq ™ DNA polymerase (Fermentas).  The PCR mixtures were incubated for 60 
seconds at 94 °C, followed by 2 cycles of 15 seconds at 94 °C, 45 seconds at 60 °C, 68 °C 
for 90 seconds, 2 cycles of 15 seconds at 94 °C, 45 seconds at 57 °C, 68 °C for 90 seconds 
and 24 cycles of 15 seconds at 94 °C, 45 seconds at 54 °C and 90 seconds at 68 ° C with a 
final incubation of 6 minutes at 68 °C.  The predicted size was 1.3 kb.   
Five micro litres of the PCR reactions were run on a 0.8% ethidium bromide agarose gel at 
120V for 20 minutes. 
Individual colonies picked for screening were also used to inoculate LB broth as described 
in section 7.6.2.1. DNA was extracted from 1 ml of the cultures by using the GeneJetTM 
Plasmid Miniprep kit (Fermentas, York, UK) and eluting in 50 µl of elution buffer. 







7.6.3 Results: Production of a Female-specific Marker in Asian Aedes aegypti 
7.6.3.1 Injection of OX4272  
Two independent transgenic lines were established using the construct OX4272 
(Appendix: 7.6.2, Figure: 7.2).  Approximately, 6000 eggs were injected and ~800 larvae 
hatched.  Approximately 200 male and 500 female mosquitoes survived to adulthood to 
be crossed with wild-type Asian Aedes aegypti.  The progeny (G1) were screened for the 
transformation marker with approximately 300 larvae expressing the 3XP3AmCyan 
marker.  OX4272-1 showed eye and anal papillae expression of Cyan (Figure: 7.5) and 
OX4272-2 showed eye expression only. Expression was monitored daily through to pupae; 


















a)                                                                     b) 
           
c)                                                                           d)                        
           
   e)                                               f)                                           g) 
       
Figure: 7.5. Expression of 3XP3AmCyan in OX4272-1 a) female pupae under white light 
b) female pupae using the filters for cyan fluorescence one pupa (left) showing the 
expression of 3XP3AmCyan c) male pupae under white light d) male pupae, one pupa 
(left) showing the expression of 3XP3AmCyan e) Larvae under normal view f) Larvae, 
one larva (left) showing the expression of 3XP3AmCyan g) Showing the expression of 
AmCyan in the optic nerve.    *Courtesy of Amandine Collado, Oxitec Ltd* 
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7.6.3.2 Reverse transcriptase PCR analysis of transgenic OX4272 
Molecular analysis of this line was conducted by extracting RNA and genomic DNA of 
pupae explained in Section: 7.6.2.3, 7.6.2.4 and 7.6.2.5.  The genomic PCR amplifying the 
Actin4 intron and DsRed showed that the transgenic line was a real transgenic as the 
same sized band (700 bp) was observed in the original DNA (4272 Maxiprep) used for the 
injections (Figure: 7.6).  However, no DNA was amplified in OX3604 which carried the 
same gene (Actin4 intron-DsRed), the amplified product was also greater than expected 
(700 bp). 
Reverse trancriptase (RT) PCR was also conducted to confirm that Line 1 and 2 did not 
express DsRed.  The sequence containing the splicing region (Actin4 intron) and DsRed 
was amplified.  Two bands were observed when the RT-PCR was conducted, the top band 
(1 kb) was dominant and the bottom band was very faint (Figure: 7.7).  Both these bands 
were cloned and sequenced and confirmed that the top band was the male-specific 
spliced transcript of DsRed and the second faint band was the female-specific transcript.  
Therefore, the DsRed expression was not observed in females as both males and females 
pre-dominantly expressed the male-specific transcript which meant that the DsRed gene 















Figure:  7.6. Actin4 intron and DsRed detection by PCR using the primers Act4intron-F and 
SeqRed2R (PCR A) and Act4intron-F and Red2MidR (PCR B).  Separation conditions 0.85% 
agarose gel, 1 X TAE using a separation voltage of 120.  Size detection using 1kb DNA ladder 




Figure: 7.7. DsRed expression detection using agarose gel electrophoresis.  Separation 
conditions 0.85% agarose gel, 1 X TAE using a separation voltage of 120.  Size detection using 
1kb DNA ladder (SMART). Two bands were detected in 4272 (L1) Female after RT-PCR using the 
primers ActRsR and Red2MidR. Both fragments were gel extracted, cloned (pJET) and 
sequenced.  
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The final aim of this thesis was to produce a successful female marker to allow for sex 
sorting during L4-pupae stage, however this proved unsuccessful at the time with 
transgenics only expressing the transformation marker. Unfortunately, the use of a 
female specific splicing region preceding the DsRed marker did not create female-specific 
expression and in fact, the partial splicing which occurs in male mosquitoes dominated. 
This result could be due to that fact that the insertion was incorrect or in the incorrect 
orientation, therefore an increase in the number of injections may increase the 
probability of obtaining a transgenic line which expresses DsRed in females.   
An alternative sex-specific marker was also constructed and tested using the splicing 
region for the Doublesex (dsx) gene, a double-switch gene at the bottom of the sex-
determination cascade that determines the differentiation of sexually dimorphic traits 
(Scali et al., 2005).  These transcripts are sex-specifically spliced in male and females (Scali 
et al., 2005).  This concept was used to create sex specific transcripts with DsRed 
expression under the Hr5IE1 promoter (Immediate early promoter 1) in male Aedes 
aegypti.  While 2000 eggs were injected, no transgenic mosquitoes were produced either 
and no transformation was observed.   
To obtain a suitable marker which will work successfully, alternative methods will need to 
be tested:  an example is the use of the alcohol dehydrogenase gene/aldehyde 
dehydrogenase (Komitopoulou et al., 2004; Robinson and Van Heemart 1981; Robinson et 
al., 1986) to increase the tolerance of one sex to alcohol, the addition of alcohol would 
then eliminate one sex and leave the required sex.    
 This may be more successful if an alternative spicing region is used rather than Doublesex 
(dsx).  This method could prove to be more advantageous when sex sorting if the female 
larvae die and do not require observations using fluorescence to determine the sex of the 
mosquito unlike the female-specific DsRed marker and a testis specific marker associated 
with the β-tubulin promoter (Smith et al., 2007).  However, ethanol exposure may be 
costly and may impact the fitness of the male insects.   
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Until the successful transformation of Aedes aegypti to create a sex-specific marker, the 
only method available is to use a pupal sorter to separate sexes by size (females larger 
than males) (Sharma et al., 1972).    
7.6.5 Conclusion 
The unsuccessful generation of a female-specific marker in Aedes aegypti indicate that 
























AMPs – Antimicrobial peptides 
ANCOVA - Analysis of covariance 
ANOVA - Analysis of variance 
dsx -Doublesex 
GO- Gene Ontology 
IMD – Immune deficiency 
IL – Interleukin 
KW – Kruskall Wallis test 
MAPK – Mitogen activated protein kinase 
MWU – Mann Whitney U test 
PCR – polymerase chain reaction 
PGRP – Peptidoglycan recognition protein 
PI3K – Phosphoinositide 3 kinase 
qRT-PCR – Quantitative reverse transcriptase polymerase chain reaction 
RT-PCR – Reverse transcriptase PCR 
TGFβ – Tumour growth factor β 
TNFα – Tumour necrosis factor α 
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